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ABSTRACT 
 Fluorescence-based imaging techniques provide a simple, highly sensitive 
method of studying live cells and whole organisms in real time. Without question, 
fluorophores such as GFP, fluorescein, and rhodamines have contributed vastly 
to our understanding of both cell biology and biochemistry. However, most of the 
fluorescent molecules currently utilized suffer from one major drawback, the use 
of visible light. Due to cellular autofluorescence and the absorbance of incident 
light by cellular components, fluorescence imaging with visible wavelength 
fluorophores often results in high background noise and thus a low signal-to-
noise ratio. Fortunately, this situation can be ameliorated by altering the 
wavelength of light used during imaging. Near-infrared (NIR) light (650-900 nm) 
is poorly absorbed by cells; therefore, fluorophores excited by this light provide a 
high signal-to-noise ratio and low background in cellular systems. While these 
properties make NIR fluorophores ideal for cellular imaging, most currently 
available NIR molecules cannot be used in live cells.  
 The first half of this thesis addresses the synthetic difficulties associated 
with preparing NIR fluorophores that can be used within living systems. Small 
molecule NIR fluorophores are inherently hydrophobic which makes them 
unsuitable for use in the aqueous environment of the cell. Water-solubility is 
imparted to these dyes through highly polar sulfonates, which subsequently 
prevents the dyes from entering the cell. The novel work presented here details 
vii 
 
synthetic routes to aid in the development of sulfonated NIR fluorophores, which 
can be delivered into live cells through the inclusion of an esterase-labile 
sulfonate protecting group. Application of these synthetic techniques should allow 
for the development of novel NIR fluorophores with intracellular applications. 
 The second half of this thesis addresses the need for novel NIR imaging 
reagents. Although several classes of NIR scaffolds do exist, most NIR probes 
are derivatives of a single class, heptamethine indocyanines. The work described 
here increases this palette by displaying the ability of NIR oxazines to function as 
an imaging reagent in live cells and in vivo and as a molecular sensor of 
biologically-relevant environmental conditions. Combined, the work contained 
herein has the capacity to not only advance the current NIR toolkit, but to expand 
it so that fluorescence imaging can move out of the dark and into the NIR light.  
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CHAPTER I: Introduction 
Fluorescence  
 Fluorescence is formally defined as a type of luminescence, the emitting 
of light by any substance not resulting from temperature increases, which results 
from photon absorption and occurs from an excited singlet state (Lakowicz, 
2006). This definition is best visualized using a Jablonski diagram, which 
describes molecular processes that can occur after electron excitation (Figure 
1.1). The vast majority of molecules exist in a singlet ground state (S0), which is 
simply an electronic state having all electron spins paired. Upon absorbing a 
photon (upward solid arrows), an electron will be promoted to a higher singlet 
energy level (Sn>0). Once excited, the electron can return to the ground state by a 
variety of methods, both non-radiative (wavy arrows) and radiative (downward 
solid arrows). When the electron returns from Sn>0 back to S0 via photon 
emission, the radiative relaxation is referred to as fluorescence.   
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Figure 1.1: Jablonski diagram illustrating electronic processes occurring 
after photon absorption. Solid arrows: photon absorption/emission. Wavy 
arrows: non-radiative energy pathways. Adapted with permission from Dr. 
Kendric C. Smith of Stanford University School of Medicine from 
http://www.photobiology.info/Photochem.html. 
 
 From the Jablonski diagram, it might appear that fluorescence could occur 
from any molecule that can absorb light (Figure 1.1). However, fluorescence is 
highly dependent on molecular structure and, in practice, is generally limited to 
structurally constrained molecules possessing a high degree of conjugation; e.g., 
aromatic compounds (Lakowicz, 2006; Nijegorodov and Downey, 1994; 
Nijegorodov et al., 2006; Sauer et al., 2011). The key feature of highly 
conjugated and aromatic molecules is the extended π-orbital system, which 
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results in an energy decrease between electronic energy levels. This energy 
decrease allows these molecules to absorb lower energy, non-ionizing radiation 
(Sauer et al., 2011). Another structural characteristic of fluorescent molecules 
results from the geometric constraints brought about by higher bond orders. 
Highly conjugated molecules in general, and fluorescent molecules in particular, 
tend to be planar. This structural feature favors fluorescence as the planarity of 
the molecule also applies to the π-orbital system; i.e., the π orbitals will tend to 
lie within the same plane (Figure 1.2) (Sauer et al., 2011). This trait is generally 
associated with electron delocalization, as observed for molecules like benzene. 
As delocalization results in resonance stabilization, the planarity produced by 
conjugation further contributes to energy decreases between electronic orbitals. 
While these features favor the production of fluorescence, they have a 
detrimental effect on the use of these molecules in biological systems, as will be 
highlighted later. 
 
 
 
 
Figure 1.2: π-orbital system of conjugated molecules. Organic molecules 
showing the extended pi-orbital system resulting from conjugation. Left side: 
Benzene. Right side: Octa-1,3,5,7-tetraene.  
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 Fluorescence has unique characteristics that distinguish it from other 
forms of luminescence. Since fluorescence is a singlet to singlet transition, 
photon emission is extremely rapid, occurring on the order of nanoseconds 
(Lakowicz, 2006). This is compared with phosphorescence, shown in Figure 1.1 
as relaxation from an excited triplet state (Tn≠0), which usually occurs on the 
order of milliseconds to seconds (Lakowicz, 2006). Furthermore, since 
fluorescence only involves electron excitation and relaxation, the fluorescent 
molecule, or fluorophore, is not limited to a single fluorescent event. This is 
contrasted with chemiluminescence and bioluminescence in which light emission 
occurs as a result of a chemical reaction and thus the light-emitter is of single 
use (Figure 1.3). The rapid response time and extended reagent life has made 
fluorescence a useful tool for biology, a feature which will be discussed in greater 
detail below. 
 
 
 
 
Figure 1.3: Methods of molecular luminescence. A. Fluorescence or 
phosphorescence. B. Chemiluminescence: reaction of hydrogen peroxide with 
luminal. C. Bioluminescence: luciferase/D-luciferin reaction. * indicates excited 
state molecule/ion, hν: light, i: initial wavelength/energy, f: final 
wavelength/energy.  
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Fluorescence and Biology 
 Fluorescence is, without doubt, one of the most indispensible tools 
employed in biology. The use of fluorescence has allowed us to sequence 
genomes, monitor protein folding, examine DNA and protein binding interactions, 
study protein localization and kinetics, quantitate gene expression, and peer into 
whole cells and organisms (Fei and Gu, 2009; Fernández-Suárez and Ting, 
2008; Franca et al., 2002; Ntziachristos, 2006; Prendergast, 1991; Rao et al., 
2007; Zimmer, 2002). In addition to basic research, fluorescence has made direct 
contributions to human health. For example, the near-infrared fluorescent 
Indocyanine Green is an FDA approved contrast reagent and has been 
employed during diagnostic and surgical procedures (Figure 1.4) (Marshall et al., 
2010; Ohba et al., 2012; Zehri et al., 2014). Of all these roles, it is in the arena of 
cellular imaging that fluorescence has made its greatest impact. 
 
 
Figure 1.4: Indocyanine Green (ICG). 
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 Fluorescence has provided biologists with the opportunity to image cells 
with detail unattainable by more classical techniques, such as bright and dark 
field microscopy (Perlasamy, 2001). This is because fluorescence imaging 
employs light emitting contrast agents, fluorophores, which can be designed to 
label proteins and DNA, a feature that has allowed the imaging of individual 
molecules within their native environments (Ntziachristos, 2006; Perlasamy, 
2001). In fact, due to the advancements in instrumentation associated with 
fluorescence microscopy, we are now even able to image single molecules within 
cells (Ntziachristos, 2006; Perlasamy, 2001). With the advent of fluorescent 
proteins, cell biologists have even been able to monitor the intracellular 
environment, in real time, without the need of additional interrogating agents 
(Ntziachristos, 2006; Zimmer, 2002). 
 The contributions of fluorescence imaging are not limited to cells. Non-
fluorescent microscopy techniques are of little use when imaging whole 
organisms (Hilderbrand and Weissleder, 2010; Ntziachristos, 2006). However, as 
certain wavelengths of light have the ability to penetrate through tissue, 
fluorescence has allowed us to non-invasively peer into the inner workings of 
whole organisms (Frangioni, 2003; Hilderbrand and Weissleder, 2010; 
Ntziachristos, 2006). For example, Indocyanine Green is used both for imaging 
liver function and as a general contrast agent for angiograms (Marshall et al., 
2010). Likewise, current work on long wavelength fluorescent proteins will soon 
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allow us to non-invasively image deeper into a living organism than has ever 
been performed in a laboratory setting.  
 There are primarily two imaging techniques employed in biological 
research: fluorescence and bioluminescence. Fluorescence has several aspects 
that make its use preferable over bioluminescence. Fluorescence is rapid, with 
light emission occurring within 10-8 to 10-9 seconds (Lakowicz, 2006). This is 
faster than most enzyme-catalyzed reactions; therefore, compared to the 
enzyme-catalyzed bioluminescence, fluorescence imaging occurs in real time. 
Fluorescence is also much brighter than bioluminescence, which means for the 
same image, less fluorophore and less time is required when employing 
fluorescence as the imaging method (Sullivan, 2007). Most importantly, 
fluorescence is inherent to the molecule. Unlike bioluminescence, which requires 
the reaction of luciferase with luciferin to generate light, a fluorescent protein is 
itself fluorescent. This means that getting signal via fluorescence imaging will not 
be dependent on a cofactor diffusing through a cell membrane and locating an 
enzyme (Lee, 2008). All these features favor the use of fluorescence for live cell 
and in vivo imaging because they all offer the promise of visualizing the subject 
with the least amount of perturbation.   
Flaws in Fluorescence Imaging Techniques 
 Despite all the benefits of fluorescence-based imaging techniques, using 
fluorescence to investigate cells and whole organisms has several drawbacks. 
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Fluorescence imaging generally employs visible (400-650 nm) light. Visible 
wavelength radiation, particularly wavelengths between 400-500 nm, has been 
found to produce genotoxic effects similar to those caused by UV radiation (Botta 
et al., 2009; Pflaum et al., 1994; Pflaum et al., 1998). This is significant, as the 
frequently employed enhanced Green Fluorescent Protein (EGFP) is excited by 
light with these toxic wavelengths (excitation: 488 nm) (Figure1.5). Other well-
known fluorophores including 4’,6-diamino-3-phenylindole (DAPI) (excitation: 358 
nm), Fluorescein (excitation: 494 nm), and Cy2 (excitation: 492 nm) also require 
the input of light that is inherently dangerous to biological systems (Figure 1.5). 
Employing an input that damages the very system under interrogation 
undoubtedly calls into question the utility of the technique as well as the results 
obtained from severely disrupted cells. 
 
 
 
Figure 1.5: Commonly employed fluorophores for biological imaging. 
 
 The issue of phototoxicity is easily addressed by using fluorophores 
excited by less phototoxic, longer wavelength radiation (500-650 nm). However, 
phototoxicity is not the only problem encountered when imaging with visible 
wavelength fluorophores. Cells and organisms contain many molecules that emit 
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visible light (Monici, 2005). These endogenous compounds include, but are not 
limited to, reduced nicotinamide adenine dinucleotide phosphate (NADPH), 
pteridine derivatives such as flavins, porphyrins, and proteins containing high 
quantities of aromatic amino acids (Andersson-Engels et al., 1997; Monici, 2005). 
The fluorescence of endogenous compounds, termed autofluorescence, is highly 
problematic for both the technique and results obtained from fluorescence 
imaging as it profoundly decreases the signal to noise ratio of exogenous 
fluorophores and thus lowers image resolution (Frangioni, 2003) (Figure 1.6). 
 
 
 
Figure 1.6: Autofluorescence of live 3T3B cells. Image obtained with Zeiss 
fluorescence microscope using a UG1 excitation filter (360 nm), a 420 nm 
dichroic filter, and a long pass emission filter (418 nm). Image adapted from 
(Aubin, 1979).  
 
 While the use of visible light for imaging live cells has some limitations, its 
utility in living organisms is almost completely hindered due to light scattering, 
10 
 
autofluorescence, and the absorbance of excitational light by molecules such as 
hemoglobin (Dobrucki, 2007; Escobedo et al., 2010; Frangioni, 2003; 
Ghoroghchian et al., 2009; König, 2000; Rao et al., 2007; Tromberg et al., 2000). 
In live cells and organisms, visible light undergoes extensive scattering due to 
interactions with non-homogenous particles, such as organelles and tissue 
components (Cheong et al., 1990; Dobrucki, 2007; Ghoroghchian et al., 2009). 
Due to photon spreading produced by light scattering, imaging with visible light is 
associated with low spatial resolution and plagued by high autofluorescence 
(Dobrucki, 2007; Genina et al., 2008; Jansen et al., 2006; Tromberg et al., 2000). 
Light scattering however is not the only cause of autofluorescence.  As with live 
cells, organisms are composed of molecules that can emit visible light upon 
direct excitation. In fact, autofluorescence in whole organisms occurs to such a 
high extent that deconvoluting light from exogenous versus endogenous 
fluorophores becomes almost impossible (Frangioni, 2003).  On top of these 
obstacles, the high absorbance of visible light by biological components, such as 
oxyhemoglobin, minimizes the availability of photons for the excitation of 
exogenous fluorophores (Figure 1.7) (Frangioni, 2003; König, 2000; Tsai et al., 
2001). Due to these complications, imaging organisms with visible light is 
inefficient beyond the most peripheral locations. 
 However, fluorescence imaging of organisms is possible. We have already 
noted that diagnostic and surgical procedures have been performed using 
Indocyanine Green as a contrast agent (Marshall et al., 2010; Ohba et al., 2012; 
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Zehri et al., 2014). The feature of this dye that makes in vivo fluorescence 
imaging possible is that it is not a visible wavelength fluorophore. Indocyanine 
Green can be used for imaging because it absorbs and emits NIR light.  
    
 
 
 
Figure 1.7: Absorbance spectra of melanin, oxyhemoglobin (HbO2), and 
water. Figure adapted from (König, 2000). 
  
 Near-infrared Light 
 Over the last two decades, fluorescence imaging with near-infrared (NIR) 
light (650-900 nm) has risen to the forefront of biology as a superior alternative to 
visible light (Escobedo et al., 2010; Frangioni, 2003; Guo et al., 2014; Rao et al., 
2007; Weissleder, 2001). NIR radiation has several extremely important features 
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that support the use of fluorophores capable of absorbing and emitting these 
wavelengths. Very few biological molecules absorb NIR light (König, 2000; 
Zhang et al., 2012). As phototoxicity results from the excitation of biological 
molecules, the limited absorption of NIR radiation means a drastic decrease in 
cell damage and death (Guo et al., 2014). This increase in cell viability easily 
translates to a higher degree of experimental reliability and clearly explains why 
NIR should be favored for imaging.  
 However, the poor absorbance of NIR light by biological components does 
not simply affect cell viability; it directly enhances the results obtained through 
imaging. Background autofluorescence is minimized when using NIR light for 
imaging because NIR light does not excite endogenous compounds to any great 
extent (Escobedo et al., 2010; Frangioni, 2003; Guo et al., 2014; Rao et al., 
2007; Zhang et al., 2012). This feature was best exemplified by Frangioni 
imaging a mouse containing no exogenous fluorophores with visible and NIR 
light (Figure 1.8) (Frangioni, 2003). Only the NIR filter set provided an image 
without interfering autofluorescence. This result clearly presents the advantages 
of imaging with NIR light. 
 
13 
 
 
 
Figure 1.8: Near-infrared light produces little to no autofluorescence 
background in whole organisms. Mouse was not treated with any exogenous 
fluorophores. After sacrificing, the mouse was immediately imaged using the 
following filter sets (b) Excitation: 460-500 nm/Emission: 505-560 nm, (c) 
Excitation: 525-555 nm/Emission: 590-650 nm, (d) Excitation: 725-775 
nm/Emission: 790-830 nm. Image adapted from (Frangioni, 2003).  
 
 Poor absorbance of NIR light by biological components has yet another 
advantage. As mentioned above, hemoglobin is one of the primary deterrents to 
using visible wavelength fluorophores in living organisms (Frangioni, 2003; 
König, 2000; Pansare et al., 2012; Tsai et al., 2001). However, Figure 1.7 shows 
that hemoglobin only poorly absorbs NIR light (König, 2000). This means that 
fluorophores that absorb and emit NIR radiation can be employed in live animals 
(Frangioni, 2003; König, 2000; Pansare et al., 2012). Indeed, this is the primary 
reason that Indocyanine Green can be used as a biomedical contrast agent 
(Marshall et al., 2010). 
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 The poor absorption of NIR light by hemoglobin and other tissue 
components means that NIR light can penetrate further into tissue than visible 
light (Frangioni, 2003; Guo et al., 2014; König, 2000; Pansare et al., 2012; Peng 
and Draney, 2004; Zhang et al., 2012. This feature is further enhanced due to a 
decrease in light scattering associated with NIR wavelengths (Escobedo et al., 
2010; Ghoroghchian et al., 2009; Peng and Draney, 2004). As described in 
Equation 1.1, 
1.1)           4/1 λ∝I  
scattering intensity from an excitation source is inversely proportional to the 
fourth power of wavelength (Ghoroghchian et al., 2009). Thus, compared to 
visible light, the longer wavelength NIR excitational light will experience a much 
smaller decrease in photon intensity when employed in biological media (Peng 
and Draney, 2004). With decreased autofluorescence, decreased excitational 
light absorption and scattering, and decreased phototoxicity, the case for using 
NIR light for cellular and whole organism imaging is not a difficult one to present. 
Strangely, compared to visible wavelength fluorophores, the NIR toolkit is 
relatively bare. 
NIR Fluorophores   
  Whereas multiple visible wavelength absorbing/emitting fluorophores can 
be found dispersed among a wide variety of classes including: acridines, 
alizarins, boron-dipyrromethenes (BODIPYs), cyanines, fluoresceins, oxazines, 
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rhodamines, and a large variety of fluorescent proteins (DsRed, GFP, RFP, YFP, 
etc.), the list of NIR absorbing/emitting fluorophores is much smaller (Figure 1.9). 
There are primarily four classes of NIR fluorophores: BODIPYs, cyanines, 
phthalocyanines, or squaraines, and of this group, only indocyanine derivatives 
are employed in fluorescence imaging to a great extent (Figure 1.10) (Guo et al., 
2014; Escobedo et al., 2010; Pansare et al., 2012; Peng and Draney, 2004; Rao 
et al., 2007; Zhang et al., 2012). Encouragingly, there has been work in 
increasing the NIR scaffold toolkit and there are now a handful of NIR fluorescent 
proteins, oxazines, and most recently, silicon-rhodamines (Si-rhodamines) 
(Figure 1.10) (Escobedo et al., 2010; Koide et al., 2011; Koide et al., 2012; Luo 
et al., 2011; Pansare et al., 2012; Peng and Draney, 2004; Piatkevich et al., 
2013; Rao et al., 2007; Shcherbakova and Verkhusha, 2013; Zhang et al., 2012). 
Each of these classes has features that favor and deter their use in biological 
imaging. 
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Figure 1.9: Examples of visible light absorbing/emitting organic 
fluorophores. Wavelengths obtained from 
http://www.olympusfluoview.com/theory/fluorochromedata.html 
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Figure 1.10: Examples of NIR organic fluorophores. Structures from (Koide et 
al., 2012; Luo et al., 2011; Marmé et al., 2003). 
 
 Squaraines dyes, recognizable by their characteristic oxocyclobutenolate 
core, have chemical and photophysical characteristics that should make them 
ideal imaging reagents (Luo et al., 2011; Pansare et al., 2012; Zhang et al; 
2012). These fluorophores generally have high extinction coefficients and 
quantum yields, which gives them desirably bright fluorescence (Luo et al., 2011; 
Pansare et al., 2012; Zhang et al; 2012). They also tend to be very photostable, 
which makes them well suited for biological applications requiring extended 
imaging times (Pansare et al., 2012). Both the central cyclobutene ring, as well 
as the terminal aryl groups can be functionalized, making these compounds 
prime targets for use as probes (Luo et al., 2011; Zhang et al., 2012). 
Unfortunately, due to their structural planarity and high degree of conjugation, 
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these compounds are notoriously insoluble in water, limiting their usefulness 
within cells and organisms (Luo et al., 2011; Pansare et al., 2012). Work has 
been done to increase their water-solubility through the addition of negatively 
charged groups, such as sulfonates, but this appears to have a detrimental effect 
on their fluorescence intensity (Pansare et al., 2012). 
 Phthalocyanines are porphyrin derivatives which have found use in both 
research and medicine (Allen et al., 2001; Escobedo et al., 2010; Whitacre et al., 
2000). These compounds are renowned for their high photostability and large 
extinction coefficients (Luo et al., 2011; Peng and Draney, 2004). Unfortunately, 
these molecules are hydrophobic and often aggregate in aqueous environments 
(Peng and Draney, 2004). Functionalization of these dyes with polar groups have 
led to increased solubility in water; however, due to their ability to function as 
photosensitizers, their use as imaging reagents can result in phototoxic side 
effects (Allen et al., 2001; Escobedo et al., 2010; Luo et al., 2011; Whitacre et al., 
2000). 
   Cyanines, particularly heptamethines, are without question the most 
commonly employed NIR dyes in biology (Luo et al., 2011; Peng and Draney, 
2004). This class contains the well known imaging reagents IR-780 and IR-783 
that have been employed as scaffolds for developing fluorescent sensors of 
metal ions, nitric oxide, and hydrogen peroxide (Karton-Lifshin et al., 2011; Li et 
al., 2011; Sasaki et al., 2005). This class also contains Indocyanine Green, the 
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only NIR dye approved for use in humans (Marshall et al., 2010; Ohba et al., 
2012; Zehri et al., 2014). Cyanine dyes are celebrated for their high extinction 
coefficients and long wavelength fluorescence (Luo et al., 2011; Pansare et al., 
2012). However, they tend to have low photostability, poor water solubility, and 
low quantum yields in aqueous environments (Luo et al., 2011; Pansare et al., 
2012; Peng and Draney, 2004). Some of these problems have been addressed 
through sulfonation of the dye scaffold, which has led to the development of 
multiple water-soluble cyanine derivatives, including the commercially available 
Alexa Fluor® dyes (Molecular Probes) (Mujumdar et al., 1993). However, 
sulfonated molecules are generally unable to diffuse through cellular 
membranes, which prevents these dyes from being employed in live cell imaging 
(Stolz, 2001; Wuhrmann et al., 1980). 
 There are a growing number of NIR BODIPY scaffolds available for 
fluorescence imaging (Ni and Wu, 2014). BODIPYS are famous for their bright 
fluorescence, high quantum yield, and high photostability (Luo et al., 2011; Ni 
and Wu, 2014; Pansare et al., 2012). Even in water, these dyes are reported to 
have a quantum yield approaching unity (Luo et al., 2011). However, the 
BODIPY scaffold is among the least water-soluble of all the dyes listed above 
and increasing conjugation to obtain NIR absorbance and emission only 
enhances this negative feature (Luo et al., 2011; Ni and Wu, 2014; Pansare et 
al., 2012).  
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 The pentacyclic oxazine scaffold is a NIR fluorophore with great potential 
for live cell and in vivo imaging (Hintersteiner et al., 2005, Stöhr et al., 2010; van 
de Linde et al., 2012). This dye has several properties that favor its use as a 
cellular imaging reagent. It has a compact structure which minimizes the 
hydrophobic surface area available for dye aggregation (Peng and Draney, 
2004). Ring pucker from the terminal azacyclohexane rings further helps to 
alleviate aggregation in aqueous environments (Figure 1.11). Oxazines also 
exhibit high photostability and bright NIR fluorescence (Anzalone et al., 2013; 
Escobedo et al., 2010; Vogelsang et al., 2009). Despite these features, this dye 
is rarely employed for NIR imaging. 
 
 
 
Figure 1.11: Ring pucker from the terminal azacyclohexane rings of the 
pentacyclic oxazine scaffold. 
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 One of the newest classes of NIR dyes are silicon analogs of rhodamines 
(Si-rhodamines) (Koide et al., 2011; Koide et al., 2011; Koide et al., 2012). These 
dyes owe their NIR absorption and emission to hyperconjugation induced by a 
central silicon, which results in an extensive decrease in the energy difference 
between the ground and excited states (Guo et al., 2014; Koide et al., 2011; 
Koide et al., 2011; Koide et al., 2012). As the increased conjugation does not 
require addition of polymethine chains or aromatic rings, the hydrophobicity of 
these compounds compared to their visible wavelength conjugates would not be 
expected to differ to any great extent. These new fluorophores have already 
been used in the preparation of ion sensors (mercury and calcium) and have 
even shown promise for imaging in live cells (Egawa et al., 2011; Guo et al., 
2014; Koide et al., 2011; Koide et al., 2012). 
 NIR fluorescent proteins are among the most desired of developments for 
the field of imaging. No single molecule has made such an impact on biology as 
the Green Fluorescent Protein, and proteins that could absorb and emit NIR light 
would circumvent the problems associated with this marvel of science (Tsien, 
1998; Zimmer, 2002). To date though, there are still very few of these molecules 
available. Little success has been achieved to manufacture GFP-type proteins 
that absorb in the NIR, although there are some that emit in the far-red (Wu et 
al., 2011). The greatest success thus far has been through the use of bacterial 
phytochrome photoreceptors (BphPs) (Shcherbakova and Verkhusha, 2013). 
These macromolecules are showing promise, but they tend to have very low 
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quantum yields and require an additional cofactor in order to become fluorescent 
(Shcherbakova and Verkhusha, 2013). 
Flaws of NIR Fluorophores 
 Although NIR light is ideal for imaging in live cells and organisms, it is 
clear from the above survey of those currently available, that NIR fluorophores 
are not ideal imaging reagents (Weissleder, 2001). Most of these molecules are 
poorly water soluble, which results from the high degree of conjugation and 
structural planarity required for the absorbance of low energy radiation (Sauer et 
al., 2011). Unfortunately, since cells and organisms are primarily aqueous, 
hydrophobic dyes are not a suitable imaging tool. Another problematic feature of 
NIR dyes is that they tend to be cationic (Figure 1.10). This presents a challenge 
for imaging live cells because these compounds will tend to be attracted to and 
localize in the negatively polarized mitochondrial membrane (Bunting et al., 
1989). The hydrophobic and cationic nature of these molecules will therefore 
produce high background fluorescence resulting from membrane and 
mitochondrial staining (Bunting et al., 1989; Cunningham et al., 2010; Escobedo 
et al., 2010; Jiang et al., 2013; Johnson, 1998). The primary method used to 
increase water-solubility and eliminate the cationic charge of the dye is to modify 
the scaffold with highly polar sulfonate groups (Li et al., 2008; Morgan et al., 
2011; Mujumdar et al., 1993; Niu et al., 2009; Panchuk-Voloshina et al., 1999). 
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While this is a successful strategy, it prevents the molecules from traversing 
cellular membranes (Stolz, 2001; Wuhrmann et al., 1980).   
Summary 
 Apart from the flaws discussed above, a key feature lacking in the NIR 
toolkit is diversity. While there are several different NIR scaffolds, most 
fluorophores targeted for use in imaging are indocyanine derivatives. This results 
in a very limited chemical palette. The feature most needed for biological imaging 
is a greater choice of imaging reagents. With choice comes opportunity and NIR 
imaging offers science the opportunity to examine live cells and organisms in 
much greater detail than can be obtained with visible light.   
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CHAPTER II: A trifluoroacetic acid-labile sulfonate protecting group and its 
use in the synthesis of a near-IR fluorophore 
 
 
 
 
 
Summary 
 Sulfonated molecules exhibit high water solubility, a property which is 
valuable for many biological applications, but often complicates their synthesis 
and purification. Here, we report a sulfonate protecting group that is resistant to 
nucleophilic attack, but is readily removed with trifluoroacetic acid (TFA). The use 
of this protecting group improved the synthesis of a sulfonated near-IR 
fluorophore and the mild deprotection conditions allowed isolation of the product 
without requiring chromatography.  
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Introduction 
 Sulfonation of hydrophobic fluorescent dyes greatly improves both their 
solubility and fluorescence properties in aqueous media (Li et al., 2008; Morgan 
et al., 2011; Mujumdar et al., 1993; Niu et al., 2009; Panchuk-Voloshina et al., 
1999). However, sulfonated molecules can be tedious to prepare and purify 
because their high polarity often necessitates the use of aqueous conditions 
during synthesis and purification. For example, we found that HPLC was required 
for purification of sulfonated oxazine near-IR fluorophores such as 1 (Figure 2.1) 
(Pauff and Miller, 2011). On the other hand, purification of stable sulfonate ester 
dyes such as 2 was possible via conventional silica gel flash chromatography 
(Figure 2.1) (Pauff and Miller, 2011). Thus, the synthesis of sulfonated molecules 
could be aided by a protecting group which allows solubility in standard organic 
solvents and purification by conventional chromatography, but is readily removed 
in a final cleavage step that does not itself require HPLC purification. 
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Figure 2.1: Bis-sulfonate oxazine (1) and bis-sulfonate ester (2). 
 
 
 Compared to carboxylates, there are relatively few choices for sulfonate 
protecting groups (Green and Wuts, 1999). Sulfonate esters are generally highly 
reactive electrophiles that alkylate a wide range of nucleophilic molecules. 
Protecting groups currently available for sulfonates all have caveats that limit 
their general applicability (Miller, 2010). Isopropyl (iPr) and isobutyl (iBu) 
sulfonates retain lability to nucleophiles, while trichloroethyl (TCE) sulfonates are 
unstable to mildly basic conditions (Ali et al., 2009; Musicki and Widlanski, 1990; 
Simpson and Widlanski, 2006; Xie and Widlanski, 1996). Neopentyl (Neo) groups 
are highly stable to nucleophiles but removal requires either strongly acidic 
conditions or heating in DMF with strong nucleophiles (Ali et al., 2009; Miller, 
2010; Roberts et al., 1997; Simpson and Widlanski, 2006). Trifluoroethyl (TFE) 
sulfonates are stable to both nucleophilic and acidic conditions, but need strongly 
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basic conditions for removal (Miller, 2010). For our purposes, existing sulfonate 
protecting groups are either insufficiently stable, require cleavage conditions that 
are too harsh, and/or deprotection would require subsequent HPLC purification. 
For example, attempted cleavage of the sulfonate ester dye 2 with NaOH led to 
dye decomposition. 
 A convenient cleavage reagent for many protecting groups is 
trifluoroacetic acid (TFA) (Green and Wuts, 1999). While TFA-labile protecting 
groups for carboxylates, alcohols, amines, and other functionalities are common, 
most sulfonate esters that are stable to nucleophiles are also stable to TFA 
(Green and Wuts, 1999; Miller, 2010). An exception is the “triggered” TFA-labile 
sulfonate ester protecting group reported by Roberts et al., Neo N-B, which is 
stable to nucleophiles by virtue of its neopentyl structure (Roberts et al., 1997). 
However, cleavage of Neo N-B is a two-step process that requires initial 
cleavage of a Boc-protected amine followed by neutralization to effect release of 
the sulfonate. Isolation of the liberated sulfonate requires the chromatographic 
removal of non-volatile side-products, and the protecting group itself is not readily 
available, requiring a four-step synthesis from commercially available materials. 
Other related neopentyl-based protection strategies for sulfonates have similar 
limitations (Morgan et al., 2011; Seeberger et al., 2007). We therefore sought to 
develop a sulfonate protecting group which could satisfy three criteria: i) intrinsic 
TFA-lability not requiring any additional treatment for cleavage to occur; ii) easy 
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separation of the cleaved sulfonate from any byproducts; and iii) ready access 
from commercially available materials. 
Results and Discussion 
 In a recent survey of commercially available alcohols that could potentially 
serve as protecting groups for sulfonates, we found that α-trifluoromethylbenzyl 
(TFMB) sulfonates  are stable to nucleophiles and could function as a scaffold for 
the design of sulfonate ester protecting groups with engineered lability (as in 2, 
Figure 2.1) (Miller, 2010). For example, we have prepared an esterase-labile 
sulfonate protecting group by incorporating an acetoxy group into the para 
position (Rusha and Miller, 2011). Thus, while TFMB sulfonates themselves are 
stable to TFA, we hypothesized that electron-rich variants could be created that 
would be labile to TFA yet retain stability to nucleophiles (Miller, 2010).     
 Solvolysis studies of 1-aryl-2,2,2-trifluoromethyl tosylates have shown that 
the rate of carbocation formation in ionizing solvents is dependent on the nature 
of the aryl group (Allen et al., 1983). We therefore introduced the strongly 
electron-donating para-methoxy group onto the TFMB scaffold by treating p-
anisaldehyde with TMSCF3 under Ruppert-Prakash conditions to afford 3 
(Scheme 2.1) (Krishnamurti et al., 1991). More weakly electron-donating p-
methyl and p-isopropyl substituents were similarly introduced to yield alcohols 4 
and 5, respectively (Scheme 2.1). Typically, the Ruppert-Prakash reaction is 
quenched with HCl to hydrolyze the initially-formed TMS ether, followed by 
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chromatographic purification (Krishnamurti et al., 1991). However, we found that 
the starting benzaldehydes and trifluoromethylated alcohol products closely elute 
during flash column purification. Thus, if the reaction is incomplete, purification 
becomes tedious. We therefore first purified the TMS ether, which was very well 
resolved from the starting aldehyde by flash chromatography. Subsequent 
treatment with aqueous acid cleanly cleaved the TMS ether to yield the desired 
product after extractive workup. We have adopted this improved synthesis 
protocol for all Ruppert-Prakash reactions with benzaldehydes. 
 
 
Scheme 2.1: Ruppert-Prakash synthesis of potential reagents for the 
development of sulfonate protecting groups. 
 
 We next tested the suitability of 3-5 as sulfonate protecting groups. 
Reaction of alcohol 3 with sulfonyl chlorides yielded sulfonate esters that were 
too labile to be easily isolated (e.g., the dansylate and 3-chloropropanesulfonate 
decomposed during purification on a silica gel column). On the other hand, 
sulfonate esters 6 and 7 derived from alcohol 4 (Scheme 2.2) were stable to 
isolation and to treatment with nucleophiles. Like the corresponding TFMB 
sulfonate esters, 6 and 7 were quantitatively recovered after 2 h treatment with 
30 
 
20% piperidine in DMF at room temperature or 4 h treatment with 1.1 eq of 
sodium iodide in refluxing acetone (Table 2.1, Figure 2.2) (Miller, 2010). While 
stable to nucleophilic attack, the para-methyl group is sufficiently electron-
donating that sulfonate esters of 4, dubbed "TFMT" sulfonates, can be cleaved 
by solvolysis in TFA (Table 2.2 and Table 2.3). Inclusion of water as a cation 
scavenging agent at 2% v/v or greater improves the cleavage yield in the case of 
the tosyl ester 6. This may reflect the formation of a tight ion pair that can 
recombine unless quenched by water (Allen et al., 1995). Under these 
conditions, cleavage is readily achieved in 2 h at room temperature (Table 2.2), 
and the pure sulfonate could be conveniently isolated by extraction and 
evaporation, without requiring chromatography. Tosylate 8 derived from p-
isopropyl alcohol 5 was also found to be TFA-labile and nucleophile stable, but 
provided no obvious advantages over TFMT. Finally, the TFMT sulfonate ester is 
stable to K2CO3 in hot DMF and to hot dilute aqueous acidic conditions that 
cleave acetals and carboxylate esters (2M HCl/acetone, 70 °C), suggesting that 
TFMT sulfonates could survive similar conditions necessary for oxazine dye 
synthesis (Table 2.1) (Heiskanen and Hormi, 2009). 
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Scheme 2.2: Synthesis of TFMT sulfonate esters. 
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Condition 
  
20% Piperidine/DMF 
rt, 2h 
100% 100% 
1.1 eq NaI, Acetone 
reflux, 4h 
100% 100% 
1 eq K2CO3/DMF 
65 °C, 24 h 
92% 92% 
1:1 2M HCl/Acetone 
70 °C, 2h 
93% N/A 
 
Table 2.1: Stability of TFMT sulfonate esters. The stability of compounds 6 
(left) and 7 (right) was investigated in conditions known to cleave protecting 
groups or react with sulfonate esters. Percentages refer to the recovery of the 
starting material that was verified by 1H- and 19F-NMR and ESI-HRMS. N/A: 
compound not tested.   
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Figure 2.2: Analytical HPLC traces of Compound 6 (A) and the purified 
material from cleavage (B) and stability (C) analyses of TFMT-sulfonate 
ester protecting group. Cleavage/stability reactions (B/C, respectively) were 
performed and worked up as described in the experimental methods prior to 
HPLC analysis. Identity of the compounds were determined by 1H- and 19F-NMR 
and ESI-HRMS. Traces show absorbance detection at 224 nm. Detection at 262 
nm was also obtained and replicated the above data.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
 
 
 
 
 
Figure 2.2A. HPLC trace of 6. 
 
 
 
 
 
6 
Retention Time: 63.34-63.61 min. 
Purity: 98.8% 
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Figure 2.2B. HPLC trace of product from cleavage reaction with 6. 
 
 
 
 
 
Retention Time: 7.37-7.42 min. 
Purity: 98% 
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Figure 2.2C. HPLC trace of product from reaction of 6 with 20% piperidine in 
DMF. 
 
 
 
 
 
 
Retention Time: 63.88 min. 
Purity: 98.6% 
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Entry Substrate % Water Time Yield 
1* 6 0 2h 39% 
2 7 0 2h 84% 
3** 6 1 2h 41% 
4 7 1 2h 99% 
5** 6 1 16h 88% 
6† 6 2 2h 84% 
7** 6 3 2h 82% 
8 6 5 2h 89% 
 
Table 2.2: TFA cleavage of sulfonate esters 6 and 7.                                     
(*): average of n = 3, (**): n = 2, (†): n = 4. Entries without superscripts: n = 1. 
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% H2O 
 
Time 
(h) 
Mass of 6 
(mg) 
Theoretical Yield 
of TosylSulfonate 
(mg) 
Actual Yield of 
TosylSulfonate 
(mg) 
% Yield 
 
0 2 99 55 18 33 
0 2 115 64 25 39 
0 2 99 55 25 45 
1 16 67 37 33 89 
1 16 99 55 48 87 
1 2 84 46 17 37 
1 2 62 34 15 44 
2 2 99 55 50 91 
2 2 67 37 30 81 
2 2 60 33 27 82 
2 2 76 42 34 81 
3 2 75 41 33 80 
3 2 78 43 36 84 
5 2 103 57 51 89 
 
Table 2.3: TFA cleavage of compound 6 employing different percentages of 
water as a cation scavenger.  
 
 
 Having established that TFMT met our three criteria for a new sulfonate 
protecting group, we next sought to test its utility in the context of sulfonated 
near-IR fluorophore synthesis. To access the TFMT-protected sulfonated dyes, 
we first synthesized the TFMT-protected sulfopropyl iodide 10 (Scheme 2.2). As 
with TFMB, the remarkable stability of TFMT sulfonates to nucleophilic attack by 
iodide is manifestly demonstrated by the selective substitution of the chloride in 9 
to cleanly afford 10 (Pauff and Miller, 2011). Iodide 10 was then used to alkylate 
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the tetrahydroquinolines 11 and 12 to afford 13 and 14 (Scheme 2.3) (Pauff and 
Miller, 2011). Like TFMB, the TFMT group was stable to these nucleophilic 
substitution reactions (Pauff and Miller, 2011). Similarly, acidic diazonium 
coupling conditions (10% aqueous H2SO4) and dye coupling conditions (hot 
acetic acid or HCl in refluxing aqueous ethanol) were tolerated, allowing access 
to the bis-TFMT protected oxazine dye 16 (Scheme 2.3), which could be purified 
by silica gel chromatography. 
 
 
Scheme 2.3: Synthesis of bis-sulfonated oxazine dye (1) using the TFA-
labile TFMT sulfonate protecting group. 
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 Treatment of the purified bis-TFMT dye 16 with TFA and 2% H2O at rt for 
2 h liberated the bis-sulfonate dye 1 (Scheme 2.3). After reaction, the volatiles 
were removed and the dye was extracted into water and lyophilized. Notably, 
complete cleavage was observed, and no impurities were introduced (Figure 
2.3). Compared to the synthesis of the bis-sulfonated oxazine dye 1 using the 
conventional sulfopropylation reagent 1,3-propanesultone (Scheme 2.4), the 
TFMT approach was higher-yielding, easier to perform, and more rapid as all 
products could be purified by standard silica gel flash chromatography methods 
rather than HPLC. 
 
 
Scheme 2.4: Synthesis of bis-sulfonate oxazine dye (1) using 1,3-
propanesultone. 
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Conclusions 
 In conclusion, TFMT is a new sulfonate protecting group that is readily 
accessible in a single high-yield step from commercially available materials. 
TFMT-protected sulfonates are resistant to nucleophilic attack but can be 
unmasked under relatively mild conditions by treatment with TFA, and the 
cleavage product separated by extraction and evaporation. The TFMT group thus 
complements and expands the repertoire of practical and useful sulfonate 
protecting groups. We have found it to be advantageous for the synthesis and 
purification of sulfonated oxazine dyes and their intermediates, and anticipate 
that it will be generally useful for the synthesis of a wide variety of sulfonated 
molecules. For example, the stability of the TFMT group to 20% piperidine in 
DMF and facile cleavage by TFA suggests that it may also find application for the 
synthesis of sulfonated peptides under Fmoc solid-phase peptide synthesis 
(SPPS) conditions. 
Materials and Methods 
General Methods 
Chemicals for synthesis were from standard suppliers. NMR spectra were 
recorded at 400 MHz for 1H, 376 MHz for 19F and 101 MHz for 13C. Electrospray 
ionization mass spectra were acquired on a Q-TOF exact mass spectrometer. 
Melting points are uncorrected. Unless otherwise stated, all reactions were 
performed under argon.  
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Analytical HPLC 
Purity of the compounds was analyzed via HPLC on a 4.6 x 250 mm C-18 
column using a diode array detector. All purification methods used aqueous 0.1% 
trifluoroacetic acid as Solvent A and acetonitrile as Solvent B and were run at a 
flow rate of 1 mL/min. HPLC methods were as follows: 
Tosyl TFMT reactions (Figure 2.2): Absorbance detector set at 224 and 262 nm. 
10% B for 5 minutes, 10-100% B over 90 minutes, 100% B for 5 minutes.  
Oxazine dye 1 (Figure 2.3): Absorbance detector set at 303, 606, 659 nm. 0% B 
for 5 minutes, 0-100% B over 100 minutes, 100% B for 5 minutes. 
Synthetic Procedures 
General procedure for Ruppert-Prakash reactions.  
 
Trimethyl(trifluoromethyl)silane (1.4 eq) was added to a solution of the 
benzaldehyde (1.0 eq) in THF (0.5 M). The solution was cooled to 0 °C followed 
by the dropwise addition of a catalytic amount (~1 drop/mmol) of 1M tetra-n-
butylammonium fluoride (TBAF) in THF. The reaction was brought to room 
temperature and stirred for 1 hour. The solution was then concentrated via rotary 
evaporation and purified by flash column chromatography (0-1% ethyl 
acetate/hexanes) giving the TMS-protected alcohol as a clear, pale-yellow liquid. 
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This intermediate was dried under vacuum and then dissolved in 1:1 THF–1 M 
HCl (0.25 M) and stirred for 2 hours at room temperature to cleave the TMS 
ether. The solution was then poured into water and the product was extracted 
with ethyl acetate. The combined organic phases were washed with 0.1 M HCl, 
water, brine, and then dried over Na2SO4. Removal of solvent in vacuo yielded 
the product.  
 
 
2,2,2-Trifluoro-1-(4-methoxy-phenyl)-ethanol (3) (Song et al., 2005): yellow oil 
(1.4 g, 94%). 1H-NMR (400 MHz, CDCl3): δ 7.40 (d, 2H, J = 8.9 Hz), 6.93 (d, 2H, 
J = 8.9 Hz), 4.97 (q, 1H, JHF = 6.7 Hz), 3.83 (s, 3H), 2.46 (br s, 1H). 19F-NMR 
(376 MHz, CDCl3): δ -79.0 (d, J = 6.7 Hz). 13C-NMR (100 MHz, CDCl3): δ 160.5, 
129.1, 126.5, 124.6 (q, 1JCF = 282 Hz), 114.2, 72.5 (q, 2JCF = 32 Hz), 55.5. ESI-
HRMS m/z: [M + H]+ Calculated for C9H10F3O2: 207.0633, found: 207.0625. 
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2,2,2-Trifluoro-1-p-tolyl-ethanol (4) (Allen et al., 1995): pale yellow oil (1.5 g, 
95%). The product becomes a soft, off-white solid when stored at 4 °C. 1H-NMR 
(400 MHz, CDCl3): δ 7.36 (d, 2H, J = 8.2 Hz), 7.22 (d, 2H, J = 7.9 Hz), 5.02-4.96 
(dq, 1H, J = 4.5 Hz, JHF = 6.7 Hz), 2.48 (d, 1H, J = 4.6 Hz), 2.37 (s, 3H). 19F-NMR 
(376 MHz, CDCl3): δ -78.9 (d, J = 6.8 Hz). 13C-NMR (100 MHz, CDCl3): δ 139.8, 
131.3, 129.6, 127.6, 124.6 (q, 1JCF = 282 Hz), 72.9 (q, 2JCF = 32 Hz), 21.4. ESI-
HRMS m/z: [M + Na]+ Calculated for C9H9F3ONa: 213.0503, found: 213.0497. 
 
 
2,2,2-Trifluoro-1-(4-isopropyl-phenyl)-ethanol (5): pale yellow oil (1.3 g, 94%). 
1H-NMR (400 MHz, CDCl3): δ 7.46 (d, 2H, J = 8.2 Hz), 7.38 (d, 2H, J = 8.2 Hz), 
4.92 (q, 1H, JHF = 6.5 Hz), 4.05 (br s, 1H), 3.11-3.00 (m, 1H), 1.40 (s, 3H), 1.38 
(s, 3H). 19F-NMR (376 MHz, CDCl3): δ -78.5 (d, J = 6.8 Hz). 13C-NMR (100 MHz, 
CDCl3): δ 150.8, 131.7, 127.9, 127.0, 124.7 (q, 1JCF = 282 Hz), 72.9 (q, 2JCF = 32 
Hz), 34.2, 24.0. ESI-HRMS m/z: [M + H]+ Calculated for C11H14F3O: 219.0997, 
found: 219.0999. 
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General procedure for sulfonate ester formation.  
 
Sulfonyl chloride (1.1 equiv) and a trifluoromethyl benzyl alcohol (1 equiv) were 
dissolved in CH2Cl2 (0.7 M). To this solution was added dropwise a solution of 
DABCO (1.2 equiv) in CH2Cl2 (2 M), resulting in precipitate formation.  The 
mixture was then stirred for 4 hours at room temperature. The reaction was 
quenched by the addition of 1M NaOH (1 mL) resulting in elimination of the 
precipitate. The solution was diluted into ethyl acetate and extracted with 
saturated NaHCO3, 0.1 M HCl, water, and brine. The organic phase was then 
dried over Na2SO4 and the solvent was removed via rotary evaporation. 
 
 
Toluene-4-sulfonic acid 2,2,2-trifluoro-1-p-tolyl-ethyl ester (6) (Allen et al., 
1995): white solid (1.17 g, 85%). mp 83-85 °C; 1H-NMR (400 MHz, CDCl3): δ 
7.65 (d, 2H, J = 8.3 Hz), 7.23-7.20 (m, 4H), 7.11 (d, 2H, 7.7 Hz), 5.62 (q, 1H, JHF 
= 6.4 Hz), 2.40 (s, 3H), 2.33 (s, 3H). 19F-NMR (376 MHz, CDCl3): δ -76.5 (d, J = 
47 
 
6.4 Hz). 13C-NMR (100 MHz, CDCl3): δ 145.5, 140.7, 133.3, 129.9, 129.5, 128.3, 
128.1, 126.9, 122.5 (q, 1JCF = 281 Hz), 78.3 (q, 2JCF = 34 Hz), 21.8, 21.5. ESI-
HRMS m/z: [M + Na]+ Calculated for C16H15F3O3SNa: 367.0592, found: 
367.0583. 
 
 
5-Dimethylamino-naphthalene-1-sulfonic acid 2,2,2-trifluoro-1-p-tolyl-ethyl 
ester (7): yellow solid (436 mg, 98%). mp 97-99 °C; 1H-NMR (400 MHz, CDCl3): 
δ 8.46 (d, 1H, J = 8.5 Hz), 8.23 (d, 1H, J = 8.7 Hz), 8.08 (dd, 1H, J = 1.3 Hz, 7.4 
Hz), 7.56 (dd, 1H, J = 7.6 Hz, 8.6 Hz), 7.37 (dd, 1H, J = 7.4 Hz, 8.5 Hz), 7.16 (d, 
1H, J = 7.1 Hz), 6.98 (d, 2H, J = 8.0 Hz), 6.81 (d, 2H, J = 7.9 Hz), 5.6 (q, 1H, JHF 
= 6.4 Hz), 2.83 (s, 6H), 2.17 (s, 3H). 19F-NMR (376 MHz, CDCl3): δ -76.3 (d, J = 
6.4 Hz). 13C-NMR (100 MHz, CDCl3): δ 151.8, 140.3, 132.1, 131.8, 130.4, 130, 
129.8, 128.9, 128.2, 126.1, 122.9, 122.5 (q, 1JCF = 281 Hz), 119.7, 115.7, 78.8 (q, 
2JCF = 34 Hz), 45.6, 21.3. ESI-HRMS m/z: [M + H]+ Calculated for 
C21H21F3NO3S: 424.1194, found: 424.1202. 
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Toluene-4-sulfonic acid 2,2,2-trifluoro-1-(4-isopropyl-phenyl)-ethyl ester (8): 
off-white solid (349 mg, 94%). mp 81-83 °C; 1H-NMR (400 MHz, CDCl3): δ 7.61 
(d, 2H, J = 8.4 Hz), 7.20 (d, 2H, J = 8.2 Hz), 7.17 (d, 2H, J = 8 Hz), 7.12 (d, 2H, 
8.2 Hz), 5.63 (q, 1H, JHF = 6.4 Hz), 2.92-2.82 (m, 1H), 2.37 (s, 3H), 1.22 (s, 3H), 
1.20 (s, 3H). 19F-NMR (376 MHz, CDCl3): δ -76.5 (d, J = 6.4 Hz). 13C-NMR (100 
MHz, CDCl3): δ 151.4, 145.3, 133.4, 129.8, 128.4, 128.1, 127.0, 126.9, 122.5 (q, 
1JCF = 281 Hz), 78.5 (q, 2JCF = 34 Hz), 34.1, 24.04, 24, 21.8. ESI-HRMS m/z: [M 
+ Na]+ Calculated for C18H19F3O3SNa: 395.0905, found: 395.0899. 
 
 
3-Chloro-propane-1-sulfonic acid 2,2,2-trifluoro-1-p-tolyl-ethyl ester (9). 
Compound 4 (1 g, 5.3 mmol) was dissolved in anhydrous dichloromethane (48 
mL) and cooled to 0 °C in an ice bath. Triethylamine (1.46 mL, 10.5 mmol) was 
then added to the solution. 3-Chloropropanesulfonyl chloride (0.83 mL, 6.8 mmol) 
dissolved in anhydrous dichloromethane (5 mL) was added dropwise via syringe 
to the reaction flask at a rate of 20 drops/min. Upon completion of compound 
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addition, the reaction was stirred at 4 °C overnight. The reaction was poured into 
1 M HCl and the product was extracted with dichloromethane. The combined 
organic phases were washed with water, saturated sodium bicarbonate and 
brine, then dried over sodium sulfate. Removal of the solvent under vacuum 
resulted in a pale yellow oil. The crude product was purified by flash column 
chromatography (0-15% ethyl acetate/hexanes) to yield the product as a white 
solid (1.64 g, 97%). mp 61-63 °C; 1H-NMR (400 MHz, CDCl3): δ 7.38 (d, 2H, J = 
8.0 Hz), 7.26 (d, 2H, J = 7.8 Hz), 5.74 (q, 1H, JHF = 6.4 Hz), 3.63-3.54 (m, 2H), 
3.27-3.14 (m, 2H), 2.39 (s, 3H), 2.31-2.21 (m, 2H). 19F-NMR (376 MHz, CDCl3): 
δ -76.3 (d, J = 6.4 Hz). 13C-NMR (100 MHz, CDCl3): δ 141.4, 130.0, 128.3, 126.8, 
122.5 (q, 1JCF = 281 Hz), 78.3 (q, 2JCF = 35 Hz), 49.8, 42.3, 26.7, 21.6. ESI-
HRMS m/z: [M + Na]+ Calculated for C12H14ClF3O3SNa: 353.0202, found: 
353.0190. 
 
 
3-Iodo-propane-1-sulfonic acid 2,2,2-trifluoro-1-p-tolyl-ethyl ester (10). 
Compound 9 (500 mg, 1.51 mmol) was added to a solution of sodium iodide (906 
mg, 6.05 mmol) in acetone (5 mL). The reaction was heated to reflux and stirred 
for 16 hours. After cooling to room temperature, the mixture was filtered to 
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remove sodium chloride and the filtrand was washed with acetone (25 mL). 
Acetone was removed via rotary evaporation and the resulting residue was 
extracted between ethyl acetate and water. The organic phase was collected and 
the aqueous phase was washed with ethyl acetate. The combined organic 
phases were washed with brine, dried over sodium sulfate, and the solvent 
removed via rotary evaporation giving a bronze oil. The crude material was 
purified with flash column chromatography (0-10% ethyl acetate/hexanes) to 
yield the product as a viscous, pale yellow oil (571 mg, 90%). 1H-NMR (400 MHz, 
CDCl3): δ 7.39 (d, 2H, J = 8.1 Hz), 7.27 (d, 2H, J = 7.9 Hz), 5.73 (q, 1H, JHF = 6.4 
Hz), 3.22-3.07 (m, 4H), 2.39 (s, 3H), 2.33-2.21 (m, 2H). 19F-NMR (376 MHz, 
CDCl3): δ -76.3 (d, J = 6.4 Hz). 13C-NMR (100 MHz, CD3OD): δ 141.5, 130.1, 
128.4, 126.8, 122.5 (q, 1JCF = 281 Hz), 78.3 (q, 2JCF = 34 Hz), 53.2, 27.2, 21.6, 
2.1. ESI-HRMS m/z: [M + Na]+ Calculated for C12H14F3IO3SNa: 444.9558, found: 
444.9520. 
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3-[7-(tert-Butyl-dimethyl-silanyloxy)-3,4-dihydro-2H-quinolin-1-yl]-propane-
1-sulfonic acid 2,2,2-trifluoro-1-p-tolyl-ethyl ester (13). 7-(t-
Butyldimethylsilyloxy)-1,2,3,4-tetrahydroquinoline 11 (Pauff and Miller, 2011) 
(200 mg, 0.76 mmol) was dissolved in DMF (0.8 mL). Compound 10 (641 mg, 1.5 
mmol) dissolved in DMF (0.8 mL) and potassium carbonate (120 mg, 0.91 mmol) 
were added to the solution and the reaction was heated to 70 °C and stirred for 
24 hours. The reaction was poured into water and acidified to pH 1 with 1M HCl. 
The product was extracted with ethyl acetate and the combined organic phases 
were washed with water and brine and dried over sodium sulfate. The solvent 
was removed by rotary evaporation and the crude material was purified by flash 
column chromatography (0-5% acetone/hexanes) to yield a viscous orange oil 
(337 mg, 80%). 1H-NMR (400 MHz, CDCl3): δ 7.37 (d, 2H, J = 8.1 Hz), 7.22 (d, 
2H, J = 7.9 Hz), 6.78 (d, 1H, J = 8.0 Hz), 6.12 (dd, 1H, J = 2.2 Hz, 8.0 Hz), 6.01 
(d, 1H, J = 1.9 Hz), 5.73 (q, 1H, J = 6.4 Hz), 3.33-3.21 (m, 2H), 3.10 (t, 2H, J = 
5.5 Hz), 3.12-2.99 (m, 2H), 2.65 (t, 2H, J = 6.3 Hz), 2.38 (s, 3H), 2.07 (p, 2H, J = 
7.2 Hz), 1.88-1.82 (m, 2H), 0.98 (s, 9H), 0.19 (s, 6H). 19F-NMR (376 MHz, 
CDCl3): δ -76.4 (d, J = 6.4 Hz). 13C-NMR (100 MHz, CD3OD): δ 155.2, 145.7, 
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141.3, 130, 129.9, 128.3, 127, 122.6 (q, 1JCF = 281 Hz), 116, 108.2, 103.1, 78.2 
(q, 2JCF = 34 Hz), 50.3, 49.7, 49.6, 27.5, 26, 22.5, 21.6, 21.1, 18.5, -4.1. ESI-
HRMS m/z: [M + H]+ Calculated for C27H39F3NO4SSi: 558.2321, found: 
558.2305.  
 
 
3-(7-Methoxy-3,4-dihydro-2H-quinolin-1-yl)-propane-1-sulfonic acid 2,2,2-
trifluoro-1-p-tolyl-ethyl ester (14). 7-Methoxy-1,2,3,4-tetrahydroquinoline 12 
(Pauff and Miller, 2011) (100 mg, 0.61 mmol) was dissolved in DMF (0.5 mL). 
Compound 10 (517 mg, 1.23 mmol) dissolved in DMF (0.8 mL) and potassium 
carbonate (96 mg, 0.74 mmol) were added to the solution and the reaction was 
heated to 70 °C and stirred for 24 hours. The reaction was poured into water and 
acidified to pH 1 with 1M HCl. The product was extracted with ethyl acetate and 
the combined organic phases were washed with water and brine and dried over 
sodium sulfate. The solvent was removed by rotary evaporation and the crude 
material was purified by flash column chromatography (0-10% ethyl 
acetate/hexanes) to yield a viscous, pale yellow oil (217 mg, 78%). 1H-NMR (400 
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MHz, CD3OD): δ 7.37 (d, 2H, J = 8.1 Hz), 7.2 (d, 2H, J = 7.9 Hz), 6.76 (d, 1H, J = 
8.1 Hz), 6.12 (dd, 1H, J = 2.4 Hz, 8.1 Hz), 6.07 (d, 1H, J = 2.4 Hz), 5.96 (q, 1H, 
JHF = 6.5 Hz), 3.69 (s, 3H), 3.23-3.02 (m, 4H), 3.01 (t, 2H, J = 5.6 Hz), 2.58 (t, 
2H, J = 6.1 Hz), 2.32 (s, 3H), 1.95-1.82 (m, 2H), 1.79-1.73 (m, 2H). 19F-NMR 
(376 MHz, CD3OD): δ -78.0 (d, J = 6.5 Hz). 13C-NMR (100 MHz, CD3OD): δ 
159.5, 145.7, 141.1, 129.5, 128.2, 127.3, 122.9 (q, 1JCF = 280 Hz), 115.3, 100.9, 
97.2, 77.8 (q, 2JCF = 34 Hz), 54.4, 49.3, 49.1, 49, 27.2, 22.4, 20.5, 20.2. ESI-
HRMS m/z: [M + H]+ Calculated for C22H27F3NO4S: 458.1613, found: 458.1596. 
 
 
3-[7-Methoxy-6-(4-nitro-phenylazo)-3,4-dihydro-2H-quinolin-1-yl]-propane-1-
sulfonic acid 2,2,2-trifluoro-1-p-tolyl-ethyl ester (15). Compound 14 (105 mg, 
0.23 mmol) was dissolved in methanol (2.3 mL). 4-Nitrobenzenediazonium 
tetrafluoroborate (54 mg, 0.23 mmol) was suspended in 10% sulfuric acid (2.3 
mL) with vigorous stirring. The organic solution was added to the aqueous 
mixture and stirred at ambient conditions for 1 hour. The solution was then 
neutralized with ammonium hydroxide, resulting in a deep red precipitate. The 
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mixture was filtered and the filtrand washed with water to give a blood red solid 
(140 mg, quantitative). This compound was dried in vacuo and used in the next 
reaction without further purification. NMR of the crude material revealed a 
contaminant of ammonium tetrafluoroborate salt. A small sample of the 
compound was therefore desalted by flash column chromatography (0-50% ethyl 
acetate/hexanes) to obtain NMR. mp 153-155 °C (dec.); 1H-NMR (400 MHz, 
CDCl3): δ 8.27 (d, 2H, J = 9.0 Hz), 7.86 (d, 2H, J = 9.0 Hz), 7.58 (s, 1H), 7.37 (d, 
2H, J = 7.8 Hz), 7.24 (d, 2H, J = 7.8 Hz), 6.17 (s, 1H), 5.76 (q, 1H, JHF = 6.3 Hz), 
3.98 (s, 3H), 3.61-3.47 (m, 2H), 3.31 (t, 2H, J = 5.4 Hz), 3.16-3.05 (m, 2H), 2.72 
(t, 2H, J = 5.9 Hz), 2.37 (s, 3H), 2.23-2.11 (m, 2H), 1.92 (p, 2H, J = 5.3 Hz). 19F-
NMR (376 MHz, CDCl3): δ -76.3 (d, J = 6.2 Hz). 13C-NMR (100 MHz, CDCl3): δ 
160.1, 157.8, 151, 147.0, 141.5, 134, 130.1, 128.3, 126.7, 124.9, 122.7, 122.6 (q, 
1JCF = 281 Hz), 117.8, 116.1, 93.5, 78.5 (q, 2JCF = 34 Hz), 56.7, 50, 49.9, 49.7, 
27.4, 22.1, 21.6, 20.7. ESI-HRMS m/z: [M + H]+ Calculated for C28H30F3N4O6S: 
607.1838, found: 607.1841. 
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1,11-Bis-[3-(2,2,2-trifluoro-1-p-tolyl-ethoxysulfonyl)-propyl]-3,4,8,9,10,11-
hexahydro-2H-13-oxa-6,11-diaza-1-azonia-pentacene tetrafluoroborate (16). 
Compound 13 (44 mg, 79 µmol) and compound 15 (55 mg, 91 µmol) were 
dissolved in a solution of ethanol: water: hydrochloric acid (500 μL: 50 μL: 25 μL) 
and heated to 80 °C with stirring for 2 hours. Solvent was removed via rotary 
evaporation to give a fluorescent blue residue. The crude material was purified 
by flash column chromatography (0-10% methanol/dichloromethane) yielding the 
tetrafluoroborate salt as a blue solid (36 mg, 47%). mp 220-222 °C (dec.); 1H-
NMR (400 MHz, CD3OD): δ 7.47 (s, 2H), 7.43 (d, 4H, J = 8.1 Hz), 7.21 (d, 4H, J = 
8 Hz), 6.81 (s, 2H), 6.07 (q, 2H, JHF = 6.5 Hz), 3.74-3.61 (m, 4H), 3.55 (t, 4H, J = 
5.5 Hz), 3.45-3.33 (m, 4H), 2.90 (t, 4H, J = 6 Hz), 2.28 (s, 6H), 2.15-2.07 (m, 4H), 
1.99 (p, 4H, J = 5.5 Hz). 19F-NMR (376 MHz, CD3OD): δ -78.0 (d, J = 6.5 Hz), -
154.58 (s), -154.6 (s) (BF4- counterion). 13C-NMR (100 MHz, CD3OD): δ 154.6, 
148.7, 141.1, 134.4, 130.8, 129.5, 129.4, 128.2, 127.4, 122.9 (q, 1JCF = 280 Hz), 
95.0, 77.7 (q, 2JCF = 34 Hz), 50.64, 50.6, 27.2, 20.6, 20.5, 20.1. ESI-HRMS m/z: 
[M]+ Calculated for C42H44F6N3O7S2: 880.2525, found: 880.2511. 
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1,11-Bis-(3-sulfo-propyl)-3,4,8,9,10,11-hexahydro-2H-13-oxa-6,11-diaza-1-
azonia-pentacene tetrafluoroborate (1) by TFA cleavage of 16. Compound 16 
(12 mg, 12 µmol) and water (20 µL) was dissolved in trifluoroacetic acid (1 mL) 
and stirred at room temperature for 2 hours. TFA was removed via rotary 
evaporation and the residue was dissolved in water (60 mL). The aqueous phase 
was extracted with ethyl acetate (1 x 40 mL, 4 x 20 mL) and lyophilized to give 
the pure blue compound as a tetrafluoroborate salt (8.1 mg, 99%). mp 365-367 
°C (dec.); 1H-NMR (400 MHz, D2O): δ 6.99 (s, 2H), 6.6 (s, 2H), 3.5 (br s, 8H), 
2.86 (t, 4H, J = 7.4 Hz), 2.62 (br s, 4H), 1.99 (p, 4H, J = 7.0 Hz), 1.82 (br s, 4H). 
19F-NMR (376 MHz, D2O): δ -150.9 (s), -151.0 (s) (BF4- counterion). ESI-HRMS 
m/z: [M]+ Calculated for C24H30N3O7S2: 536.1525, found: 536.1507. 
 
 
3-[7-(tert-Butyl-dimethyl-silanyloxy)-3,4-dihydro-2H-quinolin-1-yl]-propane-
1-sulfonic acid monohydrate (17).  7-t-Butyldimethylsiloxy-1,2,3,4-
tetrahydroquinoline 11 (Pauff and Miller, 2011) (214 mg, 0.812 mmol) and 1,3-
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propanesultone (200 mg, 1.6 mmol) were dissolved in methanol (1.6 mL) and 
stirred overnight at room temperature. The solvent was removed via rotary 
evaporation and the crude material was purified by flash column chromatography 
(10 % methanol/dichloromethane) to yield a yellow-white solid (119 mg, 36%). 
mp 202-204 °C (dec.); 1H-NMR (400 MHz, CD3OD): δ 6.73 (d, 1H, J = 8.0 Hz), 
6.14 (br s, 1H), 6.05 (dd, 1H, J = 1.8 Hz, 8 Hz), 3.35 (t, 2H, J = 7.2 Hz), 3.27 (t, 
2H, J = 5.5 Hz), 2.88 (t, 2H, J = 7.5 Hz), 2.64 (t, 2H, J = 6.3 Hz), 2.07 (p, 2H, J = 
7.6 Hz), 1.9 (p, 2H, J = 6.3 Hz), 0.97 (s, 9H), 0.17 (s, 6H). 13C-NMR (100 MHz, 
CD3OD): δ 155, 154.8, 145.5, 129.4, 116.3, 103.4, 50.5, 49.2, 49.1, 27.2, 25.2, 
22.1, 21.9, 18, -5.2. ESI-HRMS m/z: [M + H]+ Calculated for C18H32NO4SSi: 
386.1821, found: 386.1821. 
 
 
1,11-Bis-(3-sulfo-propyl)-3,4,8,9,10,11-hexahydro-2H-13-oxa-6,11-diaza-1-
azonia-pentacene trifluoroacetate (1). Compound 17 (43 mg, 110 µmol) and 3-
[7-Methoxy-6-(4-nitro-phenylazo)-3,4-dihydro-2H-quinolin-1-yl]-propane-1-
sulfonic acid 19 (Pauff and Miller, 2011) (48 mg, 110 µmol) were dissolved in a 
solution of ethanol: water: hydrochloric acid (1 mL: 100 μL: 50 μL) and heated to 
80 °C with stirring for 2 hours. The solvent was removed via rotary evaporation to 
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give a fluorescent blue residue. The crude material was purified to 99% purity by 
HPLC over a C18 column to yield a blue solid (22 mg, 29%). Solvent A and B 
were respectively aqueous 0.1% trifluoroacetic acid and acetonitrile/0.1% 
trifluoroacetic acid. The flow rate during purification was 5 mL/min. The 
absorbance detector was set at 294, 306, 383, 607, and 660 nm. Elution of the 
compound was obtained via the following method: 15% B for 5 minutes, 15-50% 
B over 35 minutes, 50-100% B over 5 minutes, 100% B for 10 minutes. mp 365-
367 °C (dec.); 1H-NMR (400 MHz, D2O): δ 6.72 (s, 2H), 6.44 (s, 2H), 3.38 (br s, 
8H), 2.81 (t, 4H, J = 6.8 Hz), 2.48 (br s, 4H), 1.91 (br s, 4H), 1.73 (br s, 4H). 19F-
NMR (376 MHz, D2O): δ -76.1 (s) (TFA counterion). 13C-NMR (100 MHz, D2O): δ 
153.9, 147.9, 132.4, 129.4, 129.2, 95.2, 51.4, 50.7, 48.0, 26.9, 21.7, 20.2. ESI-
HRMS m/z: [M - 2H]- Calculated for C24H28N3O7S2: 534.1368, found: 534.1348. 
 
General procedure for TFA cleavage of sulfonate esters.  
 
Sulfonate ester (~0.2 mmol) and water (0-30 µL) were dissolved in TFA (1 mL) 
and stirred at room temperature for 2-16 h. After rotary evaporation of TFA, the 
residue was taken up into 80 mL water. The aqueous phase was extracted with 
ethyl acetate and lyophilized to yield the cleaved tosylate or dansylate. 
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Stability Experiments 
General procedure for determining stability to 20% piperidine/DMF.  
Protected sulfonate (0.1-0.4 mmol) was dissolved in 1 mL of a freshly prepared 
20% piperidine/DMF solution and stirred at room temperature for 2 hours. The 
reaction was then poured into 1 M HCl and extracted with ethyl acetate. The 
combined organic phases were washed with water and brine and then dried over 
sodium sulfate.  The recovered compound was then isolated by removal of the 
solvent via rotary evaporation. 
General procedure for determining stability to NaI in refluxing acetone. 
 0.1 mmol of the protected sulfonate was dissolved in a solution of NaI (16 mg, 
0.11 mmol) in 0.2 mL acetone and refluxed for 4 hours. The reaction was diluted 
into 1:1 EtOAc:H2O and the organic phase was collected.  The aqueous phase 
was further extracted with ethyl acetate and the combined organic phases were 
washed with brine and dried over sodium sulfate.  The compound was then 
isolated by removal of the solvent via rotary evaporation. 
General procedure for determining stability to potassium carbonate.  
K2CO3 (0.24 mmol) was added to a solution of the protected sulfonate (0.2 mmol) 
in DMF (0.4 mL) and the mixture was heated to 65 °C for 24 hours. The reaction 
was then poured into water and acidified with 1 M HCl. The aqueous phase was 
extracted with ethyl acetate and the combined organic phases were washed with 
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water and brine and then dried over sodium sulfate. The solvent was removed by 
rotary evaporation and the recovered material was purified by flash column 
chromatography (0-10% ethyl acetate/hexanes). Both 6 and 7 were recovered in 
92% yield. 
Stability of 6 to hot dilute aqueous acid.  
Compound 6 (75 mg, 0.22 mmol) was dissolved in a 1 mL solution of 1:1 2 M 
HCl/acetone and heated to 70 °C for 2 hours. The reaction was then poured into 
ethyl acetate and the organic phase was washed with water and brine and dried 
over sodium sulfate. The solvent was removed by rotary evaporation and the 
recovered material was purified by flash column chromatography (0-10% ethyl 
acetate/hexanes) to return the starting material as a white solid (70 mg, 93%). 
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CHAPTER III:  Synthesis of near-IR fluorescent oxazine dyes with esterase-
labile sulfonate esters 
 
 
 
Summary 
 Near-IR oxazine dyes are reported that contain sulfonate esters which are 
rapidly cleaved by esterase activity to unmask highly polar anionic sulfonates. 
Strategies for the synthesis of these dyes included the development of milder dye 
condensation conditions with improved functional compatibility, and the use of an 
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alkyl halide that allows for the introduction of esterase-labile sulfonates without 
the need for sulfonation of the target molecule. 
Introduction 
 Cells and organisms are most transparent to near-IR light (650-900 nm), 
making this region of the electromagnetic spectrum optimal for optical imaging 
(Weissleder, 2001). Unfortunately, most organic near-IR dyes are not suitable for 
live intracellular applications. Dyes that are capable of diffusing across cell 
membranes typically give high background staining of cells because they 
accumulate in intracellular membranes and organelles (Cunningham et al., 2010; 
Johnson, 1998). Moreover, most near-IR dyes are cationic, which favors 
accumulation in the negatively-polarized membranes of mitochondria (Bunting et 
al., 1989). On the other hand, highly polar water-soluble sulfonated near-IR dyes 
(e.g., Alexa and Cy dyes) are unable to diffuse across cell membranes. 
 One potential strategy to overcome this problem is to design cell-
permeable near-IR dyes that can be selectively unmasked to a more water-
soluble form upon cellular entry. Toward this end, we recently reported a 
chemically-stable but esterase-labile sulfonate ester, AcOTFMB (Figure 3.1), that 
enables the delivery and unmasking of dansyl sulfonate within the cytoplasm of 
cells (Rusha and Miller, 2011) 
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Figure 3.1: Esterase-labile protecting group for sulfonates. Top: Structure of 
AcOTFMB (Rusha and Miller, 2011). Bottom: Yellow-green fluorescent 
AcOTFMB dansyl sulfonate esters are stable to nucleophilic attack due to the 
electron-withdrawing properties of the trifluoromethyl group. The acetoxy trigger 
can be readily removed by esterase activity. Subsequent rapid 1,6-elimination 
affords the blue-fluorescent dansyl sulfonate anion. 
 
 Most sulfonate esters are potent electrophiles. Exceptions include 
neopentyl sulfonates (steric block of reactivity) and α-trifluoromethylated 
sulfonates (electronic deactivation) (Miller, 2010). We have utilized these classes 
of sulfonate esters as platforms for the design of protecting groups that can be 
removed under specific conditions. In particular, we found that the incorporation 
of an acetoxy group into trifluoromethylbenzyl (TFMB) sulfonate esters 
maintained stability to nucleophiles but rendered these groups highly labile to 
esterase activity (Figure 3.1) (Rusha and Miller, 2011). 
 While this approach was facile for the small dansyl fluorophore, it was 
unclear whether the AcOTFMB group could be incorporated into near-IR dyes, 
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which are considerably larger and more challenging to synthesize. Here we 
report the successful synthesis of oxazine near-IR fluorophores bearing 
AcOTFMB esterase-labile sulfonate esters. We demonstrate that these dyes are 
chemically stable, but are readily cleaved to the free sulfonate by esterase 
activity, while the corresponding TFMB esters are unaffected. 
Results and Discussion 
 Examples of sulfonated near-IR fluorophores include cyanines, oxazines, 
and some rhodamine and BODIPY derivatives (Kolmanov et al., 2010; Mujumdar 
et al., 1993; Niu et al., 2009; Toutchkine, 2009; Zilles et al., 2006). Among these 
dye classes, near-IR oxazines have the advantages of a compact structure, 
excitation and bright fluorescence in the 650-700 nm region, and high 
photostability (Eggeling et al., 2006; Hintersteiner et al., 2005; Wakata et al., 
2010). To determine whether the AcOTFMB protection strategy was amenable to 
this class of near-IR fluorophores, we first synthesized the sulfonated oxazine 
dye 22 as shown in Scheme 3.1. Reaction of m-anisidine with acetone to form 
the dihydroquinoline 1 was facile in the presence of 2 mol % In(OTf)3 (Theoclitou 
and Robinson, 2002). This product was then N-methylated and sulfonated to 
afford 3 (Zilles et al., 2006). Diazonium coupling yielded 4, and subsequent acid-
catalyzed condensation of this arylazo compound with a m-aminophenol yielded 
the sulfonated dye 22, which exhibits maximal absorption at 673 nm and 
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emission at 689 nm in phosphate-buffered saline (PBS) (Kanitz and Hartmann, 
1999). 
 
 
 
Scheme 3.1: Synthesis of a sulfonated oxazine dye. 
 
 
 With this sulfonated near-IR fluorophore in hand, the next synthetic 
challenge was determining how and when to incorporate the TFMB and 
AcOTFMB sulfonate esters. Our initial attempts to directly introduce TFMB and 
AcOTFMB sulfonate esters into 22 by formation and reaction of the sulfonyl 
chloride were unsuccessful. We therefore installed the sulfonate esters into the 
dye precursors (Scheme 3.2). Thus, the sodium sulfonate salt 3 was converted 
into the allylic sulfonyl chloride 5 and subsequently treated with the 
corresponding alcohol and Et3N at 0°C to afford the sulfonate esters 6 and 7. 
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Scheme 3.2: Incorporation of TFMB and AcOTFMB sulfonate esters into an 
oxazine dye. 
 
 
 The sulfonate esters 6 and 7 were stable to diazonium coupling conditions 
in acidic aqueous methanol to afford 8 and 9. Subsequent acid-catalyzed 
condensation of 8 with N-ethyl-7-hydroxy-tetrahydroquinoline yielded the desired 
TFMB-protected sulfonated oxazine 23. However, the standard oxazine dye-
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formation conditions of HCl in hot aqueous ethanol led to substantial deprotection 
of AcOTFMB, presumably because carboxylic esters are labile to these 
conditions. Gratifyingly, dye formation in hot acetic acid readily afforded the 
desired oxazine dye 24 with the AcOTFMB sulfonate ester intact (Scheme 3.2). 
 To facilitate the synthesis of more dyes containing a protected sulfonate, 
we constructed TFMB and AcOTFMB-protected iodopropyl sulfonates 11 and 13 
(Scheme 3.3). Treatment of 3-chlorosulfonyl chloride with the corresponding 
alcohols and Et3N at 0°C yielded the respective chloropropyl sulfonates 10 and 
12. The chlorides were then selectively displaced with iodides. These 
compounds are especially notable because 1) their synthesis clearly 
demonstrates the remarkable stability of TFMB and AcOTFMB sulfonates to 
nucleophilic attack (chloro is displaced selectively even after overnight reflux with 
excess iodide), and 2) the iodide 13 can allow the introduction of an AcOTFMB-
protected sulfonate into molecules with a suitable nucleophile, avoiding the need 
for sulfonation. 
 
 
 
 
Scheme 3.3: Synthesis of iodopropyl sulfonates. 
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 To make use of 11 and 13 for the construction of near-IR dyes, we 
synthesized sulfonated analogs of the oxazine dye MR121 (Scheme 3.4) 
(Herrmann et al., 1996; Lieberwirth et al., 1998). The tetrahydroquinoline 15 was 
dissolved in DMF and heated with 11 or 13 in the presence of excess K2CO3 to 
yield 18 and 19. Diazonium coupling followed by acid-catalyzed condensation 
with N-ethyl-7-hydroxy-tetrahydroquinoline yielded the desired oxazine dyes 26 
and 27. The corresponding free sulfonate dye was synthesized analogously by 
treatment of 15 with 1,3-propanesultone to afford 16 which was subsequently 
elaborated to yield the sulfonated dye 25 (Scheme 3.5). The excitation and 
emission wavelengths for this dye are similar to MR121, at 659 and 671 nm 
respectively. 
 
 
 
 
Scheme 3.4: Synthesis of sulfonate ester derivatives of MR121. 
 
 
69 
 
 
 
Scheme 3.5: Synthesis of a sulfonated MR121 derivative. 
 
 We next attempted to synthesize symmetrical oxazine dyes with two 
protected sulfonates, which would generate highly polar anionic molecules upon 
cleavage. Current synthetic approaches to such dyes require a phenolic 
intermediate such as 29 (Scheme 3.6) (Herrmann et al., 1996; Hintersteiner et 
al., 2005; Kanitz and Hartmann, 1999; Toutchkine, 2009; Zilles et al., 2006). 
While the synthesis of the TFMB-protected sulfonate ester 29 was facile, we 
were unable to isolate the corresponding AcOTFMB-protected phenolic 
intermediate (Scheme 3.6). Because the corresponding TFMB-protected phenol 
29 is stable, we surmise that the phenol promotes intramolecular deacetylation 
and self-immolation of the AcOTFMB group (Scheme 3.6). Indeed, the 
corresponding AcOTFMB-protected anisole 19 is stable and readily isolated 
(Scheme 3.4). Thus, derivatives of AcOTFMB bearing intramolecular 
nucleophiles may be prone to self-immolation. 
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Scheme 3.6: Intramolecular nucleophiles can cause self-immolation of 
AcOTFMB sulfonates. 
 
 In order to access symmetrical bis-sulfonated dyes without the need for 
the isolation of a phenolic intermediate such as 29, we constructed the silyl ether 
30. We hypothesized that the AcOTFMB group would be stable in the presence 
of the silyl ether, and that the acidic conditions of dye synthesis would unmask 
the silyl ether and allow dye formation (Scheme 3.7). We were gratified to find 
that the silyl ether 32 was indeed stable, and that the silyl ethers 31 and 32 
readily formed the desired symmetric bis-sulfonated oxazine dyes 33 and 34 
when treated with 20 and 21 under acidic conditions (Scheme 3.7). 
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Scheme 3.7: Bypassing phenols: formation of bis-sulfonated oxazine dyes 
from silyl ether and anisole starting materials. 
 
 
 This method of oxazine dye synthesis has three key advantages over the 
classical methods that utilize condensation of one or more phenolic compounds 
(Herrmann et al., 1996; Hintersteiner et al., 2005; Kanitz and Hartmann, 1999; 
Toutchkine, 2009; Zilles et al., 2006). First, during the N-alkylation step, 
protection of the phenol avoids any undesired O-alkylation (Scheme 3.7), which 
improves yields and simplifies purification. Second, there is no need to deprotect 
prior to dye synthesis, eliminating a synthetic step. Finally, the use of silyl ethers 
expands the range of functionality that is compatible with oxazine dye synthesis. 
Typically, anisoles have been used for protection of phenolic intermediates in dye 
synthesis, and the requirement for HBr or BBr3 deprotection greatly limits 
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functional group compatibility (Herrmann et al., 1996; Hintersteiner et al., 2005; 
Toutchkine, 2009; Zilles et al., 2006). We anticipate that this method of dye 
synthesis will also find use in the preparation of rhodamine dyes bearing 
sensitive chemical functionality. 
 The AcOTFMB-protected sulfonated oxazine dyes 24 and 27 are readily 
unmasked by pig liver esterase (PLE) to afford the zwitterionic free sulfonate 
dyes 22 and 25, respectively (Figure 3.2). Similarly, treatment of 34 with PLE 
rapidly formed the highly polar bis-sulfonate (Figure 3.3). In contrast, TFMB-
protected dyes are stable to esterase activity (Figure 3.3), and both TFMB and 
AcOTFMB dyes are stable to treatment with biological nucleophiles such as 5 
mM glutathione and 1 mg/mL ovalbumin (Figure 3.2 and 3.3). These findings are 
consistent with our results with dansyl dyes, and suggest that the AcOTFMB 
group is generally suitable as a chemically-stable, esterase-labile protecting 
group for dyes containing either aryl, allyl, or alkyl sulfonates (Rusha and Miller, 
2011). 
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Figure 3.2: NIR oxazines functionalized with AcOTFMB-sulfonate esters are 
cleaved to the free sulfonate dye in vitro by pig liver esterase. AcOTFMB-
oxazine dyes 24 and 27 were incubated in 1X PBS, pH 7.4 (P), 5 mM glutathione 
(G), 1 mg/mL ovalbumin (O) or 1U/mL pig liver esterase (E) for 30 minutes, then 
separated by TLC (10% MeOH/CH2Cl2) and imaged. The respective free 
sulfonate dyes 22 and 25 were incubated in PBS and used as a reference. 
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Figure 3.3: Only the NIR oxazine dye functionalized with AcOTFMB-
sulfonate esters (34) is cleaved to the free sulfonate dye upon treatment 
with pig liver esterase in vitro. Oxazine dyes (1 µM) were incubated in 1X 
PBS, pH 7.4 (P), 5 mM glutathione (G), 1 mg/mL ovalbumin (O) or 1 U/mL pig 
liver esterase (E) at room temperature for 30 minutes, then separated by TLC 
(10% MeOH/CH2Cl2) and imaged. Free mono-sulfonate oxazines (22 and 25) 
were incubated in PBS and used as a reference. 
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Conclusions 
 We have described complex near-IR fluorophores that contain the 
esterase-labile sulfonate protecting group AcOTFMB. Moreover, intermediates 
such as 7, 21, and 32 are basic building blocks for the incorporation of esterase-
labile sulfonates into oxazines and other dyes such as rhodamines, and 
intermediate 13 can allow the incorporation of the esterase-labile AcOTFMB 
sulfonate into an even wider variety of molecules. Further optimization of this 
approach and cell-based applications of these molecules are currently underway. 
Materials and Methods 
General Methods 
3,4-Dihydro-7-hydroxy-2(1H)-quinolinone was purchased from TCI. Organic 
solvents were ACS grade (hexanes), AR® grade (acetone, ethyl acetate), and 
ChromAR® grade (methanol, dichloromethane, chloroform) and were purchased 
from BDH and Mallinckrodt. Dry solvents were purchased from Aldrich and 
Acros. NMR solvents were purchased from Cambridge Isotope Laboratories. All 
other chemicals were purchased from Aldrich, Acros, or Fisher Scientific. 
NMR spectra were recorded with a Varian Mercury 400 MHz instrument.  1H, 19F 
and 13C NMR spectra were recorded in CDCl3, CD3OD, or DMSO-D6. High-
resolution mass spectra were obtained on a Waters QToF Premier. Fluorescence 
spectra were obtained using a Jobin Yvon Horiba SPEX FluoroMax-3.  
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Semi-preparative HPLC Purification 
Oxazine dyes were purified, as needed, by semi-preparative HPLC on a 22 x 250 
mm C-18 column using a Hewlett Packard Agilent 1100 HPLC equipped with a 
G1315A DAD absorbance detector. All purification methods used aqueous 0.1% 
trifluoroacetic acid as Solvent A and acetonitrile/0.1% trifluoroacetic acid as 
Solvent B and were run at a flow rate of 5 mL/min. Acetonitrile and trifluoroacetic 
acid were HPLC grade and were purchased, respectively, from J. T. Baker and 
Aldrich. HPLC methods were as follows: 
Method A: Absorbance detector set at 286, 354, 428, 626, and 675 nm. 40% B 
for 5 minutes, 40-65% B over 25 minutes, 65-100% B over 5 minutes, 100% B for 
5 minutes.  
Method B: Absorbance detector set at 290, 362, 615, and 667 nm. 60% B for 5 
minutes, 60-90% B over 30 minutes, 90-100% B over 5 minutes, 100% B for 5 
minutes.  
Method C: Absorbance detector set at 285, 373, 452, 618, and 669 nm. 50% B 
for 5 minutes, 50-90% B over 40 minutes, 90-100% B over 5 minutes, 100% B for 
5 minutes.  
Method D: Absorbance detector set at 301, 354, 406, 608, and 657 nm. 40% B 
for 5 minutes, 40-70% B over 30 minutes, 70-100% B over 5 minutes, 100% B for 
10 minutes.  
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Method E: Absorbance detector set at 300, 456, 607, and 653 nm. 60% B for 5 
minutes, 60-100% B over 40 minutes, 100% B for 5 minutes.  
Method F: Absorbance detector set at 301, 454, 603, and 653 nm. 45% B for 5 
minutes, 45-90% B over 45 minutes, 90-100% B over 5 minutes, 100% B for 5 
minutes. 
Sulfonate Protecting Group Cleavage Assay.  
To determine the ability of the sulfonate esters to be unmasked by esterase 
activity, oxazine dyes were incubated at room temperature for 30 minutes in the 
following conditions: PBS, 5 mM glutathione (MP Biomedicals) in PBS, 1 mg/mL 
ovalbumin (Sigma) in PBS, 1 unit of pig liver esterase (Sigma) activity in PBS. 
Oxazine dyes were prepared as 10 mM stocks in DMSO (Aldrich) and diluted to 
1 µM for the experiments. After incubation, the samples were run on TLC plates 
in 10 % methanol/dichloromethane and analyzed using an LAS-3000 (FujiFilm) 
with a 670 nm long pass filter and excitation at 630 nm. 
Synthetic Procedures 
 
7-methoxy-2,2,4-trimethyl-1,2-dihydroquinoline (1). m-Anisidine (4 mL, 36 
mmol) was added with stirring to a mixture of acetone (104 mL, 1.42 mol) and 2 
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mol % In(OTf)3 (405 mg, 0.72 mmol). The reaction was stirred for 16 hours at 
room temperature. Evaporation of solvent via rotary evaporation yielded a 
viscous amber oil. The crude material was purified by flash column 
chromatography (0-3% ethyl acetate/hexanes) giving the product as a white solid 
(4.45 g, 61%). 1H-NMR (CDCl3): δ 6.97 (d, 1H, J = 8.4 Hz), 6.20 (dd, 1H, J = 2.5 
Hz, 8.4 Hz), 6.01 (d, 1H, J = 2.5 Hz), 5.19 (q, 1H, J = 1.3 Hz), 3.75 (s, 3H), 3.69 
(br. s, 1H), 1.96 (d, 3H, J = 1.3 Hz), 1.26 (s, 6H). 13C-NMR (CDCl3): δ 160.4, 
144.9, 128.4, 126.2, 124.9, 115.6, 102.5, 98.8, 55.3, 52.2, 31.3, 18.9. HR-EIMS: 
m/z calculated for C13H18NO: 204.1388, found: 204.1402. 
 
 
7-methoxy-1,2,2,4-tetramethyl-1,2-dihydroquinoline (2). Compound 1 (3 g, 15 
mmol) was dissolved in DMF (20 mL). Potassium carbonate (2.9 g, 21 mmol) 
was added, followed by methyl iodide (1.2 mL, 19 mmol), and the reaction 
mixture was heated to 50 °C with stirring for 20 hours. The mixture was cooled to 
room temperature, poured into water (200 mL) and the product extracted with 
ethyl acetate (4 X 50 mL). The combined organic layers were washed with water 
(3 X 50 mL), brine (1 X 125 mL), and dried over sodium sulfate. Removal of the 
solvent by rotary evaporation yielded a clear purple liquid. The crude material 
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was purified by flash column chromatography (0-2% ethyl acetate/hexanes), 
yielding a viscous purple liquid (3.62 g, 82%). 1H-NMR (CDCl3): δ 6.98 (d, 1H, J = 
8.3 Hz), 6.20 (dd, 1H, J = 2.4 Hz, 8.3 Hz), 6.11 (d, 1H, J = 2.4 Hz), 5.18 (q, 1H, J 
= 1.3 Hz), 3.80 (s, 3H), 2.79 (s, 3H), 1.96 (d, 3H, J = 1.4 Hz), 1.29 (s, 6H). 13C-
NMR (CDCl3): δ 160.8, 146.9, 128.1, 127.9, 124.2, 117.4, 99.8, 98.3, 56.5, 55.3, 
30.9, 27.5, 18.9. HR-EIMS m/z calculated for C14H20NO: 218.1545, found: 
218.1525. 
 
 
Sodium (7-methoxy-1,2,2-trimethyl-1,2-dihydroquinolin-4-yl)-
methanesulfonate (3). A 5:1 sulfuric acid:oleum solution (10 mL) was prepared 
with cooling in an ice bath. Compound 2 (2.3 g, 11 mmol) was dissolved in the 
cooled acid solution and the reaction was brought to room temperature and 
stirred for 20 hours. The reaction was poured onto ice, cooled in an ice/methanol 
bath, and adjusted to pH 12 with 5 M sodium hydroxide. Unreacted starting 
material was removed by extraction with chloroform (1 X 200 mL and 2 X 100 
mL) and the aqueous phase was concentrated via rotary evaporation to yield a 
patchy white and brown solid. The solid was dissolved in 95% ethanol, filtered to 
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separate the product from the sodium sulfate salt, and the filtrate was 
concentrated under vacuum to yield a white solid. The crude compound was 
purified by flash column chromatography (0-50% methanol/chloroform) to give 
the product as a pale green solid (2.75 g, 80%). 1H-NMR (DMSO-D6): δ 7.16 (d, 
1H, J = 8.4 Hz), 6.08 (dd, 1H, J = 2.5 Hz, 8.4 Hz), 5.97 (d, 1H, J = 2.4 Hz), 5.33 
(s, 1H), 3.68 (s, 3H), 3.40 (s, 2H), 2.67 (s, 3H), 1.20 (s, 6H). 13C-NMR (DMSO-
D6): δ 160.4, 147.1, 131.3, 126.3, 126.1, 116.6, 100.4, 98.1, 56.5, 55.4, 54.5, 
31.1, 27.4. HR-EIMS m/z calculated for C14H20NO4S: 298.1113, found: 298.1100. 
 
 
Ammonium [7-Methoxy-1,2,2-trimethyl-6-(4-nitro-phenylazo)-1,2-dihydro-
quinolin-4-yl]-methanesulfonate (4).  Compound 3 (405 mg, 1.27 mmol) was 
dissolved in methanol (13 mL). 4-Nitrobenzenediazonium tetrafluoroborate (301 
mg, 1.27 mmol) was suspended in 10% sulfuric acid (13 mL) with vortexing. The 
organic solution was added to the aqueous mixture and stirred at ambient 
conditions for 1 hour. The solution was then neutralized with ammonium 
hydroxide, resulting in a purple precipitate. The mixture was filtered and the 
filtrand washed with chloroform (5 X 20 mL) to yield a purple solid (496 mg, 
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84%). This compound was dried in vacuo and used in the next reaction without 
further purification. 1H-NMR (DMSO-D6): δ 8.29 (d, 2H, J = 9.1 Hz), 7.83 (d, 2H, 
J = 9.1 Hz), 7.74 (s, 1H), 6.17 (s, 1H), 5.61 (s, 1H), 3.97 (s, 3H), 3.44 (s, 2H), 
3.00 (s, 3H), 1.36 (s, 6H). 13C-NMR (DMSO-D6): δ 161.6, 157.9, 152.6, 146.4, 
133.2, 132.9, 125.5, 124.8, 122.8, 115.4, 112.7, 93.9, 58.7, 56.6, 53.6, 32.5, 
29.0. HR-EIMS m/z calculated for C20H23N4O6S: 447.1338, found: 447.1337. 
 
 
(7-methoxy-1,2,2-trimethyl-1,2-dihydroquinolin-4-yl)-methanesulfonyl 
chloride (5). Compound 3 (616 mg, 1.93 mmol) was suspended in POCl3 (9.2 
mL) and stirred at room temperature. PCl5 (401 mg, 1.93 mmol) was added to the 
mixture and the reaction was stirred at room temperature overnight. The reaction 
was poured into ice water (200 mL) which resulted in the product crashing out as 
a red oil. Upon neutralizing with NaHCO3 (400 mL), the oil became a sticky solid 
which floated to the top of the solution. The product was then extracted with 
dichloromethane (800 mL), washed with brine (500 mL), and dried over sodium 
sulfate. Removal of the solvent under vacuum yielded the product as a viscous 
amber oil (504 mg, 83%). This compound was used without further purification. 
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1H-NMR (CDCl3): δ 7.07 (d, 1H, J = 8.5 Hz), 6.24 (dd, 1H, J = 2.3 Hz, 8.4 Hz), 
6.14 (br s, 1H), 5.67 (s, 1H), 4.67 (d, 2H, J = 0.5 Hz), 3.80 (s, 3H), 2.80 (s, 3H), 
1.37 (s, 6H). 13C-NMR (CDCl3): δ 161.6, 147.0, 137.4, 124.9, 120.7, 113.4, 100.7, 
99.2, 77.5, 68.2, 55.4, 30.0, 26.7. HR-EIMS m/z calculated for C14H19ClNO3S: 
316.0774, found: 316.0764. 
 
 
(7-methoxy-1,2,2-trimethyl-1,2-dihydroquinolin-4-yl)-methanesulfonic acid 
2,2,2-trifluoro-1-phenyl-ethyl ester (6). α-(Trifluoromethyl)-benzyl alcohol (0.18 
mL, 1.3 mmol) was dissolved in anhydrous dichloromethane (3 mL) and cooled 
to 0 °C in an ice bath. Triethylamine (0.12 mL, 0.84 mmol) was then added to the 
reaction. Compound 5 (132 mg, 0.418 mmol) dissolved in anhydrous 
dichloromethane (1.2 mL) was added dropwise via syringe to the reaction flask at 
a rate of 20 drops/min. Upon completion of the dropwise addition, the reaction 
was stirred at 0 °C for 1 hour.  The reaction was poured into 1 M hydrochloric 
acid (40 mL) and extracted with dichloromethane (1 X 50 mL and 3 X 20 mL). 
The organic phases were combined, washed with water (50 mL), sodium 
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bicarbonate (50 mL), brine (50 mL) and dried over sodium sulfate.  The solvent 
was evaporated and the crude material was purified by flash column 
chromatography (0-10% ethyl acetate/hexanes) to yield the product as a viscous, 
lime-green oil (122 mg, 64%). 1H-NMR (CDCl3): δ 7.48-7.39 (m, 5H), 6.96 (d, 1H, 
J = 8.5 Hz), 6.19 (dd, 1H, J = 2.4 Hz, 8.5 Hz), 6.09 (d, 1H, J = 2.4 Hz), 5.80 (q, 
1H, JHF = 6.3 Hz), 5.43 (s, 1H), 4.10 (d of ABq, 2H, ∆δAB = 0.03, JAB = 14.8 Hz, J 
= 0.7 Hz), 3.79 (s, 3H), 2.74 (s, 3H), 1.27 (s, 3H), 1.24 (s, 3H). 19F-NMR 
(CDCl3): δ -76.2 (d, J = 6.3 Hz). 13C-NMR (CD3OD): δ 161.4, 147.1, 135.1, 130.5, 
130.4, 128.8, 128.3, 124.8, 122.9 (q, 1JCF = 281 Hz), 120.9, 114.2, 100.5, 98.4, 
77.4 (q, 2JCF = 34 Hz), 56.3, 54.3, 54.1, 29.8, 25.4, 25.3. HR-EIMS m/z calculated 
for C22H25F3NO4S: 456.1456, found: 456.1457. 
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Acetic acid 4-[2,2,2-trifluoro-1-(7-methoxy-1,2,2-trimethyl-1,2-dihydro-
quinolin-4-ylmethanesulfonyloxy)-ethyl]-phenyl ester (7). Acetic acid 4-
(2,2,2-trifluoro-1-hydroxy-ethyl)-phenyl ester (AcOTFMB, Rusha and Miller, 2011) 
(212 mg, 0.904 mmol) was dissolved in anhydrous dichloromethane (4 mL) and 
cooled to 0 °C in an ice bath. Triethylamine (0.101 mL, 0.723 mmol) was then 
added to the reaction. Compound 5 (190 mg, 0.602 mmol) dissolved in 
anhydrous dichloromethane (2 mL, 31 mmol) was added dropwise via syringe to 
the reaction flask at a rate of 20 drops/min. Upon completion of dropwise 
addition, the reaction was stirred at 0 °C for 1 hour.  The reaction was poured 
into 1 M hydrochloric acid (60 mL) and extracted with dichloromethane (1 X 60 
mL and 4 X 20 mL). The organic phases were combined, washed with 0.1 M 
hydrochloric acid (4 X 20 mL), sodium bicarbonate (40 mL), brine (80 mL) and 
dried over sodium sulfate. The solvent was evaporated and the crude material 
was purified by flash column chromatography on two successive columns. The 
purest fractions from the first column (0-25% ethyl acetate/hexanes) were 
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separated on a second column with 0-2% methanol/dichloromethane to yield the 
product as a viscous, green oil (178 mg, 58%). 1H-NMR (CDCl3): δ 7.45 (d, 2H, J 
= 8.7 Hz), 7.14 (d, 2H, J = 8.8 Hz), 6.97 (d, 1H, J = 8.4 Hz), 6.20 (dd, 1H, J = 2.4 
Hz, 8.4 Hz), 6.09 (d, 1H, J = 2.3 Hz), 5.80 (q, 1H, JHF = 6.2 Hz), 5.45 (s, 1H), 
4.14 (d of ABq, 2H, ∆δAB = 0.03, JAB = 14.8 Hz, J = 0.7 Hz), 3.79 (s, 3H), 2.74 (s, 
3H), 2.31 (s, 3H), 1.27 (s, 3H), 1.24 (s, 3H). 19F-NMR (CDCl3): δ -76.2 (d, J = 6.2 
Hz). 13C-NMR (CD3OD): δ 169.5, 161.4, 152.6, 147.1, 135.1, 129.5, 127.9, 124.7, 
122.8 (q, 1JCF = 280 Hz), 122.2, 122.14, 121.5,120.9, 114.2, 100.5, 98.4, 76.6 (q, 
2JCF = 34 Hz), 56.3, 54.3, 53.9, 29.8, 25.4, 25.2, 19.7. HR-EIMS m/z calculated 
for C24H27F3NO6S: 514.1506, found: 514.1491. 
 
 
[7-Methoxy-1,2,2-trimethyl-6-(4-nitro-phenylazo)-1,2-dihydro-quinolin-4-yl]-
methanesulfonic acid 2,2,2-trifluoro-1-phenyl-ethyl ester (8). Compound 6 
(121 mg, 0.267 mmol) was dissolved in methanol (3 mL). 4-
Nitrobenzenediazonium tetrafluoroborate (63.1 mg, 0.267 mmol) was suspended 
in 10% sulfuric acid (3 mL) with vortexing. The organic solution was added to the 
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aqueous mixture and stirred at ambient conditions for 1 hour. The solution was 
then neutralized with ammonium hydroxide, resulting in a reddish-purple 
precipitate. The mixture was filtered and the filtrand washed with water (3 X 20 
mL) to yield a deep purple-black solid (144 mg, 89 %). This compound was dried 
in vacuo and used in the next reaction without further purification. 1H-NMR 
(CDCl3): δ 8.31 (d, 2H, J = 9.1 Hz), 7.90 (d, 2H, J = 9.1 Hz), 7.68 (s, 1H), 7.46-
7.33 (m, 5H), 6.06 (s, 1H), 5.81 (q, 1H, JHF = 6.3 Hz), 5.62 (s, 1H), 4.18 (ABq, 
2H, ∆δAB = 0.05, JAB = 14.8 Hz), 4.05 (s, 3H), 2.96 (s, 3H), 1.40 (s, 3H),1.38 (s, 
3H). 19F-NMR (CDCl3): δ -76.1 (d, J = 6.3 Hz). HR-EIMS: m/z calculated for 
C28H28F3N4O6S: 605.1676, found: 605.1653. 
 
 
Acetic acid 4-{2,2,2-trifluoro-1-[7-Methoxy-1,2,2-trimethyl-6-(4-nitro-
phenylazo)-1,2-dihydro-quinolin-4-ylmethanesulfonyloxy]-ethyl)-phenyl 
ester (9). Compound 7 (179 mg, 0.35 mmol) was dissolved in methanol (4 mL). 
4-Nitrobenzenediazonium tetrafluoroborate (83 mg, 0.35 mmol) was suspended 
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in 10% sulfuric acid (4 mL) with vortexing. The organic solution was added to the 
aqueous mixture and stirred at ambient conditions for 1 hour. The solution was 
then neutralized with ammonium hydroxide, resulting in a reddish-purple 
precipitate. The mixture was filtered and the filtrand washed with water (3 X 25 
mL) to yield a purple solid (185 mg, 80%). This compound was dried in vacuo 
and used in the next reaction without further purification. 1H-NMR (CD3OD): 
δ 8.32 (d, 2H, J = 9.1 Hz), 7.90 (d, 2H, J = 9.1 Hz), 7.70 (s, 1H), 7.47 (d, 2H, J = 
8.6 Hz), 7.09 (d, 2H, J = 8.7 Hz), 6.15 (s, 1H), 6.12 (q, 1H, JHF = 6.4 Hz), 5.65 (s, 
1H), 4.40 (s, 2H), 4.03 (s, 3H), 2.98 (s, 3H), 2.27 (s, 3H), 1.37 (s, 3H), 1.36 (s, 
3H). 19F-NMR (CD3OD): δ -78.0 (d, J = 6.4 Hz). HR-EIMS: m/z calculated for 
C30H30F3N4O8S: 663.1736, found: 663.1730. 
 
 
3-Chloro-propane-1-sulfonic acid 2,2,2-trifluoro-1-phenyl-ethyl ester (10). α-
(Trifluoromethyl)-benzyl alcohol (1.29 mL, 9.47 mmol) was dissolved in 
anhydrous dichloromethane (29 mL) and cooled to 0 °C in an ice bath. 
Triethylamine (0.879 mL, 6.31 mmol) was then added to the reaction. 3-
Chloropropanesulfonyl chloride (0.386 mL, 3.15 mmol) dissolved in anhydrous 
dichloromethane (2 mL) was added dropwise via syringe to the reaction flask at a 
rate of 20 drops/min. Upon completion of dropwise addition, the reaction was 
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stirred at 0 °C for 1 hour. The reaction was poured into 1 M hydrochloric acid 
(300 mL) and extracted with dichloromethane (1 X 300 mL and 4 X 60 mL). The 
combined organic phases were washed with water (200 mL), brine (250 mL) and 
dried over sodium sulfate. Removal of the solvent under vacuum yielded the 
product as a white solid (886 mg, 89%). 1H-NMR (CDCl3): δ 7.53-7.44 (m, 5H), 
5.78 (q, 1H, JHF = 6.4 Hz), 3.59 (t, 2H, J = 6.1 Hz), 3.30-3.17 (m, 2H), 2.31-2.22 
(m, 2H). 19F-NMR (CDCl3): δ -76.3 (d, J = 6.3 Hz). 13C-NMR (CD3OD): δ 130.6, 
130.5, 128.9, 128.2, 122.9 (q, 1JCF = 280 Hz), 77.6 (q, 2JCF = 34 Hz), 48.9, 41.9, 
26.7.  HR-EIMS m/z calculated for C11H12ClF3O3SNa: 339.0045, found: 
339.0060. 
 
 
3-Iodo-propane-1-sulfonic acid 2,2,2-trifluoro-1-phenyl-ethyl ester (11). 
Sodium iodide (757 mg, 5.05 mmol) was dissolved in acetone (5 mL). Compound 
10 (400 mg, 1.26 mmol) was added to the solution and the reaction was heated 
to reflux and stirred overnight. After cooling to room temperature, the mixture was 
filtered to remove sodium chloride and the filtrand was washed with acetone (40 
mL). The filtrate was concentrated under vacuum and the resulting residue was 
extracted between 75 mL ethyl acetate and 75 mL water. The organic phase was 
collected, dried over sodium sulfate, and the solvent removed via rotary 
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evaporation giving an amber oil. The crude material was purified by flash column 
chromatography (15% ethyl acetate/hexanes) to yield the compound as a yellow 
liquid (488 mg, 95%). 1H-NMR (CDCl3): δ 7.53-7.45 (m, 5H), 5.77 (q, 1H, JHF = 
6.3 Hz), 3.24-3.11 (m, 4H), 2.33-2.24 (m, 2H). 19F-NMR (CDCl3): δ -76.3 (d, J = 
6.3 Hz). 13C-NMR (CD3OD): δ 130.7, 130.5, 130.4, 128.9, 128.23, 128.22, 122.9 
(q, 1JCF = 280 Hz), 77.6 (q, 2JCF = 34 Hz), 52.2, 27.5, 0.8. HR-EIMS m/z 
calculated for C11H12F3O3SINa: 430.9402, found: 430.9382. 
 
 
Acetic acid 4-[1-(3-chloro-propane-1-sulfonyloxy)-2,2,2-trifluoro-ethyl]-
phenyl ester (12). Acetic acid 4-(2,2,2-trifluoro-1-hydroxy-ethyl)-phenyl ester 
(AcOTFMB, Rusha and Miller, 2011) (537 mg, 2.29 mmol) was dissolved in 
anhydrous dichloromethane (9 mL) and cooled to 0 °C in an ice bath. 
Triethylamine (0.32 mL, 2.29 mmol) was the added to the reaction. 3-
Chloropropanesulfonyl chloride (0.14 mL, 1.13 mmol) dissolved in anhydrous 
dichloromethane (2 mL) was added dropwise via syringe to the reaction flask at a 
rate of 20 drops/min. Upon completion of dropwise addition, the reaction was 
stirred at 0 °C for 1 hour.  The reaction was poured into 1 M hydrochloric acid 
(110 mL) and extracted with dichloromethane (1 X 110 mL and 4 X 20 mL). The 
combined organic phases were washed with water (75 mL), brine (90 mL), and 
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dried over sodium sulfate. Removal of the solvent under vacuum resulted in a 
yellowish oil. The crude product was purified by flash column chromatography (0-
2% methanol/dichloromethane) to yield the product as a clear viscous oil (386 
mg, 91%). 1H-NMR (CDCl3): δ 7.52 (d, 2H, J = 8.8 Hz), 7.21 (d, 2H, J = 8.8 Hz), 
5.79 (q, 1H, JHF = 6.3 Hz), 3.61 (t, 2H, J = 6.2 Hz), 3.33-3.20 (m, 2H), 2.32 (s, 
3H), 2.31-2.24 (m, 2H). 19F-NMR (CDCl3): δ -76.3 (d, J = 6.3 Hz). 13C-NMR 
(CDCl3): δ 169.5, 152.8, 129.5, 128, 122.8 (q, 1JCF = 280 Hz), 122.4, 76.9 (q, 2JCF 
= 34 Hz), 48.9, 41.9, 26.7, 19.7. HR-EIMS m/z calculated for C13H14ClF3O5SNa: 
397.0100, found: 397.0097. 
 
 
Acetic acid 4-[2,2,2-trifluoro-1-(3-iodo-propane-1-sulfonyloxy)-ethyl]-phenyl 
ester (13). Sodium iodide (398 mg, 2.66 mmol) was dissolved in acetone (2 mL). 
Compound 12 (249 mg, 0.664 mmol) was added to the solution and the reaction 
was heated to reflux and stirred for 17 hours. After cooling to room temperature, 
the mixture was filtered to remove sodium chloride and the filtrand was washed 
with acetone (25 mL). Acetone was removed via rotary evaporation and the 
resulting residue was extracted between 60 mL ethyl acetate and 60 mL water. 
The organic phase was collected and the aqueous phase was washed with ethyl 
acetate (2 X 50 mL). The combined organic phases were washed with brine (75 
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mL), dried over sodium sulfate, and the solvent removed via rotary evaporation 
giving an amber oil. The crude material was purified by flash column 
chromatography (15% ethyl acetate/hexanes) to yield the product as a viscous 
yellow oil (300 mg, 97%). 1H-NMR (CDCl3): δ 7.52 (d, 2H, J = 8.8 Hz), 7.21 (d, 
2H, J = 8.8 Hz), 5.78 (q, 1H, JHF = 6.3 Hz), 3.24-3.17 (m, 4H), 2.33-2.26 (m, 5H), 
2.32 (s, 3H). 19F-NMR (CDCl3): δ -76.3 (d, J = 6.3 Hz). 13C-NMR (CD3OD): 
δ 169.6, 152.8, 129.6, 127.9, 122.8 (q, 1JCF = 280 Hz), 122.5, 77.0 (q, 2JCF = 34 
Hz), 52.3, 27.5, 19.9, 1.1. HR-EIMS m/z calculated for C13H14F3O5SINa: 
488.9456, found: 488.9482. 
 
 
7-Methoxy-3,4-dihydro-1H-quinolin-2-one (14) (Tsuritani et al., 2009). 7-
Hydroxy-3,4-dihydroquinolin-2(1H)-one (1.5 g, 9.2 mmol) was dissolved in DMF 
(10 mL) and potassium carbonate (1.85 g, 13.4 mmol) was added. Methyl iodide 
(0.7 mL, 11 mmol) was added to the mixture and the reaction was stirred at room 
temperature overnight. The reaction was poured into water (100 mL) and 
neutralized with 1 M HCl. The compound was extracted with ethyl acetate (6 X 
50 mL) and the combined organic phases were washed with water (200 mL), 1:1 
saturated Na2S2O3: brine (200 mL), and brine (200 mL). The organic phase was 
dried over sodium sulfate and solvent was removed via rotary evaporation. The 
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crude material was purified by flash column chromatography (50% ethyl 
acetate/hexanes) to yield the product as a white crystalline solid (1.34 g, 82%). 
1H-NMR (CDCl3): δ 7.77 (br s, 1H), 7.06 (d, 1H, J = 8.3 Hz), 6.53 (dd, 1H, J = 2.5 
Hz, 8.3 Hz), 6.30 (d, 1H, J = 2.4 Hz), 3.78 (s, 3H), 2.90 (t, 2H, J = 7.9 Hz), 2.62 
(t, 2H, J = 7.8 Hz). HR-EIMS m/z calculated for C10H12NO2: 178.0868, found: 
178.0867. 
 
 
7-Methoxy-1,2,3,4-tetrahydroquinoline (15). Compound 14 (1 g, 5.6 mmol) 
was dissolved in THF (10 mL) and cooled to 0 °C. 1M BH3·THF (70 mL, 70 
mmol) was added to the solution dropwise through an addition funnel over 1 hour 
and the reaction was refluxed overnight. The reaction was then cooled to 0 °C 
and quenched by the slow addition of methanol (24 mL). After quenching, the 
reaction was acidified with concentrated hydrochloric acid (10 mL) and heated to 
65 °C for 1 hour. The reaction was then cooled to 0 °C, neutralized with 
concentrated sodium hydroxide, and extracted with ethyl acetate (1 X 300 mL 
and 3 X 50 mL). The organic phases were combined, washed with brine (300 
mL) and dried over sodium sulfate. Solvent was removed via rotary evaporation 
and crude material was purified by flash column chromatography (25% ethyl 
acetate/hexanes) to yield the product as a bright yellow oil (820 mg, 89%). 1H-
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NMR (CDCl3): δ 6.83 (d, 1H, J = 8.2 Hz), 6.20 (dd, 1H, J = 2.5 Hz, 8.2 Hz), 6.03 
(d, 1H, J = 2.5 Hz), 3.80 (br s, 1H), 3.73 (s, 3H), 3.28 (t, 2H, J = 5.5 Hz), 2.69 (t, 
3H, J = 6.4 Hz), 1.95-1.88 (m, 2H). 13C-NMR (CDCl3): δ 159.2, 146.0, 130.4, 
114.3, 103.0, 99.7, 55.4, 42.3, 26.7, 22.8. HR-EIMS m/z calculated for C10H14NO: 
164.1075, found: 164.1075. 
 
 
3-(7-Methoxy-3,4-dihydro-2H-quinolin-1-yl)-propane-1-sulfonic acid (16). 
Compound 15 (100 mg, 0.61 mmol) and 1,3-Propanesultone (300 mg, 2.5 mmol) 
were dissolved in methanol (2 mL) and stirred overnight at room temperature. 
The solvent was removed via rotary evaporation and the crude material purified 
by flash column chromatography (0-20 % methanol/dichloromethane) to give an 
orange oil. This material was dissolved in deuterated methanol and concentrated 
under vacuum five times to remove residual methanol and dichloromethane, 
yielding the compound as a white solid (83 mg, 48%). 1H-NMR (CD3OD): δ 6.74 
(d, 1H, J = 8.1 Hz), 6.19 (d, 1H, J = 2.4 Hz), 6.07 (dd, 1H, J = 2.4 Hz, 8.1 Hz), 
3.70 (s, 3H), 3.36 (t, 2H, J = 7.3 Hz), 3.25 (t, 2H, J = 5.5 Hz), 2.89 (t, 2H, J = 7.6 
Hz), 2.63 (t, 2H, J = 6.3 Hz), 2.05 (p, 2H, J = 7.6 Hz), 1.91-1.85 (m, 2H). 13C-
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NMR (CD3OD): δ 159.5, 146.0, 129.3, 115.3, 97.4, 54.3, 49.9, 49.2, 49.0, 27.3, 
22.5, 21.7. HR-EIMS m/z calculated for C13H20NO4S: 286.1113, found: 286.1134. 
 
 
3-[7-Methoxy-6-(4-nitro-phenylazo)-3,4-dihydro-2H-quinolin-1-yl]-propane-1-
sulfonic acid (17). Compound 16 (200 mg, 0.7 mmol) was dissolved in methanol 
(7 mL). 4-Nitrobenzenediazonium tetrafluoroborate (165 mg, 0.696 mmol) was 
suspended in 10% sulfuric acid (7 mL) with vortexing. The organic solution was 
added to the aqueous mixture and stirred at ambient conditions for 1 hour. The 
solution was then neutralized with ammonium hydroxide, resulting in a purple 
precipitate. The mixture was filtered and the filtrand washed with chloroform (10 
X 10 mL) to yield a deep purple solid. The solid was then washed with ethanol 
(600 mL) to separate the product from ammonium sulfate. The filtrate was 
concentrated under vacuum to yield the product as a purple solid (239 mg, 78%). 
This compound was used in the next reaction without further purification. 1H-
NMR (CD3OD): δ 8.27 (d, 2H, J = 9.2 Hz), 7.83 (d, 2H, J = 9.1 Hz), 7.50 (s, 1H), 
6.44 (s, 1H), 4.02 (s, 3H), 3.68 (t, 2H, J = 7.7 Hz), 3.47 (t, 2H, J = 6.3 Hz), 2.91 (t, 
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2H, J = 6.9 Hz), 2.71 (m, 2H), 2.16 (p, 2H, J = 7 Hz), 1.94 (p, 2H, J = 6.4 Hz). 
HR-EIMS m/z calculated for C19H23N4O6S: 435.1338, found: 435.1336.  
 
 
3-(7-Methoxy-3,4-dihydro-2H-quinolin-1-yl)-propane-1-sulfonic acid 2,2,2-
trifluoro-1-phenyl-ethyl ester (18). Compound 15 (163 mg, 0.996 mmol) was 
dissolved in DMF (3 mL). Compound 11 (488 mg, 1.2 mmol) and potassium 
carbonate (193 mg, 1.39 mmol) were added to the solution and the reaction was 
heated to 65 °C and stirred overnight. The reaction was poured into 0.5 M 
hydrochloric acid (40 mL) and extracted with ethyl acetate (1 X 40 mL and 4 X 20 
mL). The combined organic phases were washed with brine (75 mL) and dried 
over sodium sulfate. The solvent was removed by rotary evaporation to give a 
thick orange residue. The crude material was purified by flash column 
chromatography (20% ethyl acetate/hexanes) to yield the product as a viscous, 
red oil (244 mg, 55%). 1H-NMR (CDCl3): δ 7.51-7.40 (m, 5H), 6.86 (d, 1H, J = 8.2 
Hz), 6.18 (dd, 1H, J = 2.4 Hz, 8.2 Hz), 6.05 (d, 1H, J = 2.4 Hz), 5.76 (q, 1H, JHF = 
6.4 Hz), 3.76 (s, 3H), 3.32-3.26 (m, 2H), 3.13 (t, 2H, J = 5.5 Hz), 3.10-3.00 (m, 
2H), 2.66 (t, 2H, J = 6.2 Hz), 2.07 (p, 2H, J = 7.3 Hz), 1.90-1.83 (m, 2H). 19F-
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NMR (CDCl3): δ -76.3 (d, J = 6.3 Hz). 13C-NMR (CD3OD): δ 159.5, 145.7, 130.6, 
130.4, 129.6, 128.9, 128.2, 122.9 (q, 1JCF = 280 Hz), 115.4, 100.9, 97.3, 77.7 (q, 
2JCF = 34 Hz), 54.4, 49.3, 49.1, 49, 27.2, 22.4, 20.4. HR-EIMS: m/z calculated for 
C21H25F3NO4S: 444.1456, found: 444.1470.  
 
 
Acetic acid 4-{2,2,2-trifluoro-1-[3-(7-methoxy-3,4-dihydro-2H-quinolin-1-yl)-
propane-1-sulfonyloxy]-ethyl}-phenyl ester (19). Compound 15 (100 mg, 
0.613 mmol) was dissolved in DMF (1.2 mL). Compound 13 (343 mg, 0.735 
mmol) and potassium carbonate (119 mg, 0.858 mmol) were added to the 
solution and the reaction was heated to 65 °C and stirred overnight. The reaction 
was poured into 0.5 M hydrochloric acid (30 mL) and extracted with ethyl acetate 
(1 X 30 mL and 5 X 10 mL). The combined organic phases were washed with 
brine (40 mL) and dried over sodium sulfate. Solvent was removed by rotary 
evaporation to give a thick orange residue. The crude material was purified by 
flash column chromatography (0-25% ethyl acetate/hexanes) to yield the product 
as an extremely viscous, amber oil (149 mg, 48%). 1H-NMR (CDCl3): δ 7.50 (d, 
2H. J = 8.7 Hz), 7.18 (d, 2H, J = 8.7 Hz), 6.86 (d, 1H, J = 8.2 Hz), 6.18 (dd, 1H, J 
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= 2.4 Hz, 8.1 Hz), 6.08 (d, 1H, J = 2.4 Hz), 5.77 (q, 1H, JHF = 6.3 Hz), 3.76 (s, 
3H), 3.32 (t, 2H, J = 6.6 Hz), 3.15 (t, 2H, J = 5.5 Hz), 3.12-3.03 (m, 2H), 2.67 (t, 
2H, J = 6.3 Hz), 2.32 (s, 3H), 2.10 (p, 2H, J = 7.3 Hz), 1.92-1.84 (m, 2H). 19F-
NMR (CDCl3): δ -76.3 (d, J = 6.3 Hz). 13C-NMR (CD3OD): δ 169.5, 159.5, 152.8, 
145.7, 129.55, 129.5, 127.9, 122.8 (q, 1JCF = 280 Hz), 122.4, 115.4, 100.8, 97.3, 
77.0 (q, 2JCF = 34 Hz), 54.4, 49.3, 49.1, 49.0, 27.2, 22.4, 20.4, 19.8. HR-EIMS: 
m/z calculated for C23H27F3NO6S: 502.1506, found: 502.1492.  
 
 
3-[7-Methoxy-6-(4-nitro-phenylazo)-3,4-dihydro-2H-quinolin-1-yl]-propane-1-
sulfonic acid 2,2,2-trifluoro-1-phenyl-ethyl ester (20). Compound 18 (120 mg, 
0.271 mmol) was dissolved in methanol (2.7 mL). 4-Nitrobenzenediazonium 
tetrafluoroborate (64.2 mg, 0.271 mmol) was suspended in 10% sulfuric acid (2.7 
mL) with vortexing. The organic solution was added to the aqueous mixture and 
stirred at ambient conditions for 1 hour. The solution was then neutralized with 
ammonium hydroxide, resulting in a purple precipitate. The mixture was filtered 
and the filtrand washed with water (3 X 25 mL) and dried in vacuo to yield a 
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shiny, green and purple solid (132 mg, 82%). This compound was used in the 
next reaction without further purification. 1H-NMR (CDCl3): δ 8.29 (d, 2H, J = 9.1 
Hz), 7.87 (d, 2H, J = 8.9 Hz), 7.59 (s, 1H), 7.50-7.42 (m, 5H), 6.18 (s, 1H), 5.79 
(q, 1H, JHF = 6.3 Hz), 3.99 (s, 3H), 3.62-3.49 (m, 2H), 3.32 (t, 2H, J = 5.5 Hz), 
3.13 (t, 2H, J = 6.9 Hz), 2.73 (t, 2H, J = 6.0 Hz), 2.25-2.13 (m, 2H), 1.93 (p, 2H, J 
= 6.1 Hz). 19F-NMR (CDCl3): δ -76.2 (d, J = 6.3 Hz). HR-EIMS: m/z calculated for 
C27H28F3N4O6S: 593.1676, found: 593.1666. 
 
 
Acetic acid 4-(2,2,2-trifluoro-1-{3-[7-methoxy-6-(4-nitro-phenylazo)-3,4-
dihydro-2H-quinolin-1-yl]-propane-1-sulfonyloxy}-ethyl)-phenyl ester (21). 
Compound 19 (85 mg, 0.17 mmol) was dissolved in methanol (2 mL). 4-
Nitrobenzenediazonium tetrafluoroborate (40 mg, 0.17 mmol) was suspended in 
10% sulfuric acid (2 mL) with vortexing. The organic solution was added to the 
aqueous mixture and stirred at ambient conditions for 1 hour. The solution was 
neutralized with ammonium hydroxide resulting in a purple precipitate. The 
mixture was filtered and the filtrand washed with water (4 X 20 mL) and dried in 
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vacuo to yield a sticky, deep-purple solid with greenish spots (91 mg, 82%). This 
compound was used in the next reaction without further purification. 1H-NMR 
(CDCl3): δ 8.29 (d, 2H, J = 9.1 Hz), 7.87 (d, 2H, J = 9 Hz), 7.59 (s, 1H), 7.51 (d, 
2H, J = 8.5 Hz), 7.19 (d, 2H, J = 8.7 Hz), 6.19 (s, 1H), 5.80 (q, 1H, JHF = 6.2 Hz), 
4.00 (s, 3H), 3.63-3.49 (m, 2H), 3.33 (t, 2H, J = 5.5 Hz), 3.15 (t, 2H, J = 6.8 Hz), 
2.73 (t, 2H, J = 6.1 Hz), 2.32 (s, 3H), 2.26-2.13 (m, 2H), 1.94 (p, 2H, J = 6.1 Hz). 
19F-NMR (CDCl3): δ -76.2 (d, J = 6.2 Hz). HR-EIMS: m/z calculated for 
C29H30F3N4O8S: 651.1731, found: 651.1714. 
 
 
1-Ethyl-10,10,11-trimethyl-8-sulfomethyl-3,4,10,11-tetrahydro-2H-13-oxa-
6,11-diaza-1-azonia-pentacene trifluoroacetate (22). Compound 4 (150 mg, 
0.324 mmol) and 1-Ethyl-1,2,3,4-tetrahydro-quinolin-7-ol (Miller, 2009) (57.4 mg, 
0.324 mmol) were dissolved in a solution of ethanol: water: hydrochloric acid 
(3.24 mL: 324 μL: 162 μL) and heated to 80 °C with stirring for 2 hours. Solvent 
was removed via rotary evaporation to give a fluorescent blue residue. The crude 
material was purified by flash column chromatography (0-25% 
methanol/dichloromethane) yielding the product as a blue solid (chloride 
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counterion) (76 mg, 48%). This compound was further purified by HPLC (Method 
A) to yield the product (trifluoroacetate counterion) in 99% purity. 1H-NMR 
(CD3OD): δ 7.77 (s, 1H), 7.41 (s, 1H), 6.88 (s, 1H), 6.78 (s, 1H), 6.04 (s, 1H), 
4.00 (s, 2H), 3.73-3.65 (m, 4H), 3.25 (s, 3H), 2.91 (t, 2H, J = 6 Hz), 2.04 (p, 2H, J 
= 6.6 Hz), 1.60 (s, 6H), 1.34 (t, 3H, J = 7.1 Hz). 13C-NMR (CD3OD): δ 154.6, 
154.4, 154.3, 148.7, 138.4, 134.8, 134.2, 130.6, 129.5, 126.2, 124.0, 123.1, 95.0, 
94.97, 63.5, 61.2, 53.1, 50.0, 33.1, 27.6, 27.2, 20.8, 10.5. HR-EIMS m/z 
calculated for C24H28N3O4S: 454.1801, found: 454.1785. 
 
 
1-Ethyl-10,10,11-trimethyl-8-(2,2,2-trifluoro-1-phenyl-ethoxysulfonylmethyl)-
3,4,10,11-tetrahydro-2H-13-oxa-6,11-diaza-1-azonia-pentacene 
trifluoroacetate (23). Compound 8 (44 mg, 73 μmol) and 1-Ethyl-1,2,3,4-
tetrahydro-quinolin-7-ol (Miller, 2009) (13 mg, 73 μmol) were dissolved in acetic 
acid (0.5 mL) and heated to 80 °C with stirring for 2 hours. Acetic acid was 
removed by azeotroping with toluene under rotary evaporation to give a 
fluorescent blue residue. The crude material was purified by flash column 
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chromatography (0-10% methanol/dichloromethane) yielding the product as a 
blue solid (acetate counterion) (23 mg, 47%). This compound was further purified 
by HPLC (Method B) to yield the product (trifluoroacetate counterion) in 99% 
purity. 1H-NMR (CD3OD): δ 7.60 (s, 1H), 7.52-7.5 (m, 2H), 7.45 (s, 1H), 7.43-7.36 
(m, 2H), 6.93 (s, 1H), 6.73 (s,1H), 6.17 (q, 1H, JHF = 6.4 hz), 6.04 (s, 1H), 4.59 
(ABq, 2H, ∆δAB = 0.05, JAB = 14.8 Hz), 3.77-3.70 (m, 4H), 3.18 (s, 3H), 2.94 (t, 
2H, J = 5.7 Hz), 2.05 (p, 2H, J = 6.1 Hz), 1.53 (s, 3H), 1.50 (s, 3H), 1.35 (t, 3H, J 
= 7.1 Hz). 19F-NMR (CD3OD): δ -77.3 (br s), -77.7 (d, J = 6.4 Hz). 13C-NMR 
(CD3OD): δ 155.1, 153.5, 149.7, 149.1, 141.0, 135.9, 133.1, 130.8, 130.5, 130.4, 
130.3, 128.8, 128.3, 125.9, 122.0, 121.4, 119.1, 112.6, 112.0, 95.4, 95.3, 77.4, 
60.9, 53.0, 50.3, 32.9, 27.5, 27.4, 27.2, 20.7, 10.6. HR-EIMS m/z calculated for 
C32H33F3N3O4S: 612.2144, found: 612.2162. 
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8-[1-(4-Acetoxy-phenyl)-2,2,2-trifluoro-ethoxysulfonylmethyl]-1-ethyl-
10,10,11-trimethyl-3,4,10,11-tetrahydro-2H-13-oxa-6,11-diaza-1-azonia-
pentacene trifluoroacetate (24). Compound 9 (60 mg, 90 μmol) and 1-Ethyl-
1,2,3,4-tetrahydro-quinolin-7-ol (Miller, 2009) (16.1 mg, 90 μmol) were dissolved 
in acetic acid (0.5 mL) and heated to 80 °C with stirring for 70 minutes. Acetic 
acid was removed by azeotroping with toluene under rotary evaporation to give a 
fluorescent blue residue. The crude material was purified by flash column 
chromatography (0-10% methanol/dichloromethane) yielding the acetate salt as 
a blue solid (17 mg, 25%). This compound was further purified by HPLC (Method 
C) to yield the product (trifluoroacetate counterion) in 99% purity. 1H-NMR 
(CD3OD): δ 7.60 (s, 1H), 7.54-7.5 (m, 3H), 7.12 (d, 2H, J = 8.7 Hz), 6.96 (s, 1H), 
6.75 (s, 1H), 6.19 (q, 1H, JHF = 6.3 Hz), 6.04 (s, 1H), 4.62 (s, 2H), 3.79-3.72 (m, 
4H), 3.20 (s, 3H), 2.96 (t, 2H, J = 5.7 Hz), 2.25 (s, 3H), 2.07 (p, 2H, J = 6 Hz), 
1.53 (s, 3H), 1.51 (s, 3H), 1.37 (t, 3H, J = 7.2 Hz). 19F-NMR (CD3OD): δ -77.3 (br 
s), -77.9 (d, J = 6.3 Hz). 13C-NMR (CD3OD): δ 169.3, 155.1, 153.5, 152.7, 149.8, 
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149.1, 141.0, 135.9, 133.2, 130.9, 130.3, 129.7, 127.6, 125.9, 122.2, 122.1, 
119.1, 95.4, 95.3, 77.1, 61.0, 52.8, 50.3, 32.9, 27.5, 27.4, 27.2, 20.7, 19.7, 10.6. 
HR-EIMS m/z calculated for C34H35F3N3O6S: 670.2198, found: 670.2176.  
 
 
1-Ethyl-11-(3-sulfo-propyl)-3,4,8,9,10,11-hexahydro-2H-13-oxa-6,11-diaza-1-
azonia-pentacene trifluoroacetate (25). Compound 17 (25 mg, 56 µmol) and 1-
Ethyl-1,2,3,4-tetrahydro-quinolin-7-ol (Miller, 2009) (10 mg, 56 µmol) were 
dissolved in a solution of ethanol: water: hydrochloric acid (0.5 mL: 50 μL: 25 μL) 
and heated to 80 °C with stirring for 2 hours. Solvent was removed via rotary 
evaporation to give a fluorescent blue residue. The crude material was purified 
by flash column chromatography (0-10% methanol/dichloromethane) yielding the 
product as a blue solid (chloride counterion) (21 mg, 76%). This compound was 
further purified by HPLC (Method D) to yield the product (trifluoroacetate 
counterion) in 99% purity. 1H-NMR (CD3OD): δ 7.40 (s, 1H), 7.39 (s, 1H), 7.03 (s, 
1H), 6.88 (s, 1H), 6.04 (s, 1H), 3.82 (t, 2H, J = 7.9 Hz), 3.73-3.67 (m, 6H), 2.94-
2.9 (m, 6H), 2.18 (p, 2H, J = 5.0 Hz), 2.04 (p, 4H, J = 5.4 Hz), 1.34 (t, 3H, J = 7.1 
Hz). 13C-NMR (CD3OD): δ 154.5, 154.3, 148.9, 148.7, 134.2, 133.9, 130.5, 
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130.48, 129.3, 128.9, 95.4, 94.9, 51.7, 50.6, 50, 27.3, 22, 20.8, 20.7, 10.5. HR-
EIMS m/z calculated for C23H28N3O4S: 442.1801, found: 442.1779. 
 
 
1-ethyl-11-[3-(2,2,2-trifluoro-1-phenyl-ethoxysulfonyl)-propyl]-3,4,8,9,10,11-
hexahydro-2H-13-oxa-6,11-diaza-1-azonia-pentacene trifluoroacetate (26). 
Compound 20 (33 mg, 56 μmol) and 1-Ethyl-1,2,3,4-tetrahydro-quinolin-7-ol 
(Miller, 2009) (10 mg, 56 μmol) were dissolved in acetic acid (0.5 mL) and heated 
to 80 °C with stirring for 110 minutes. Acetic acid was removed by azeotroping 
with toluene under rotary evaporation to give a fluorescent blue residue. The 
crude material was purified by flash column chromatography (0-10% 
methanol/dichloromethane) yielding the acetate salt as a blue solid (21 mg, 
57%). This compound was further purified by HPLC (Method E) to yield the 
product (trifluoroacetate counterion) in 99% purity. 1H-NMR (CD3OD): δ 7.57-7.56 
(m, 2H), 7.51-7.5 (m, 2H), 7.43-7.4 (m, 3H), 6.95 (s,1H), 6.82 (s, 1H), 6.14 q, 1H, 
JHF = 6.5 Hz), 3.78- 3.65 (m, 6H), 3.54 (t, 2H, J = 5 Hz), 3.45-3.34 (m, 2H), 2.97-
2.90 (m, 4H), 2.16-1.96 (m, 6H), 1.36 (t, 3H, J = 7.1 Hz). 19F-NMR (CD3OD): δ -
77.3 (br s), -78.1 (d, J = 6.4 Hz). 13C-NMR (CD3OD): δ 154.9, 154.0, 149.1, 
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148.5, 135.2, 133.5, 130.8, 130.7, 130.54, 130.5, 130, 128.9, 128.5, 128.2, 122.9 
(q, 1JCF = 280 Hz), 95, 94.9, 77.6 (q, 2JCF = 34 Hz), 73.9, 50.5, 50.4, 50.2, 34.1, 
27.22, 27.2, 20.7, 20.6, 20.5, 10.6 . HR-EIMS m/z calculated for C31H33F3N3O4S: 
600.2144, found: 600.2152. 
  
 
11-{3-[1-(4-acetoxy-phenyl)-2,2,2-trifluoro-ethoxysulfonyl]-propyl}-1-ethyl-
3,4,8,9,10,11-hexahydro-2H-13-oxa-6,11-diaza-1-azonia-pentacene 
trifluoroacetate (27). Compound 21 (42 mg, 65 μmol) and 1-Ethyl-1,2,3,4-
tetrahydro-quinolin-7-ol (Miller, 2009) (12 mg, 65 μmol) were dissolved in acetic 
acid (0.5 mL) and heated to 80 °C with stirring for 70 minutes. Acetic acid was 
removed by azeotroping with toluene under rotary evaporation to give a 
fluorescent blue residue. The crude material was purified by flash column 
chromatography (0-10% methanol/dichloromethane) yielding the acetate salt as 
a blue solid (22 mg, 47%). This compound was further purified by HPLC (Method 
F) to yield the product (trifluoroacetate counterion) in 99% purity. 1H-NMR 
(CD3OD): δ 7.62 (d, 2H, J = 8.6 Hz), 7.473-7.457 (m, 2H), 7.18 (d, 2H, J = 8.7 
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Hz), 6.92 (s, 1H), 6.77 (s, 1H), 6.19 (q, 1H, JHF = 6.4 Hz), 3.76-3.58 (m, 6H), 3.53 
(t, 2H, J = 5.4 Hz), 3.46-3.3 (m, 2H), 2.96-2.88 (m, 4H), 2.22 (s, 3H), 2.12-1.95 
(m, 6H) 1.35 (t, 3H, J = 7.1 Hz). 19F-NMR (CD3CN): δ -76 (br s), -77.4 (d, J = 6.3 
Hz). 13C-NMR (CD3OD): δ 169.4, 154.8, 154.0, 152.8, 149.1, 148.5, 135.1, 133.5, 
130.74, 130.7, 130, 129.6, 128.6, 127.9, 122.8 (q, 1JCF = 281 Hz), 122.4, 95, 
94.9, 77 (q, 2JCF = 34 Hz), 50.5, 50.4, 50.2, 27.22, 27.2, 20.7, 20.6, 20.5, 19.7, 
10.5. HR-EIMS m/z calculated for C33H35F3N3O6S: 658.2198, found: 658.2165. 
 
 
1,2,3,4-tetrahydroquinolin-7-ol (28). 7-hydroxy-3,4-dihydroquinolin-2(1H)-one 
(2.19 g, 13.4 mmol) was dissolved in THF (20 mL) and cooled to 0 °C. 1 M 
BH3·THF (136 mL, 136 mmol) was added to the solution dropwise via an addition 
funnel. The reaction flask was then fitted with a condenser and refluxed 
overnight. The solution was cooled to 0 °C and excess borane was quenched by 
the slow addition of methanol (24 mL). The solution was then acidified with 
concentrated hydrochloric acid (12 mL) and heated to 60 °C for 1 hour. The 
reaction was then neutralized with concentrated sodium hydroxide and extracted 
with ethyl acetate (1 X 200 mL and 3 X 50 mL). The combined organic phases 
were washed with water (2 X 100 mL), brine (1 X 80 mL and 3 X 50 mL), and 
dried over sodium sulfate. Evaporation of the solvent resulted in a viscous yellow 
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oil. This crude material was purified by flash column chromatography (0-25% 
ethyl acetate/hexanes) to yield the product as a white crystalline solid (1.91 g, 
94%). 1H-NMR (CDCl3): δ 6.79 (d, 1H, J = 8.1 Hz), 6.09 (dd, 1H, J = 2.5 Hz, 8.1 
Hz), 5.97 (d, 1H, J = 2.5 Hz), 4.19 (br s, 1H), 3.27 (t, 2H, J = 5.5 Hz), 2.68 (t, 2H, 
J = 6.4 Hz), 1.94-1.88 (m, 2H). 13C-NMR (CDCl3): δ 155, 145.4, 130.6, 114.7, 
105.7, 101.9, 42.2, 26.4, 22.6. HR-EIMS: m/z calculated for C9H12NO: 150.0919, 
found: 150.0938. 
 
 
3-(7-Hydroxy-3,4-dihydro-2H-quinolin-1-yl)-propane-1-sulfonic acid 2,2,2-
trifluoro-1-phenyl-ethyl ester (29). Compound 28 (50 mg, 0.34 mmol) was 
dissolved in DMF (0.7 mL). Compound 11 (164 mg, 0.4 mmol) and potassium 
carbonate (56 mg, 0.4 mmol) were added to the solution and the reaction was 
heated to 65 °C and stirred overnight. The reaction was poured into 0.5 M 
hydrochloric acid (10 mL) and extracted with ethyl acetate (1 X 12 mL and 4 X 10 
mL). The combined organic phases were washed with water (10 mL), brine (10 
mL) and dried over sodium sulfate. The solvent was removed by rotary 
evaporation to give a red-purple oil. The crude material was purified by flash 
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column chromatography (0-25% ethyl acetate/hexanes) to yield the product as a 
viscous, amber oil (63 mg, 44%). 1H-NMR (CDCl3): δ 7.52-7.41 (m, 5H), 6.79 (d, 
1H, J = 8.0 Hz), 6.07 (dd, 1H, J = 2.3 Hz, 7.9 Hz), 5.98 (d, 1H, J = 2.4 Hz), 5.76 
(q, 1H, JHF = 6.3 Hz), 3.29-3.25 (m, 2H), 3.14-3 (m, 4H), 2.65 (t, 2H, J = 6.2 Hz), 
2.10-2.03 (m, 2H), 1.89-1.83 (m, 2H). 19F-NMR (CDCl3): δ -76.3 (d, J = 6.3 Hz). 
13C-NMR (CD3OD): δ 156.3, 145.8, 130.6, 130.4, 129.6, 128.9, 128.2, 122.9 (q, 
1JCF = 280 Hz), 114.2, 103.0, 98, 77.7 (q, 2JCF = 35 Hz), 49.4, 49.2, 49.0, 27.2, 
22.5, 20.7. HR-EIMS: m/z calculated for C20H23F3NO4S: 430.1300, found: 
430.1316.  
 
 
7-(tert-Butyl-dimethyl-silanyloxy)-1,2,3,4-tetrahydro-quinoline (30). 
Compound 28 (1 g, 6.7 mmol) was dissolved in DMF (14 mL). Imidazole (1.14 g, 
16.8 mmol) and tert-butyldimethylchlorosilane (1.2 g, 8.0 mmol) were added to 
the solution and the reaction was stirred at room temperature overnight. The 
reaction was then poured into 5% NaHCO3 (200 mL) and extracted with ethyl 
acetate (6 X 75 mL). The combined organic phases were washed with brine (175 
mL) and dried over sodium sulfate. The solvent was removed by rotary 
evaporation and the crude material was purified by flash column chromatography 
(0-10% ethyl acetate/hexanes) yielding the product as a yellow-white solid (1.5 g, 
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83%). 1H-NMR (CDCl3): δ 6.76 (d, 1H, J = 8.1 Hz), 6.11 (dd, 1H, J = 2.4 Hz, 8.1 
Hz), 5.98 (d, 1H, J = 2.4 Hz), 3.73 (br s, 1H), 3.26 (t, 2H, J = 5.5 Hz), 2.68 (t, 2H, 
J = 6.4 Hz), 1.94-1.88 (m, 2H), 0.96 (s, 9H), 0.17 (s, 6H). 13C-NMR (CDCl3): 
δ 154.8, 145.9, 130.2, 114.8, 109.1, 105.8, 42.2, 26.8, 26.2, 22.8, 18.6, -4. HR-
EIMS: m/z calculated for C15H26NOSi: 264.1784, found: 264.1752. 
  
 
3-[7-(tert-Butyl-dimethyl-silanyloxy)-3,4-dihydro-2H-quinolin-1-yl]-propane-
1-sulfonic acid 2,2,2-trifluoro-1-phenyl-ethyl ester (31). Compound 30 (100 
mg, 0.38 mmol) was dissolved in DMF (0.75 mL). Compound 11 (186 mg, 0.46 
mmol) and potassium carbonate (63 mg, 0.46 mmol) were added to the solution 
and the reaction was heated to 65 °C and stirred overnight. The reaction was 
poured into 0.5 M hydrochloric acid (30 mL) and extracted with ethyl acetate (1 X 
30 mL and 4 X 20 mL). The combined organic phases were washed with water 
(30 mL), brine (50 mL) and dried over sodium sulfate. The solvent was removed 
by rotary evaporation and the crude material was purified by flash column 
chromatography (0-10% ethyl acetate/hexanes) to yield a yellow liquid. This 
material was further purified by gravity column chromatography (25% 
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acetone/hexanes) to yield the product as a viscous, yellow oil (155 mg, 75%). 1H-
NMR (CDCl3): δ 7.49-7.4 (m, 5H), 6.77 (d, 1H, J = 8.0 Hz), 6.10 (dd, 1H, J = 2.3 
Hz, 8.0 Hz), 5.98 (d, 1H, J = 2.3 Hz), 5.78 (q, 1H, JHF = 6.4 Hz), 3.28-3.24 (m, 
2H), 3.13-3 (m, 4H), 2.64 (t, 2H, J = 6.3 Hz), 2.07 (p, 2H, J = 7.3 Hz), 1.85 (p, 2H, 
J = 6.5 Hz), 0.97 (s, 9H), 0.18 (s, 6H). 19F-NMR (CDCl3): δ -76.3 (d, J = 6.4 Hz). 
13C-NMR (CD3OD): δ 154.9, 145.7, 130.6, 130.4, 129.5, 128.9, 128.2, 122.9 (q, 
1JCF = 280 Hz), 116.0, 107.7, 102.9, 77.7 (q, 2JCF = 34 Hz), 49.3, 49.13, 49.1, 
27.2, 25.1, 22.3, 20.5, 17.9, -5.3. HR-EIMS: m/z calculated for C26H37F3NO4SSi: 
544.2165, found: 544.2128.  
 
 
Acetic acid 4-(1-{3-[7-(tert-butyl-dimethyl-silanyloxy)-3,4-dihydro-2H-
quinolin-1-yl]-propane-1-sulfonyloxy}-2,2,2-trifluoro-ethyl)-phenyl ester 
(32). Compound 30 (156 mg, 0.59 mmol) was dissolved in DMF (1.1 mL). 
Compound 13 (303 mg, 0.65 mmol) and potassium carbonate (98 mg, 0.71 
mmol) were added to the solution and the reaction was heated to 65 °C and 
stirred overnight. The reaction was poured into 0.5 M hydrochloric acid (20 mL) 
and extracted with ethyl acetate (1 X 20 mL and 6 X 10 mL). The combined 
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organic phases were washed with water (30 mL), brine (30 mL) and dried over 
sodium sulfate. The solvent was removed by rotary evaporation and the crude 
material was purified by flash column chromatography (0-20% ethyl 
acetate/hexanes) to yield the product as a viscous, orange oil (241 mg, 68%). 1H-
NMR (CDCl3): δ 7.50 (d, 2H, J = 8.7 Hz), 7.17 (d, 2H, J = 8.7 Hz), 6.79 (d, 1H, J = 
8 Hz), 6.12 (dd, 1H, J = 2.2 Hz, 8 Hz), 6.04 (d, 1H, J = 2.3 Hz), 5.79 (q, 1H, JHF = 
6.3 Hz), 3.32-3.27 (m, 2H), 3.21-3.05 (m, 4H), 2.66 (t, 2H, J = 6.3 Hz), 2.32 (s, 
3H), 2.09 (p, 2H, J = 7.1 Hz), 1.89-1.84 (m, 2H), 0.99 (s, 9H), 0.20 (s, 6H). 19F-
NMR (CDCl3): δ -76.3 (d, J = 6.3 Hz). 13C-NMR (CDCl3): δ 169.1, 155.2, 152.6, 
145.8, 130, 129.6, 127.5, 122.6, 122.5 (q, 1JCF = 281 Hz), 116, 108.1, 103, 77.4 
(q, 2JCF = 35 Hz), 50.3, 49.63, 49.6, 27.5, 26.0, 22.6, 21.4, 21.1, 18.5, -4.1. HR-
EIMS: m/z calculated for C28H39F3NO6SSi: 602.2219, found: 602.2197. 
 
 
1,11-Bis-[3-(2,2,2-trifluoro-1-phenyl-ethoxysulfonyl)-propyl]-3,4,8,9,10,11-
hexahydro-2H-13-oxa-6,11-diaza-1-azonia-pentacene chloride (33). 
Compounds 20 (47 mg, 79 μmol) and 31 (43 mg, 79 μmol) were dissolved in a 
solution of ethanol: water: hydrochloric acid (750 μL: 75 μL: 35 μL) and heated to 
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80 °C with stirring for 1.5 hours. Solvent was removed via rotary evaporation to 
give a fluorescent blue residue. The crude material was purified by flash column 
chromatography (0-10% methanol/dichloromethane) yielding the pure product as 
a blue solid (39 mg, 55%). 1H-NMR (CD3OD): δ 7.57-7.55 (m, 4H), 7.46 (s, 2H), 
7.43-7.38 (m, 6H), 6.80 (s, 2H), 6.14 (q, 2H, JHF = 6.4 Hz), 3.76-3.63 (m, 4H), 
3.56 (t, 4H, J = 5.2 Hz), 3.46-3.34 (m, 4H), 2.91 (t, 4H, J = 5.9 Hz), 2.12 (p, 4H, J 
= 7.7 Hz), 2.00-1.98 (m, 4H). 19F-NMR (CD3OD): δ -77.9 (d, J = 6.4 Hz). 13C-
NMR (CD3OD): δ 154.6, 148.6, 134.4, 130.9, 130.6, 130.4, 129.4, 128.9, 128.2, 
122.8 (q, 1JCF = 280 Hz), 95, 77.7 (q, 2JCF = 35 Hz), 50.7, 50.6, 27.2, 20.6. HR-
EIMS m/z calculated for C40H40F6N3O7S2: 852.2212, found: 852.2180. 
 
 
1,11-Bis-{3-[1-(4-acetoxy-phenyl)-2,2,2-trifluoro-ethoxysulfonyl]-propyl}-
3,4,8,9,10,11-hexahydro-2H-13-oxa-6,11-diaza-1-azonia-pentacene 
tetrafluoroborate (34). Compounds 21 (46 mg, 71 μmol) and 32 (43 mg, 71 
μmol) were dissolved in acetic acid (0.7 mL) and heated to 80 °C with stirring for 
2.5 hours. Acetic acid was removed by azeotroping with toluene under rotary 
evaporation to give a fluorescent blue residue. The crude material was purified 
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by flash column chromatography (0-10% methanol/dichloromethane) yielding the 
pure product as a blue solid (35 mg, 46%). During the preparation of compound 
21 for this reaction, the compound was washed with water as described but the 
washing did not remove all BF4-. Upon spectral analysis, BF4- was found to be 
the counterion for compound 34. 1H-NMR (CD3OD): δ 7.61 (d, 4H, J = 8.6 Hz), 
7.42 (s, 2H), 7.17 (d, 4H, 8.7 Hz), 6.74 (s, 2H), 6.18 (q, 2H, JHF = 6.3 Hz), 3.71-
3.59 (m, 4H), 3.54 (t, 4H, J = 5.4 Hz), 3.50-3.35 (m, 4H), 2.88 (t, 4H, J = 5.6 Hz), 
2.21 (s, 6H), 2.08 (p, 4H, J = 7.7 Hz), 2.02-1.96 (m, 4H). 19F-NMR (CD3OD): δ -
78 (d, J = 6.3 Hz), [-154.28, -154.34] (1:4 ratio, 10B/11B isotope effect) (Falcone, 
2011). 13C-NMR (CD3OD): δ 169.5, 154.5, 152.8, 148.6, 134.4, 130.8, 129.6, 
129.4, 127.9, 122.8 (q, 1JCF = 280 Hz), 122.4, 94.9, 77.0 (q, 2JCF = 35 Hz), 50.7, 
50.6, 48.4, 27.2, 20.5, 19.7. HR-EIMS m/z calculated for C44H44F6N3O11S2: 
968.2322, found: 968.2305.  
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Chapter IV: Delivery of sulfonated near-IR oxazines into the cytoplasm of 
living cells 
 
 
 
 
 
Summary 
 Near-infrared (NIR) light is the ideal optical window for imaging in live cells 
and organisms. However, most NIR dyes are poorly suited for use in the 
aqueous cytosol due to their hydrophobicity. We have developed NIR oxazines 
functionalized with sulfonate esters that are converted to highly water-soluble 
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sulfonated dyes upon interaction with esterases in vitro. Here we show that these 
functionalized oxazines can diffuse into live cells, are cleaved to the free 
sulfonate dye by intracellular esterases, and are able to access the entire 
aqueous environment of the cell. We have characterized the behavior of our 
oxazines within cells and explore how these features will be useful in studying 
the intracellular environment. Additionally, we show that our dyes are suitable for 
use in vivo by imaging in live mice and compare the results with that of the FDA 
approved NIR dye, Indocyanine Green. 
Introduction 
 The near-infrared (NIR) region of the electromagnetic spectrum (650-900 
nm) is ideal for imaging in live cells and organisms. This is due to the poor 
absorbance and minimal emission of NIR light by endogenous biological 
molecules, which allows for deeper photon penetration and decreased 
autofluorescence background as compared to visible wavelength imaging 
(Escobedo et al., 2010; Frangioni, 2003; Guo et al., 2014; Hilderbrand and 
Weissleder, 2010; König, 2000). Unfortunately, with the exception of a limited 
number of bacterial phytochromes, fluorescent proteins do not absorb light above 
650 nm (Piatkevich et al., 2013; Tasler et al., 2005; Wu et al., 2011). Moreover, 
although there are organic dyes that absorb and emit NIR light, most are not 
suitable for applications in live cells. The primary obstacles faced by NIR organic 
fluorophores are the hydrophobic and cationic nature of these molecules. These 
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features cause accumulation within cellular membranes and organelles, 
especially the negatively polarized membrane of the mitochondria, resulting in 
non-specific background staining (Bunting et al., 1989; Cunningham et al., 2010; 
Escobedo et al., 2010; Jiang et al., 2013; Johnson, 1998).  
 To improve both their solubility and fluorescence properties within 
aqueous environments, hydrophobic fluorophores are often sulfonated (Li et al., 
2008; Morgan et al., 2011; Mujumdar et al., 1993; Niu et al., 2009; Panchuk-
Voloshina et al., 1999). The addition of the negatively charged sulfonate group 
also has the benefit of neutralizing the positive charge of NIR dyes. The 
increased hydrophilicity and loss of cationic character should make sulfonated 
NIR fluorophores ideal intracellular imaging reagents. Unfortunately, the highly 
polar, water-soluble sulfonated dyes are generally unable to diffuse across the 
lipophilic cell membrane and thus cannot access the intracellular environment 
(Stolz, 2001; Wuhrmann et al., 1980).  
 Previously, our lab reported a number of chemically-stable, esterase-labile 
sulfonate esters, and showed that one of these groups (AcOTFMB) could be 
used to deliver dansyl sulfonate into live cells (Figure 4.1) (Miller, 2010; Rusha 
and Miller, 2011). We subsequently reported the synthesis of a family of NIR 
oxazines functionalized with AcOTFMB-sulfonate esters and showed that in vitro 
treatment with pig liver esterase converts these fluorophores to their sulfonated 
counterparts (Figure 4.2) (Pauff and Miller, 2011). We now present the delivery 
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and intracellular characterization of our sulfonated NIR oxazines in live cells and 
explore how these fluorophores can be employed in the study of both live cells 
and organisms. 
 
 
 
Figure 4.1: Structure of AcOTFMB (Miller, 2010; Rusha and Miller, 2011).  
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Figure 4.2: NIR oxazines functionalized with AcOTFMB-sulfonate esters are 
converted to sulfonated NIR oxazines upon in vitro treatment with pig liver 
esterase (Pauff and Miller 2011). 
 
  
Results and Discussion 
 We previously synthesized a family of NIR oxazines bearing free 
sulfonates (Sulf-Ox1 and Sulf-Ox2), esterase-stable sulfonate esters (TFMB-
Ox1 and TFMB-Ox2), or esterase-labile sulfonate esters (AcOTFMB-Ox1 and 
AcOTFMB-Ox2) (Figure 4.3) (Pauff and Miller, 2011; Pauff and Miller, 2013). We 
next sought to determine whether our cellular sulfonate-delivery strategy, 
successfully applied to the small fluorophore dansyl sulfonate, could be applied 
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to these NIR dyes. To investigate this, we treated the human osteosarcoma cell 
line, U2-OS, with 1 μM solutions of our dyes for 10 minutes and monitored the 
cells for an increase in intracellular fluorescence via wide field fluorescence 
microscopy (Figure 4.4). We were excited to see a high degree of intracellular 
accumulation of AcOTFMB-Ox1 and 2 and TFMB-Ox1 and 2 as this confirmed 
that our fluorophores were indeed traversing the plasma membrane (Figure 4.4). 
In fact, real time monitoring of dye import using spinning disc confocal 
microscopy indicated that uptake of our oxazine dyes begins to occur 
immediately upon addition of the dyes to the cell media (Movies 4.1-4.8). As 
expected, Sulf-Ox1 and 2 were completely excluded from the cells due to the 
presence of the negatively-charged sulfonate moieties (Figure 4.4). The rapid 
import of our cationic sulfonate ester oxazines and exclusion of the highly polar 
free sulfonate oxazines suggests that the dyes are diffusing through the 
membrane, as expected for small organic molecules. 
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Figure 4.3: Pentacyclic NIR oxazines functionalized with sulfonates and 
sulfonate esters (Pauff and Miller, 2011; Pauff and Miller, 2013).  
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Figure 4.4: The lipophilic NIR oxazines AcOTFMB-Ox and TFMB-Ox diffuse 
into live U2-OS cells while the hydrophilic Sulf-Ox NIR oxazines are 
excluded from the cytoplasm. U2-OS cells were incubated with 1 μM dye 
solutions in OPTI-MEM I for 10 minutes at 37 °C, 5% CO2. Following aspiration 
of dye solution and washing, the cells were treated with fresh OPTI-MEM I for 
imaging.  A) Mono-sulfonate ester oxazines TFMB/AcOTFMB-Ox1. B) Bis-
sulfonate ester oxazines TFMB/AcOTFMB-Ox2. C) Sulfonated oxazines Sulf-
Ox1 and 2. 
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Figure 4.4A. Mono-sulfonate ester functionalized NIR oxazines. Top: Bright Field 
(BF) images. Bottom: NIR images. Exposure time for TFMB-Ox1 NIR image 
(bottom left) was 10 ms. Exposure time for AcOTFMB-Ox1 NIR image (bottom 
right) was 150 ms. 
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Figure 4.4B. Bis-sulfonate ester functionalized NIR oxazines. Top: Bright Field 
(BF) images. Bottom: NIR images. Exposure time for TFMB-Ox2 NIR image 
(bottom left) was 10 ms. Exposure time for AcOTFMB-Ox2 NIR image (bottom 
right) was 60 ms. 
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Figure 4.4C. Mono/Bis-sulfonated NIR oxazines. Top: Bright Field (BF) images. 
Bottom: NIR images. Exposure time for NIR images was 150 ms. 
 
 Upon initial entry into the cell, the fluorescence of both the AcOTFMB-Ox 
and TFMB-Ox dyes has a distinct cellular localization (Figure 4.4). Small cationic 
compounds, including many dyes, have a tendency to accumulate in the 
mitochondria due to the negative potential across the mitochondrial membrane 
(Bunting et al., 1989). Since our sulfonate-ester oxazines bear an overall positive 
charge, we hypothesized that the localized fluorescence we observed results 
from ionic attractions between our dye and the mitochondria (Figure 4.3). This 
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hypothesis was confirmed by costaining U2-OS cells with our NIR oxazines and 
the mitochondrial stain, MitoTracker® Green FM (Figure 4.5). The overlayed 
images show that the fluorescence of all of our NIR oxazines initially colocalizes 
with the fluorescence from MitoTracker® Green (Figure 4.5: bottom images). 
This finding is consistent with the rapid uptake of these cationic dyes and their 
subsequent interaction with the negatively polarized mitochondrial membrane. 
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Figure 4.5: Sulfonate ester NIR oxazines localize to mitochondria upon 
entry into the cytoplasm. U2-OS cells were incubated at 37 °C, 5% CO2 with 
100 nM MitoTracker® Green FM for 30 minutes followed by incubation with 1 μM 
AcOTFMB-Ox1 (A), TFMB-Ox1 (B), TFMB-Ox2 (C), AcOTFMB-Ox2 (D) for 10 
minutes. Following aspiration of dye solution and washing, the cells were treated 
with fresh OPTI-MEM I for imaging. BF: Bright Field. Overlay images were 
prepared using ImageJ software. 
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Figure 4.5A. U2-OS cells costained with MitoTracker® Green FM and 
AcOTFMB-Ox1. 
A 
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Figure 4.5B. U2-OS cells costained with MitoTracker® Green FM and TFMB-
Ox1. 
B 
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Figure 4.5C. U2-OS cells costained with MitoTracker® Green FM and TFMB-
Ox2. 
C 
130 
 
 
 
Figure 4.5D. U2-OS cells costained with MitoTracker® Green FM and 
AcOTFMB-Ox2. 
D 
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 Although the initial localization of our NIR oxazines to mitochondria was 
expected, this was not the ultimate fate for which our esterase-labile sulfonate 
ester dyes were designed. Upon interaction with cellular esterases, we expect 
that AcOTFMB-Ox1 and 2 would be converted to their free sulfonate 
counterparts and would be able to freely access the entire cell. To confirm that 
our esterase cleavage strategy works in live cells, we followed the fates of the 
TFMB-Ox and AcOTFMB-Ox dyes in U2-OS cells over three hours using wide 
field fluorescence microscopy (Figure 4.6 and 4.7). At all times throughout the 
imaging, TFMB-Ox1 and 2 remain localized at the mitochondria, as expected for 
dyes which are always cationic (Figure 4.6). Excitingly, within 5 minutes following 
the dye treatment, the fluorescence from the esterase-labile AcOTFMB-Ox2 
begins to become diffuse (see AcOTFMB-Ox2 images in Figures 4.4 and 4.5), 
and at 20 minutes post-dye treatment, cells treated with AcOTFMB-Ox2 
displayed completely diffuse fluorescence, accessing both nucleus and 
cytoplasm (Figure 4.7B, left side). On the other hand, while AcOTFMB-Ox1 
fluorescence did become diffuse, localized punctate staining remained 
throughout the duration of the experiment (Figure 4.7A, left side). This persistent 
mitochondrial localization of AcOTFMB-Ox1 likely results from the fact that, 
when the mono-sulfonate ester dye is converted to its sulfonate form, the overall 
charge on the dye is neutral rather than negative. It is therefore possible that the 
localized negative charge on the sulfonate is not sufficient to overcome the 
attraction of the positively-charged oxazine scaffold to the high negative potential 
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of the mitochondrial membrane. Although we were somewhat disappointed by 
the results of the AcOTFMB-Ox1 treatment, the rapid conversion of AcOTFMB-
Ox2 fluorescence from localized to cell-encompassing was overwhelmingly 
encouraging.  
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Figure 4.6: NIR oxazines functionalized with esterase-stable TFMB 
sulfonate esters (TFMB-Ox) display persistent mitochondrial localization 
over 3 hours. U2-OS cells were incubated at 37 °C, 5% CO2 with 100 nM 
MitoTracker® Green FM for 30 minutes followed by incubation with 1 μM TFMB-
Ox1 (A) or TFMB-Ox2 (B) for 10 minutes. Following aspiration of dye solution 
and washing, the cells were incubated in OPTI-MEM I and imaged periodically 
over 3 hours. BF: Bright Field. Overlay images were prepared using ImageJ 
software. 
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Figure 4.6A. Exposure times for MitoTracker® Green FM and TFMB-Ox1 were 
50 ms. 
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Figure 4.6B. Exposure times for MitoTracker® Green FM were 50 ms (20-minute 
incubation) and 100 ms (3-hour incubation). Exposure times for TFMB-Ox2 were 
10 ms (20-minute incubation) and 50 ms (3-hour incubation). 
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Figure 4.7: U2-OS cells treated with NIR oxazines functionalized with 
esterase-labile AcOTFMB sulfonate esters (AcOTFMB-Ox) display diffuse 
fluorescence within 20 minutes of dye treatment but lose intracellular NIR 
fluorescence within 90 minutes of dye treatment. U2-OS cells were incubated 
at 37 °C, 5% CO2 with 100 nM MitoTracker® Green FM for 30 minutes followed 
by incubation with 1 μM AcOTFMB-Ox1 (A) or AcOTFMB-Ox2 (B) for 10 
minutes. Following aspiration of dye solution and washing, the cells were 
incubated in OPTI-MEM I and imaged periodically until no NIR fluorescence was 
observed. Fluorescent signal for the mono-sulfonate ester AcOTFMB-Ox1 
treated cells ceased after 90 minutes. Fluorescent signal for the bis-sulfonate 
ester AcOTFMB-Ox2 treated cells ceased after 60 minutes. BF: Bright Field. 
Overlay images were prepared using ImageJ software 
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Figure 4.7A. Exposure times for MitoTracker® Green FM and AcOTFMB-Ox1 
were 100 ms. 
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Figure 4.7B. Exposure times for MitoTracker® Green FM and AcOTFMB-Ox2 
were 60 ms. 
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 The conversion of localized to diffuse fluorescence observed in the 
AcOTFMB-Ox2 treated U2-OS cells supports the hypothesis that the positively-
charged sulfonate ester is cleaved to the negatively-charged bis-sulfonated 
oxazine, Sulf-Ox2, by cellular esterases. To prove, beyond a reasonable doubt, 
that the dye associated with diffuse cellular fluorescence was indeed the bis-
sulfonated NIR oxazine, we incubated U2-OS cells with 1 µM AcOTFMB-Ox2 
and periodically imaged the cells until diffuse fluorescence was observed. The 
cells were then lysed and the dye was collected via centrifugation. The collected 
dye was subsequently analyzed via RP-HPLC and ESI-HRMS (Figure 4.8A and 
Table 4.1). The HPLC traces show that the dye collected from the U2-OS cells 
elutes as Sulf-Ox2 (Figure 4.8A). Additionally, HRMS confirmed that the dye 
collected from the cells has the same molecular mass as Sulf-Ox2 (Table 4.1). A 
similar result was found for AcOTFMB-Ox1, confirming that this dye is cleaved to 
the mono-sulfonated NIR oxazine Sulf-Ox1 within the cytoplasm of live U2-OS 
cells (Figure 4.8B). Dyes collected from TFMB-Ox1 and 2 treated cells eluted as 
the respective parent dye on HPLC, confirming, as expected, that there was no 
change to the esterase-stable TFMB sulfonate ester (Figures 4.8C and D). 
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Figure 4.8: Esterase-labile AcOTFMB-Ox dyes are converted to Sulf-Ox 
within living cells while esterase-stable TFMB-Ox dyes are unaffected by 
the cellular environment. U2-OS cells were incubated at 37 °C, 5% CO2 with 1 
μM AcOTFMB-Ox2 (A), TFMB-Ox2 (B), AcOTFMB-Ox1 (C), TFMB-Ox1 (D), 
allowing sufficient time for dye uptake and delocalized fluorescence to be 
observed within the cells (where applicable). Oxazine dyes were retrieved from 
the cells as described (See Methods). The collected dye samples were then 
analyzed via HPLC as described (See Methods). As controls, DMSO stocks of 
Sulf-Ox, TFMB-Ox, and AcOTFMB-Ox dyes were also subjected to analytical 
HPLC.   
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Figure 4.8D. Top trace: 657 nm. Middle/Bottom trace: 653 nm. 
D 
 
Dye from TFMB-Ox1 
treated U2-OS cells 
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Compound Retention Time (min) ESI-HRMS (m/z) 
Sulf-Ox2 24.795 534.1348 
AcOTFMB-Ox2 61.327 968.2305 
AcOTFMB-Ox2 from cells 24.831 534.1392 
TFMB-Ox2 63.752 852.2180 
TFMB-Ox2 from cells 63.699 852.2214 
Sulf-Ox1 33.066 442.1779 
AcOTFMB-Ox1 55.737 658.2165 
AcOTFMB-Ox1 from cells 33.189 442.1789 
AcOTFMB-Ox1 from cells 56.217 658.2188 
TFMB-Ox1 57.255 600.2152 
TFMB-Ox1 from cells 57.552 600.2122 
 
Table 4.1: ESI-HRMS m/z values for NIR oxazine fluorophores collected 
from U2-OS cells (Figure 4.8). Retention times and observed masses for dyes 
collected from cells are shown in bold. Retention times and observed masses for 
control dyes are shown for comparison.   
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 Since the sulfonated NIR oxazines, Sulf-Ox1 and 2, are unable to diffuse 
into the cells, the sulfonated NIR oxazines formed by interaction of the 
AcOTFMB-Ox dyes with intracellular esterases will be unable to passively 
diffuse out of the cell. However, we observed that the intracellular fluorescence 
intensity of AcOTFMB-Ox2 treated cells decreases substantially after 
fluorescence becomes diffuse. In fact, one hour after dye treatment, little to no 
fluorescence is observed in AcOTFMB-Ox2 treated U2-OS cells (Figure 4.7B). 
The situation is far different for U2-OS cells treated with the esterase-stable 
TFMB-Ox2 (Figure 4.6B). While there is some flux in fluorescence intensity due 
to diffusion of the cationic TFMB-Ox2, bright mitochondrial-localized 
fluorescence is consistently observed over the 3 hour imaging period (Figure 
4.6B). Based on this observation, it is unlikely that the loss of fluorescence in the 
AcOTFMB-Ox2 treated U2-OS cells is due to fluorescence quenching or 
photobleaching. Since diffusion through the plasma membrane is inconsistent 
with the behavior of highly polar, sulfonated dyes, we hypothesized that the 
intracellular sulfonated NIR oxazines were being actively transported out of the 
cells. 
 A diverse array of molecules including drugs, peptides, and nucleotides 
are actively pumped out of the cell by ATP-binding cassette (ABC) transporters 
(Borst and Elferink, 2002). A small subset of these ABC transporters have been 
implicated in the phenomenon of multidrug resistance: permeability glycoprotein 
(ABCB1, MDR1, Pgp); multidrug resistance associated proteins 1, 2, and 4 
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(ABCC1/2/4, MRP1/2/4); and the breast cancer resistance protein (ABCG2, 
BCRP) (Lebedeva et al., 2011; Russel et al., 2008; Sharom, 2008). Three of 
these transporters, Pgp, MRP1, and BCRP, commonly referred to as the 
multidrug efflux pumps, have also been found to remove small organic 
fluorophores including: calcein (MRP1), Hoechst 33342 (MDR1, BCRP), and 
rhodamine 123 (MDR1) (Sharom, 2008). From these observations, we 
considered the possibility that our bis-sulfonated oxazine dye was also being 
effluxed by one or more of these transporters. 
 To identify which, if any, of the multidrug efflux pumps were involved in 
dye export, we treated U2-OS cells with inhibitors of Pgp (verapamil), MRP1 
(MK-571), or BCRP (Ko143). We then incubated the cells with AcOTFMB-Ox2 
and monitored the cells for 30 minutes to determine the effect of pump inhibition 
on fluorescence retention (Figure 4.9). We found that cells treated with Ko143 
showed no difference in fluorescence retention compared with the untreated 
control (Figure 4.9B). Ko143 is one of the most potent and specific inhibitors of 
BCRP and thus the loss of intracellular fluorescence from Ko143 treated cells 
indicates that BCRP is not necessary for efflux of our bis-sulfonated dye (Allen et 
al., 2002; Pick et al., 2010). On the other hand, cells treated with either verapamil 
or MK-571 retained observably more intracellular fluorescence than untreated 
U2-OS cells, suggesting that both Pgp and MRP1 are involved in intracellular 
clearance of Sulf-Ox2 (Figure 4.9B). 
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Figure 4.9: Inhibition of the efflux transporters MRP1 and Pgp results in 
increased retention of bis-sulfonated NIR oxazines. U2-OS cells were 
pretreated with 50 μM verapamil (Pgp inhibitor), 50 μM MK-571 (MRP1 inhibitor), 
0.5 μM Ko143 (BCRP inhibitor), or no inhibitor (control). Cells were then 
incubated with 1 μM AcOTFMB-Ox2 plus inhibitor for 30 minutes to allow for dye 
uptake and conversion into the bis-sulfonated oxazine. Following aspiration of 
dye solution and washing, the cells were treated with fresh inhibitor-
supplemented OPTI-MEM I and imaged (A). Cells were then incubated in 
inhibitor-supplemented media and imaged after 30 minutes (B). To confirm that 
treatment did not affect cell viability, cells were washed with inhibitor-free HBSS, 
incubated in inhibitor-free media for an additional 30 minutes to allow for return of 
efflux activity and then imaged (C). BF: bright field. 
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Figure 4.9A. Immediately after dye treatment. NIR exposure time: 50 ms. 
 
150 
 
 
Figure 4.9B. 30 minutes post-dye treatment. NIR exposure time: 54 ms. 
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Figure 4.9C. 30 minutes post-inhibitor wash-out. 1 hour post dye treatment. NIR 
exposure time: 54 ms. 
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 It was not surprising to find that both Pgp and MRP1 could be involved in 
efflux of our bis-sulfonated dye since substrate overlap between multidrug efflux 
transporters is common (Munoz et al., 2007). However, Pgp is most well known 
for clearing hydrophobic substrates, whereas MRP1 has been linked to organic 
anion efflux (Munoz et al., 2007; Sharom, 2014). Moreover, while verapamil is 
considered to be a potent inhibitor of Pgp, there have been observations that it 
also has some indirect effects on the activity of MRP1 (Cole et al., 1994; Loe et 
al., 2000; Pauli-Magnus et al., 2000). To confirm the contributions of MRP1 and 
Pgp to efflux of our NIR oxazines, we depleted MRP1 or Pgp expression in U2-
OS cells via stable expression of shRNA. We then incubated our knockdown 
cells with AcOTFMB-Ox2 and monitored the loss of intracellular fluorescence 
over 2 hours using wide field fluorescence microscopy (Figure 4.10). Over the 
first hour, the Pgp-knockdown cells are slightly more fluorescent than the control, 
whereas the MRP1-knockdown cells retain observably more fluorescence than 
either the control or Pgp-knockdowns (Figure 4.10B and C). This suggests that 
MRP1 is the primary efflux transporter for the sulfonated oxazine. However, by 
the end of the second hour, the control and knockdown cells all have very little 
intracellular fluorescence (Figure 4.10D). Since MRP1 and Pgp expression are 
reduced but not eliminated, the loss of fluorescence could be due to the residual 
activity of the transporters that are present. However, since the knockdown of 
Pgp does appear to have some effect on fluorescence retention, it is possible 
that some of the loss of fluorescence from the MRP1-knockdown cells results 
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from Pgp activity. It is also possible that other members of the MRP family are 
also involved in efflux of our dyes, such as MRP2 or MRP4. These transporters 
should have been inactivated by treatment with MK571 but are unaffected by 
MRP1-specific shRNA knockdown (Reid et al., 2003; Williams et al., 2002). Yet, 
the extended duration of intracellular fluorescence retention in our MRP1-
knockdown U2-OS cells clearly displays the primary role of MRP1 in efflux of our 
sulfonated oxazines and relegates Pgp to a secondary pathway. The contribution 
of the other MRP family members to dye efflux was not investigated. 
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Figure 4.10: shRNA knockdown of MRP1 and Pgp results in the increased 
retention of bis-sulfonated NIR oxazines. U2-OS cells stably expressing 
shRNA against Pgp or MRP1 were prepared as described (see Methods). U2-OS 
cells not expressing shRNA were used as a negative control. Cells were 
incubated with 1 μM AcOTFMB-Ox2 for 15 minutes to allow for dye uptake. 
Following aspiration of dye solution and washing, cells were treated with fresh 
OPTI-MEM I and imaged (A). Cells were then incubated in OPTI-MEM I and 
imaged periodically over 2 hours (B-D). KD: knockdown. BF: bright field. NIR 
exposure time: 50 ms. 
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Figure 4.10A. Immediately after dye treatment. 
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Figure 4.10B. 20 minutes post-dye treatment. 
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Figure 4.10C. 50 minutes post-dye treatment. 
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Figure 4.10D. 110 minutes post-dye treatment. 
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 Having confirmed that our sulfonate ester delivery strategy is able to 
deliver sulfonated NIR oxazines into live cells, we wanted to show that these 
dyes could be used for imaging in whole organisms. Since the esterase-labile 
bis-sulfonate ester AcOTFMB-Ox2 gives the highest degree of diffuse 
intracellular fluorescence, we limited this work to the Ox-2 group of our NIR 
oxazines. Research involving NIR oxazines and live animal imaging is sparse 
(Hintersteiner et al., 2005; Park et al., 2014) and almost no work has been done 
on the performance of sulfonated NIR oxazines in whole organisms; therefore, 
we first sought to characterize the in vivo behavior of the bis-sulfonated Sulf-
Ox2. 
  To investigate the activity of Sulf-Ox2 in vivo, we treated albino C57BL/6 
mice with 320 fmol/kg dye via intraperitoneal injection (IP) or intravenous tail vein 
injection (IV) and imaged the mice at two time points over a 4-hour period (Figure 
4.11; Sulf-IP and Sulf-IV, respectively). Immediately following injection, bright 
fluorescence can be observed within the mice at the site of introduction (Figure 
4.11A and B; top panels). This result was expected as Sulf-Ox2 is a NIR 
fluorophore and organisms are known to be highly transparent to NIR light 
(Frangioni, 2003; Weissleder, 2001). However, we were still delighted by this 
observation as it confirmed that our dye could be successfully used to image 
within a living organism. 
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Figure 4.11: in vivo imaging in mice with NIR bis-sulfonated oxazines. 
Albino C57BL/6 mice were treated with 320 fmol/kg oxazine dye in PBS via IP or 
IV injection and imaged at two time points over 4 hours using an IVIS-100 as 
described in Methods. Control mouse was not injected. Images were obtained 
using Cy5.5 excitation (615-665 nm) and emission (695-770 nm) filters. Images 
shown have been background subtracted and were prepared using Living Image 
4.3.1 software. (A) Dorsal view. (B) Ventral view. Upper image is approximately 5 
minutes after dye injection. Lower image is 3.5 hours after dye injection. Photon 
output is recorded as radiant efficiency, which is defined as the fluorescence 
emission radiance per incident excitation irradiance. 
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Figure 4.11A. Dorsal view. 
A 
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Figure 4.11B. Ventral view. 
B 
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 Compared to the initial behavior of Sulf-Ox2 in vivo, the long-term fate of 
our bis-sulfonated dye was not as easily predicted. We observed two key 
features of Sulf-Ox2 behavior when imaging the mice 3.5 hours post-injection 
(Figure 4.11A and B; bottom panels). First, the method of dye delivery (IP or IV) 
affects the long-term behavior of the dye. The Sulf-IP mouse emits relatively little 
NIR light and visually resembles the untreated control (Figure 4.11B; bottom 
panel, 3rd mouse from left). Contrast this to the Sulf-IV mouse that emits 
approximately 14 times more light than Sulf-IP and appears to have fluorescence 
localized at several organs throughout the mouse (Figure 4.11B; bottom panel, 
mouse on right). Often, in vivo pharmacokinetic studies find that molecules 
behave differently depending on how they are introduced into an organism, so 
these results are not unexpected (Guichard et al., 1998; Sim et al., 2011; Zhao et 
al., 2012). 
 Second, and of greater interest, is the distinct biodistribution of Sulf-Ox2 
in the IV treated mouse (Figure 4.11B; bottom panel, Sulf-IV). Although no 
confirmatory ex vivo imaging was performed, the image in Figure 4.11B suggests 
that over the 4-hour imaging period, Sulf-Ox2 localizes to organs consistent with 
the heart and intestines. The medical diagnostic NIR dye, Indocyanine Green, is 
rapidly cleared by the liver, and IV injection primarily illuminates this organ (Ma et 
al., 2008; Soons et al., 1991). Our preliminary results with Sulf-Ox2 suggests 
that, rather than being rapidly removed from the blood stream by the liver and 
kidneys, our NIR dye can actually be employed in the imaging of other tissues. 
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 Having evaluated the in vivo characteristics of Sulf-Ox2, we were able to 
analyze the actions of its cell-permeable counterparts, AcOTFMB-Ox2 and 
TFMB-Ox2. Similar to Sulf-Ox2, albino C57BL/6 mice were treated with 320 
fmol/kg AcOTFMB-Ox2 or TFMB-Ox2 and imaged at two time points over a 4- 
hour period (Figure 4.11 AcO-IP and TFMB-IP, respectively). However, due to 
poor solubility in the aqueous buffer, these dyes were only introduced via IP 
injection. While this limited the comparison between these dyes and the Sulf-
Ox2 introduced IV, it eliminated the need to include a higher percentage of 
DMSO (see Methods) and thus provided a greater degree of experimental 
consistency. 
 As with Sulf-IP, bright fluorescence was observed about the injection site 
from both AcO-IP and TFMB-IP mice immediately following treatment (Figure 
4.11A and B, Top panels). Three and a half hours post-injection, the AcO-IP 
mouse closely resembles the Sulf-IP mouse; i.e., relatively little fluorescence was 
detected (Figure 4.11A and B; Bottom panels, mice on left and center). This 
result is notably distinct from that of the TFMB-Ox2 treated mouse. For example, 
at 3.5 hours post-injection, the TFMB-IP mouse was emitting more fluorescence 
than the AcO-IP mouse (11 times greater), the Sulf-IP mouse (41 times greater) 
or the Sulf-IV mouse (3 times greater) (Figure 4.11B, Bottom panel). More 
interestingly, the TFMB-IP mouse appeared to emit a higher degree of 
fluorescence at 3.5 hours than when it was first injected: approximately 2-fold 
both dorsally and ventrally (Figure 4.11A and B). Lastly, unlike the Sulf-IV or 
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AcO-IP mice, fluorescence from the TFMB-Ox2 treated mouse remains localized 
about the site of injection (Figure 4.11B).  
 The results from the AcO-IP and TFMB-IP in vivo treatments are 
consistent with the design of these molecules. Since the AcOTFMB-Ox2 dye is 
esterase-labile, interaction with esterases within the mouse should convert it into 
the Sulf-Ox2 dye. Once the AcOTFMB-Ox2 has lost its sulfonate protecting 
groups, its activity in vivo should resemble that of Sulf-Ox2. The similar 
appearance of the AcO-IP and Sulf-IP mice 3.5 hours post-injection indicates that 
this is indeed occurring and thus suggests that our strategy to deliver sulfonated 
NIR dyes into cells can be successfully applied in vivo as well (Figure 4.11). 
Conversely, the TFMB-Ox2 dye was designed to be esterase-stable and is 
unaffected by esterase activity both in vitro and in live cells (Figure 4.8B and 
Pauff and Miller, 2011). The extended retention of fluorescence in the TFMB-IP 
mouse compared to both the Sulf-IV and Sulf-IP treatments suggests that this 
stability holds in vivo as well (Figure 4.11B). Furthermore, since TFMB-Ox2 
tends to accumulate and remain within mitochondria, it is no surprise that the 
fluorescence of this dye remains localized at the site of injection over the 4-hour 
imaging period (Figure 4.6B). This simply indicates that IP-injected TFMB-Ox2 is 
diffusing into cells at the area it was first introduced into the animal. Lastly, the 
increase in fluorescence in the TFMB-IP mouse from the initial to the 3.5-hour 
time-point likely results from the relative hydrophobicity of the dye (Figure 4.11A, 
ROI 2 and 6; Figure 4.11B, ROI 2). In other words, since the dye is somewhat 
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hydrophobic, it may tend to self-aggregate in aqueous solution, which could 
result in fluorescence quenching. Once the dye diffuses into cells and travels to 
mitochondria, this aggregation would be minimized and bright fluorescence 
would be restored.  
Conclusions 
 It is widely accepted that NIR light is optimal for imaging live cells and 
organisms. However, NIR fluorophores are extremely hydrophobic and require 
the addition of highly charged moieties, such as sulfonate groups, when used in 
aqueous environments. Unfortunately, the lipophilic cellular membrane prevents 
the diffusion of sulfonated molecules into cells, preventing the use of sulfonated 
NIR dyes in live cell imaging. In this work, we have shown that we can deliver 
sulfonated near-IR oxazines into both live cells and mice using our AcOTFMB 
delivery method (Figures 4.8 and 4.11). One dye in particular, the bis-sulfonate 
ester AcOTFMB-Ox2, shows very high promise for use in cellular imaging.   
 AcOTFMB-Ox2 rapidly diffuses into cells and, upon interaction with 
cellular esterases, is converted into the anionic bis-sulfonate, Sulf-Ox2, which 
has the ability to access the entire cell (Figures 4.4B, 4.7B, and 4.8A). This is 
one of the first examples of a NIR dye displaying truly diffuse localization, a 
feature which would allow it be employed for any number of imaging purposes. 
For example, since intracellular Sulf-Ox2 has access to both the nucleus and 
cytoplasm, addition of a protein-labeling moiety to AcOTFMB-Ox2 would allow 
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the study of nuclear and cytoplasmic proteins. Furthermore, since AcOTFMB-
Ox2 absorbs and emits in the NIR, protein localization studies using our 
fluorophore would not suffer from the cellular autofluorescence observed when 
using visible wavelength fluorescent proteins like GFP.  
 The intracellular fate of AcOTFMB-Ox2 highlights another exceptional 
feature of our NIR oxazines. After diffusing throughout the cytoplasm, we 
observed that the newly formed Sulf-Ox2 is quickly cleared from the cell by the 
multidrug efflux transporters MRP1 and Pgp (Figures 4.9 and 4.10). In fact, within 
an hour following dye treatment, cells treated with AcOTFMB-Ox2 displayed little 
to no intracellular fluorescence (Figure 4.7B). This is no little feat as fluorophores 
in general, and NIR dyes in particular, are often associated with non-specific 
background labeling resulting from their inherent cationic and hydrophobic nature 
(Bunting et al., 1989; Cunningham et al., 2010; Escobedo et al., 2010; Jiang et 
al., 2013; Johnson, 1998). AcOTFMB-Ox2 functionalized with a protein-labeling 
tag could thus provide a system for live cell imaging without the autofluorescence 
and background noise too commonly associated with fluorescence imaging. 
Additionally, the interaction of Sulf-Ox2 with ABC transporters offers the ability to 
study the activity of these pharmacologically-relevant proteins in a very 
straightforward manner. For example, intracellular drug activity is often reduced 
due to their removal from cells by efflux transporters (Borst and Elferink, 2002; 
Glavinas et al., 2004). Inhibitors of these proteins could easily be assayed by 
evaluating their function with relation to the fluorescence retention of Sulf-Ox2.   
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 Some of the most exciting results of this work came from exploring the in 
vivo behavior of our NIR oxazines. The intravenously delivered Sulf-Ox2 has 
several in vivo characteristics which may favor its use over the commonly 
employed NIR fluorophore Indocyanine Green (ICG). For example, IV-injected 
ICG is rapidly removed from the bloodstream by the liver, followed by excretion 
into the bile (Ma et al., 2008; Soons et al., 1991). We confirmed this 
biodistribution by imaging albino C57BL/6 mice with 320 fmol/kg ICG (Figure 
4.12). This limits the use of ICG. On the other hand, IV-injected Sulf-Ox2 
appears to travel through the bloodstream to several distinct organ systems, a 
feature that could be useful when imaging in organs other than the liver is 
desired (Figure 4.11B; bottom, Sulf-IV). Along with their biodistribution, ICG and 
Sulf-Ox2 have a distinct temporal footprint. We found that, at 66 minutes post 
injection, the ICG-treated mouse was 26-fold less fluorescent than the Sulf-Ox2-
treated mouse imaged 3.5 hours post injection (Figure 4.11B, bottom, ROI 1; 
Figure 4.12, ROI 2). This finding was no surprise as the half-life of IV-injected 
ICG is reported to be 2-4 minutes (Ma et al., 2008). This feature is viewed as one 
of the benefits of ICG since the short lifetime permits consecutive injections of 
the compound. However, in situations where longer imaging periods rather than 
consecutive treatments are favored, it is clear that our Sulf-Ox2 fluorophore 
would be preferable.  
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Figure 4.12: in vivo imaging with Indocyanine Green. An albino C57BL/6 
mouse was treated with 320 fmol/kg ICG in PBS via IV injection and imaged at 
two time points over 2 hours using an IVIS-100 as described in Methods. Control 
mouse was not injected. Image was obtained using ICG excitation (710-760 nm) 
and emission (810-875 nm) filters and analyzed using Living Image 4.3.1 
software following background subtraction. Photon output is recorded as radiant 
efficiency. 
 
 While we are enthusiastic about the diagnostically-important features 
displayed by Sulf-Ox2, we were more excited to observe the in vivo behavior of 
our cell-permeable NIR fluorophore, AcOTFMB-Ox2. Since this dye has the 
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ability to deliver NIR sulfonates into live cells, it offers the potential to study in 
vivo intracellular functions. From our proof of principle experiment, it does appear 
that AcOTFMB-Ox2 functions similarly in vivo as in live cells. For example, while 
the esterase stable TFMB-Ox2 remains localized to mouse abdomen throughout 
the time course, AcOTFMB-Ox2 is cleared from the mouse in a manner similar 
to the IP-injected Sulf-Ox2 (Figure 4.11). The question could be raised however, 
of whether AcOTFMB-Ox2 is being converted into Sulf-Ox2 within the cells or by 
extracellular esterases within the mouse. One observation favoring the 
intracellular conversion of AcOTFMB-Ox2 to Sulf-Ox2 is the higher degree of 
fluorescence emitted by the AcO-IP mouse 3.5 hours post injection (Figure 
4.11B; bottom, ROIs 3 and 5). Compared to Sulf-IP treatment, AcO-IP results in 
3.5 times more fluorescence at the later time point. This suggests a temporal 
aspect to the Sulf-IP-like behavior of AcOTFMB-Ox2. In other words, time is 
required for AcOTFMB-Ox2 to enter the mouse cells, be converted into Sulf-Ox2 
by esterases, get exported back into the bloodstream, and be cleared from the 
mouse. This temporal requirement could also explain the appearance of 
fluorescence in the AcO-IP mouse at a location distant from the injection site, as 
some dye may have traveled through the mouse before it diffused into cells 
(Figure 4.11B, bottom, ROI 6). While these results are promising, further 
experiments must be performed to confirm that the dye is indeed accessing the 
intracellular regions of the mouse. One method to confirm this would be the ex 
vivo analysis of organs to determine whether AcOTFMB-Ox2 has become 
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localized within cells. Alternatively, and less invasively, would be the possibility of 
co-treating mice with AcOTFMB-Ox2 and an in vivo mitochondrial probe, such 
as the hypochlorite probe recently developed by the Yu group, and imaging the 
mice to determine if there is any co-localization of fluorescence (Hou et al., 
2014). In either scenario, a positive result could open the door for the use of our 
AcOTFMB-Ox2 as an in vivo intracellular imaging reagent. 
 In this work, I have shown the successful delivery of our sulfonated NIR 
oxazines into live cells and mice and characterized the intracellular and in vivo 
behavior of our dyes. While we expect that our fluorophores could be effectively 
utilized in imaging experiments, there are implications from our findings that 
reach beyond the limited focus of our dyes. As mentioned earlier, sulfonation is a 
common strategy employed for increasing the water-solubility of NIR 
fluorophores (Li et al., 2008; Morgan et al., 2011; Mujumdar et al., 1993; Niu et 
al., 2009; Panchuk-Voloshina et al., 1999). Our AcOTFMB sulfonate-protecting 
group is not specific to our oxazines and its application to sulfonated cyanines, 
BODIPYs and other dye families would allow many water-soluble NIR dyes to 
find employment in intracellular studies. In like manner, AcOTFMB can be 
applied to any sulfonated molecule and would therefore allow drugs that are too 
hydrophobic to be used within aqueous environments to be solubilized by 
sulfonation and delivered via AcOTFMB-mediated diffusion. With the correct 
application of our delivery method, we believe that it would be possible to tune 
the molecular structure of a myriad of biologically- relevant organic molecules 
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with minimal concern for cell permeability, as this permeability could be 
maximized by implementing a strategy with the seductive simplicity of AcOTFMB.  
Materials and Methods 
General Methods 
Chromasolv® HPLC grade acetonitrile, methanol, and trifluoroacetic acid were 
purchased from Sigma-Aldrich. Molecular biology grade dimethyl sulfoxide 
(DMSO) was purchased from Sigma-Aldrich. MK-571 sodium salt was purchased 
from Cayman Chemical and prepared as a 50 mM stock solution in DMSO. 
Ko143 was purchased from Tocris Bioscience and prepared as a 5 mM stock 
solution in DMSO. (±)-Verapamil hydrochloride was purchased from Sigma-
Aldrich and was freshly prepared as a 50 mM stock solution in DMSO. 
MitoTracker® Green FM was purchased from Life Technologies. Indocyanine 
Green sodium salt was purchased from TCI America.  
Cell culture supplies were purchased from the University of Massachusetts 
Medical School’s Tissue Culture and Enzyme Freezer Supply. Dulbecco’s 
Modified Eagle’s Medium (DMEM) (with L-glutamine and pyruvate), Hank’s 
Balanced Salt Solution (HBSS) (with calcium and magnesium, without phenol 
red), and fetal bovine serum (FBS) (USDA certified) were CellGro® from 
Mediatech. OPTI-MEM I reduced serum media, penicillin/streptomycin, and 
trypsin 0.25% were Invitrogen™ from Life Technologies. 
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Wide-field fluorescence imaging was performed on a Zeiss Axiovert 200 
fluorescence microscope with a 40X dry objective using a Hamamatsu ORCA-ER 
digital camera and excitation from an X-Cite 120 light source. MitoTracker® 
Green FM images were obtained using Zeiss filter set 38 (Endow GFP shift free 
(E) BP 470/40 excitation filter, beam splitter FT495, BP 525/50 emission filter). 
NIR images were obtained using Semrock BrightLine Basic™ single-band filter 
set (BP 630/38 excitation filter, beam splitter FF655, BP 694/44 emission filter). 
Cell images were processed using ImageJ with images set to 32 bit followed by 
1000 pixel background subtraction. 
Cell Culture 
The human osteosarcoma cell line U2-OS (ATCC number HTB-96) was donated 
by Dr. Eric Swanson from the Lawrence lab at the University of Massachusetts 
Medical School and were employed for all experiments in this work. Cells were 
maintained in DMEM supplemented with 10% FBS, 100 units/mL penicillin and 
100 μg/mLstreptomycin (herein referred to as complete media) and grown at 37 
°C in a 5% CO2 atmosphere. Cells were subcultured at a ratio of 1:4 when plates 
reached 85-90% confluency using standard cell culture protocols. Cells were 
incubated at 37 °C in a 5% CO2 atmosphere for all experiments. 
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Near-infrared Dye Treatment and Live Cell Imaging 
Preparation of NIR Dyes 
NIR dyes were prepared as 10 mM stocks in DMSO, aliquoted, and stored at -20 
°C. Aliquoted preparations were used only once then discarded. Dye-labeling 
media (1 μM NIR dye in OPTI-MEM I) was prepared immediately prior to 
treatment. 
Dye Treatment and Imaging 
Cells were subcultured into 6-well plates at a seeding density of 0.3 x 106 cells 
and grown to 80% confluency in complete media. Growth media was aspirated 
and cells were washed twice with HBSS. Cells were then incubated with 1 μM 
NIR dye in OPTI-MEM I for 10-30 minutes, after which the dye-labeling media 
was aspirated and the cells were washed twice with HBSS. The cells were 
treated with fresh OPTI-MEM I, and then subjected to bright field and 
fluorescence microscopy. 
 Repeated Imaging 
After initial imaging, OPTI-MEM I was aspirated, replaced with fresh OPTI-MEM 
I, and cells were incubated until needed. Prior to imaging, cells were washed 
twice with HBSS and treated with fresh OPTI-MEM I. This series was repeated 
until imaging was no longer desired. 
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Costaining Cells with MitoTracker® 
Preparation of MitoTracker® Green FM 
MitoTracker® Green FM was freshly prepared as a 1 mM stock solution in 
DMSO. Dye-labeling media (100 nM in OPTI-MEM I) was prepared immediately 
prior to treatment. 
Dye Treatment and Imaging 
Cells were subcultured as described for NIR experiments. Growth media was 
aspirated and cells were washed twice with HBSS. Cells were then incubated 
with 100 μM MitoTracker® Green FM in OPTI-MEM I for 30 minutes. Upon 
completion of mitochondrial-labeling, the dye-labeling media was aspirated and 
the cells were washed twice with HBSS. Cells were then treated with NIR dye-
labeling media (1 μM in OPTI-MEM I) and incubated for 10 minutes. Imaging was 
performed as described above. Overlayed images were prepared with ImageJ. 
Multidrug Efflux Pump Inhibition 
Inhibitor and NIR Dye Preparation 
Complete media, HBSS, and OPTI-MEM I containing either 0.5 μM Ko143, 50 
μM MK-571, or 50 μM verapamil were prepared prior to experiment by dilution of 
the stock compound into the appropriate medium. Dye-labeling media (1 μM NIR 
dye in OPTI-MEM I plus inhibitor) was prepared immediately prior to treatment. 
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Initial Treatment with Inhibitors 
Cells were subcultured as described for NIR experiments. Growth media was 
aspirated and cells were washed twice with HBSS. Cells were then incubated 
with inhibitor in complete media for 5 minutes to allow for pump inhibition. 
Dye Treatment and Imaging 
Complete media containing inhibitors was aspirated and cells were washed twice 
with inhibitor-supplemented HBSS. Cells were then incubated with 1 μM NIR dye 
+ inhibitor in OPTI-MEM I for 30 minutes. Upon completion of dye treatment, the 
dye-labeling media was aspirated and the cells were washed twice with inhibitor-
supplemented HBSS. After layering in fresh inhibitor-supplemented OPTI-MEM I, 
bright field and NIR images were collected. 
After initial imaging, inhibitor-supplemented OPTI-MEM I was aspirated and cells 
were washed twice with inhibitor-supplemented HBSS. The cells were then 
incubated for 30 minutes in complete media containing inhibitors. Upon 
completion of incubation, the cells were washed twice with inhibitor-
supplemented HBSS, treated with fresh inhibitor-supplemented OPTI-MEM I, and 
subjected to bright field and fluorescence microscopy. 
Upon completion of the second imaging, the inhibitor-supplemented OPTI-MEM I 
was aspirated. Efflux pump activity was then restored by washing the cells twice 
with inhibitor-free HBSS and incubating the cells in inhibitor-free complete media 
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for 30 minutes. The cells were then washed twice with inhibitor-free HBSS, 
treated with fresh inhibitor-free OPTI-MEM I, and then subjected to bright field 
and fluorescence microscopy.     
shRNA Knockdown of ABCB1 (Pgp) and ABCC1 (MRP1) Efflux Pumps  
shRNA Knockdown Cells 
U2-OS cells expressing shRNA against ABC transporters ABCB1 and ABCC1 
were prepared by Poshen Chen in the Fazzio lab at the University of 
Massachusetts Medical School as described in (Chen et al., 2013). Five potential 
shRNA sequences against each gene were chosen for analyses. The shRNA 
sequence which produced the highest degree of mRNA repression by RT-qPCR 
was then utilized for fluorescence experiments (Figure 4.13). The shRNA 
sequences chosen were ABCB1 clone B4 (CCGAACACATTGGAAGGAAAT: 
94% decrease in expression) and ABCC1 clone E10 
(CCACATGAAGAGCAAAGACAA: 71% decrease in expression). shRNA 
expressing U2-OS cells were selected for by maintenance in complete media 
supplemented with 2 μg/mL puromycin. Apart from this addition, culturing and 
subculturing of these cell lines was performed as described for normal U2-OS 
cells.     
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Figure 4.13: RT-qPCR results of ABCB1 (top) and ABCC1 (bottom) 
expression in U2-OS cells expressing shRNA against the transporter. Mock: 
empty vector. Clones obtained from the University of Massachusetts Medical 
School RNAi Core Facility.  
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Dye Treatment and Imaging 
Cells were subcultured as described for NIR experiments with the exception that 
growth media was supplemented with 2 μg/mL puromycin (provided by the 
Fazzio Lab). No puromycin was used upon initiation of the experiment. Growth 
media was aspirated and cells were washed twice with HBSS. Cells were then 
incubated with 1 μM NIR dye in OPTI-MEM I for 15 minutes. Upon completion of 
dye treatment, the dye-labeling media was aspirated and the cells were washed 
twice with HBSS. After layering in fresh OPTI-MEM I, bright field and NIR images 
were collected. OPTI-MEM I was then aspirated, replaced with fresh OPTI-MEM 
I, and cells were incubated for an additional 20 minutes. OPTI-MEM I was 
aspirated and the cells were washed twice with HBSS, treated with fresh OPTI-
MEM I, and then subjected to bright field and fluorescence microscopy. This 
process was repeated until imaging was concluded at 2 hours post dye 
treatment. 
Spinning Disk Confocal Microscopy  
Prior to experiments, cells were subcultured into 35 mm plates fitted with a 14 
mm collagen coated glass coverslip (MatTek) at a seeding density of 0.05 x 106 
cells. Cells were then incubated in complete media overnight. 
Preceding dye treatment, growth media was aspirated and cells were washed 
twice with HBSS. Cells were then layered in 1 mL OPTI-MEM I and placed in a 
stage top incubator with a 5% CO2 atmosphere and temperature maintained at 
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37 °C. DIC and NIR images were then collected for 2 to 5 minutes at a rate of 1 
image/minute on a Nikon TE-2000E2 inverted microscope with a 40X Plan Apo 
oil objective using a Photometrics Coolsnap HQ2 camera. NIR emission was 
obtained by excitation with an argon ion laser (25 mW, 636 nm). During these 
initial images, a 2 μM solution of NIR dye was prepared in OPTI-MEM I. Imaging 
of the cells was ceased and 1 mL of dye-labeling media was added to the cells to 
give a final dye concentration of 1 μM. Cell imaging was immediately restarted 
and DIC/NIR images were collected at a rate of 1 image/minute for 30 to 40 
minutes. Cell movies were then prepared using the Universal Imaging 
Metamorph software with playback at 1.5 frames/second. 
Live Cell Cleavage of AcOTFMB-Sulfonate Ester 
Dye Treatment 
Prior to experiments, cells were subcultured into 6-well plates at a seeding 
density of 0.3 x 106 cells and grown to 80% confluency in complete media. 
Growth media was aspirated and cells were washed twice with HBSS. Cells were 
then incubated with 1 μM NIR dye in OPTI-MEM I for 15-30 minutes. Dye uptake 
was monitored by wide field microscopy. Upon completion of dye treatment, the 
dye-labeling media was aspirated and the cells were washed twice with HBSS. 
Cells were then layered in fresh OPTI-MEM I and quickly imaged to confirm 
presence of intracellular dye fluorescence. 
 
181 
 
Cell Lysis and Dye Collection 
After imaging, OPTI-MEM I was removed by aspiration and the cells were 
covered with 2 mL 50% methanol/water and incubated at room temperature for 
30 minutes. The cells were then lifted from the plate by scraping and transferred 
to eppendorf tubes. The wells of the plate were then washed twice with 1 mL 
50% methanol/water with additional scraping and the washes were transferred to 
fresh eppendorf tubes. To complete lysis, the cell collections were voraciously 
vortexed and then frozen in liquid nitrogen. After freezing, the cell tubes were set 
aside to thaw at room temperature. The vortex/freeze/thaw cycle was then 
repeated two more times followed by centrifugation at 14,000 rpm for 15 minutes 
at room temperature. The supernatant containing the retrieved NIR dye was then 
concentrated on a SpeedVac while the pellet containing cell debris was 
discarded. The concentrated dye collections were then dissolved in 50% 
methanol/water, combined, and reconcentrated on a SpeedVac. 
Reversed Phase-High Performance Liquid Chromatography Analysis 
Retrieved dye was analyzed by RP-HPLC on a 4.6 x 250 mm C-18 column using 
a Hewlett Packard Agilent 1100 HPLC equipped with a G1315A DAD 
absorbance detector. Absorbance detector was set at 800 nm for reference 
Analysis was performed using aqueous 0.1% trifluoroacetic acid as Solvent A 
and acetonitrile/0.1% trifluoroacetic acid as Solvent B and were run at a flow rate 
of 1.4 mL/min. Retrieved dye samples were loaded onto column as 50% 
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acetonitrile/water solutions. AcOTFMB-Ox, TFMB-Ox, and Sulf-Ox dyes were 
used as controls for the analysis and were prepared from dilutions of the10 mM 
DMSO stock in 50% acetonitrile/water. 
Analytical HPLC method for all samples was 10% B for 5 minutes, 10-100% B 
over 90 minutes, 100% B for 10 minutes. Absorbances were measured at the 
following wavelengths: 
Ox-1 dyes: 280, 360, 603, 653, and 657 nm. 
Ox-2 dyes: 280, 360, 607, 653, and 660 nm. 
Electrospray Ionization-High-Resolution Mass Spectrometry 
ESI-HRMS spectra of samples collected from analytical HPLC were obtained on 
a Waters QToF Premier exact mass spectrometer. Data was used in combination 
with RP-HPLC to confirm the identity of the retrieved dye. 
NIR Imaging in Live Mice 
Live animal imaging was performed by Spencer Adams Jr. of the Miller lab at the 
University of Massachusetts Medical School. All protocols were performed within 
compliance with the Institutional Animal Care and Use Committee (IACUC) of the 
University of Massachusetts Medical School (IACUC: A-2474). 
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Dye Preparation  
Prior to mouse imaging, dyes were prepared in sterile PBS (Amicon® 10X PBS 
diluted 1:9 in Amicon® nuclease-free water). Each solution was then filtered 
through a 0.22 μm filter (Millex® GV 4mm filters). 
Dye Treatment and Imaging 
C57BL/6 mice were weighed and then anesthetized with 2% isoflurane. Mice 
were transferred to the IVIS-100 imaging system from Xenogen®, (now a Perkin-
Elmer company). Fluorescence imaging of the mice was performed with Cy5.5 
filters (excitation: 615-665 nm, emission: 695-770 nm) or indocyanine green 
(ICG) filters (excitation: 710-760 nm, emission: 810-875 nm). Background 
subtraction was performed per the IVIS-100 manual. After collecting pre-injection 
images, mice were injected with 320 fm/kg dye, either intraperitoneally (ip) or into 
the tail vein (iv). Injections were performed with 271/2 gauge insulin syringes 
(Terumo® 0.5cc insulin syringes). Tails were pre-cleaned with alcohol-prep pads 
before injections and the alcohol-prep pad was used to apply pressure to the 
injection site post-injection to stop bleeding. Mice were imaged with the above 
filters immediately following injection and then again at a later time point 
(between 2 to 4 hours). Between the initial and final imaging periods, mice were 
returned to their cages and allowed to recover before re-inducing anesthesia. 
Imaging analysis was performed with Living Image 4.3.1 software (Caliper Life 
Sciences Inc.®, now Perkin-Elmer).  
184 
 
Chapter V: Synthesis and characterization of near-IR oxazine sensors of pH 
and nitric oxide 
 
 
 
Summary 
Fluorescence based biological sensors commonly employ photoinduced electron 
transfer (PET) to quench the sensor until it encounters its analyte of interest. The 
fluorescence of near-infrared (NIR) oxazine dyes is known to be efficiently 
modulated by PET, yet there are almost no fluorescence sensors using this 
scaffold. Here, we report the synthesis and in vitro evaluation of NIR oxazines 
that function as fluorescent sensors of either nitric oxide or changes in pH. 
Introduction 
 Fluorescent sensors are useful reagents for reporting on cellular 
conditions. For example, biologically relevant ions such as sodium, calcium and 
zinc have been monitored with fluorescein and rhodamine derivatives (Kikuchi et 
al., 2004; Martin et al., 2004; Martin et al., 2005; Minta et al., 1989). Reactive 
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oxygen and nitrogen species have also been detected using derivatives of 
fluorescein, rhodamine and BODIPY (Barta et al., 2002; Gabe et al., 2006; Koide 
et al., 2007; Kojima et al., 1998; Kojima et al., 2001). Yet, despite the variety of 
sensors available for biology, most of these fluorophores are poorly suited for 
use within cells and organisms. This is because most commonly used 
fluorophores absorb and emit visible light. The presence of endogenous 
fluorophores in cells (e.g., NADPH and flavins) that also absorb and emit visible 
light results in high autofluorescence background (Andersson-Engels et al., 1997; 
Monici, 2005). The situation is exacerbated in vivo due to the presence of 
hemoglobin, which strongly absorbs visible light and dramatically decreases the 
signal to noise ratio (Hilderbrand and Weissleder, 2010; König, 2000). Together, 
these factors render visible wavelength fluorophores essentially useless for 
detecting cellular changes in living organisms. Near-infrared (NIR) light (650-900 
nm) is more suited for biological applications than visible light as cells do not 
fluoresce in the NIR and few endogenous molecules absorb long wavelength 
light (Escobedo et al., 2010; Frangioni, 2003; Guo et al., 2014; Hilderbrand and 
Weissleder, 2010 ). Due to the poor absorption of NIR light by biological 
molecules, NIR light penetrates deeper into tissue and is less phototoxic than 
visible light (Escobedo et al., 2010; Frangioni, 2003; Ghoroghchian et al., 2009; 
Guo et al., 2014; Hilderbrand and Weissleder, 2010; Kobayashi et al., 2010). 
Thus, NIR light is considered to be in the optimal spectral window for cellular and 
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in vivo imaging and it follows that NIR fluorophores are the most suited for 
detecting changes within cellular environments. 
 Most NIR probes are derived from four primary scaffolds: BODIPYs, 
indocyanines, oxazines, and most recently, silicon-functionalized rhodamines (Si-
rhodamines). Of these scaffolds, heptamethine indocyanines, such as IR780 and 
IR783, have been exhaustively employed in biology as both stains and sensors 
(Figure 5.1) (Karton-Lifshin et al., 2011; Li et al., 2011; Sasaki et al., 2005; Tian 
et al., 2011; Xu et al., 2012;Yang et al., 2010; Zhang et al., 2010). This is due 
both to the photophysical properties of the dyes (peak absorbance of 780 nm or 
higher) and the synthetic ease with which these dyes can be functionalized. 
However, despite their extensive use as imaging reagents, NIR indocyanines 
have several drawbacks. First, non-sulfonated, IR780 type dyes are large, 
planar, hydrophobic molecules that tend to aggregate within aqueous 
environments, such as the cytosol (Peng and Draney, 2004; Mishra et al., 2000). 
Second, these dyes are cationic and, inside cells, will accumulate within the 
negatively polarized membrane of the mitochondria (Bunting et al., 1989; Perry et 
al., 2011). These features limit the cellular imaging utility of indocyanine dyes. On 
the other hand, sulfonated indocyanines, such as IR-783, are water-soluble; yet, 
the negative charge of the dye prevents the compound from traversing the 
plasma membrane (Berridge et al., 2005; Stolz, 2001; Wuhrmann et al., 1980). 
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Figure 5.1: IR780/783-derived fluorescent sensors (Li et al., 2011; Sasaki et 
al., 2005; Tian et al., 2011). 
 
 Along with the need to circumvent the negative aspects associated with 
NIR indocyanines, there is a need to expand the palette of NIR tools for 
biological imaging in general. Some efforts to do this have focused on 
functionalizing the BODIPY scaffold, both to red shift the wavelength and enable 
the dye to interact with ions and small molecules  (Figure 5.2) (Coskun et al., 
2007; Hall et al., 2006; Matsui et al., 2011; Ni and Wu, 2014). Visible light 
emitting BODIPYs have very favorable photophysical characteristics including 
high extinction coefficients and high quantum yields (Gabe et al., 2006, Karolin et 
al., 1994). While some of these features are observed in NIR BODIPYs, these 
molecules tend to be extremely hydrophobic, and thus suffer the same problems 
associated with indocyanines (Ni and Wu, 2014).  
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Figure 5.2: NIR BODIPY and Aza-BODIPY fluorescent sensors (Coskun et al., 
2007; Hall et al., 2006; Matsui et al., 2011). 
 
 Although the majority of NIR dyes derivatized for biological sensing are 
based on cyanines and BODIPYs, another NIR scaffold, pentacyclic oxazine, has 
several characteristics that would favor its use for sensing small molecules 
(Figure 5.3). The NIR oxazine scaffold is more compact than either NIR 
indocyanines or BODIPYs. This reduces the hydrophobic surface area available 
for undesirable dye dimerization and binding to serum proteins observed among 
cyanines (Grabolle et al., 2014; Moody, et al., 1999; Muckle, 1976). Oxazines 
also exhibit higher photostability than cyanines, which is desirable when imaging 
for extended periods (Anzalone et al., 2013; Vogelsang et al., 2009). NIR 
oxazines have also been successfully employed for both live cell and in vivo 
imaging (Hintersteiner et al., 2005, Stöhr et al., 2010; van de Linde et al., 2012). 
Despite all these beneficial features, NIR oxazines are rarely employed as 
fluorescent sensors. 
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Figure 5.3: NIR oxazine scaffold.  
 
 The essential feature of fluorescent sensors is a measurable change in 
fluorescence, e.g. emission intensity or wavelength, upon interaction with the 
analyte of interest (Lemke and Schultz, 2011; Schäferling, 2012). An increase in 
fluorescence intensity upon analyte detection is a favored strategy for fluorescent 
sensors. One simple and highly utilized way to prepare a NIR fluorophore with 
reversibly quenched fluorescence is through photoinduced electron transfer 
(PET) (Ni and Wu, 2014; Song et al., 2005). PET is a non-destructive form of 
fluorescence quenching which employs an electron rich functionality (PET donor) 
to prevent radiative relaxation of a fluorophore’s excited electron after photon 
absorption (Figure 5.4) (Bryan et al., 1989; Doose et al., 2009; Fox, 1990). PET-
based turn-on fluorescent sensors function by using a PET donor that reacts with 
the target analyte, converting it to an electron-poor moiety (Bryan et al., 1989). 
This electron-poor moiety is unable to quench fluorescence thus permitting the 
fluorophore to relax radiatively.  
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Figure 5.4: Quenching of fluorescence via photoinduced electron transfer 
(PET). Photon absorption results in electron promotion from the ground state 
HOMO to a singlet LUMO. Top: An unquenched fluorophore will relax via photon 
emission after absorbing light. Bottom: The PET donor, having ground state 
electrons in a HOMO of higher energy than the ground state of the fluorophore, 
can donate an electron to the evacuated fluorophore orbital thus preventing the 
excited electron from relaxing via photon emission.    
 
 Despite the use of PET as a quenching mechanism for numerous 
fluorescent sensors, it is generally less effective in modulating the fluorescence 
of long wavelength emitting fluorophores compared to visible light emitting dyes 
(Ozmen and Akkaya, 2000; Song et al., 2005). However, NIR oxazines are an 
exception to that rule. The fluorescence of NIR oxazines is known to be well 
modulated by PET (Doose et al., 2009; Marmé et al., 2003; Stöhr et al., 2010; 
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Valana et al., 2003). Sauer’s group found that the fluorescence of the NIR 
oxazines MR121 and ATTO655 is efficiently quenched by tryptophan (Marmé et 
al., 2003). His group has also shown that the nucleotide guanosine can modulate 
the fluorescence of MR121and another oxazine derivative, JA242, (Lieberwith et 
al., 1998; Sauer et al., 1995). Based on this feature, the Herten lab successfully 
developed a low background NIR oxazine probe for labeling intracellular proteins 
by conjugating the dye to an O6-benzylguanine moiety (Stöhr et al., 2010). 
Fluorescence of the dye is only restored upon removal of the guanine by SNAP 
tag fused-proteins (Keppler et al., 2003; Stöhr et al., 2010). Clearly, the 
modulatable fluorescence, high photostability, and favorable structural features of 
the pentacyclic oxazine make this a desirable scaffold for use in sensing 
technology. Seeing an opportunity to expand the palette of NIR fluorescent 
sensors, we set out to develop oxazine-based sensors of nitric oxide and pH.  
Results and Discussion  
 Due to its role as a biological second messenger in a plethora of cellular 
pathways, the small radical nitric oxide (NO) has long been a target for sensing 
technologies (Akaike et. al., 2000, Hall and Garthwaite, 2009). The concentration 
of nitric oxide in living cells is very low and thus detecting NO in living systems 
requires methods with a high degree of sensitivity (Hall and Garthwaite, 2009). 
Fluorescence imaging has the high sensitivity desired for detecting low 
concentrations of a substance and NIR fluorescence imaging is aptly suited for 
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use in cells (Lakowicz, 2006). We therefore sought to develop a NIR oxazine-
derived NO sensor. 
 One compound commonly employed as a PET donor for nitric oxide 
sensors is o-diaminobenzene (Figure 5.5) (Pluth et al., 2011). The unbound 
electron pairs of the two exocyclic amines make this an electron rich molecule. 
However, in the presence of NO, o-diaminobenzene reacts to form the electron-
poor benzotriazole, which cannot function as a PET donor due to the electron 
withdrawing -N=N- and resonance -C=N- functionalities (Figure 5.5). This 
reaction provides the mechanism by which fluorescence can be modulated. The 
Nagano lab utilized this strategy in the preparation of NO sensors derived from 
fluorescein, rhodamine, BODIPY and indocyanine dyes (Gabe et al., 2004; Gabe 
et al., 2006; Hirotani et al., 2000; Kojima et al., 2001; Sasaki et al., 2005); several 
of these compounds, diaminofluorescein-FM (DAF-FM), diaminorhodamine-FM 
(DAR-FM), and diaminorhodamine-4M (DAR-4M), are now commercially 
available. It should be noted that the o-diaminobenzene group does not directly 
react with nitric oxide, but with NO oxidation products that are rapidly formed in 
aqueous, aerobic environments (Figure 5.5) (Ignarro et al., 1993; Kojima et al., 
1998; Kojima et al., 2001; Pluth et al., 2011). It has also been observed that o-
diaminobenzene-based NO sensors are sensitive to dehydroascorbic acid and 
ascorbic acid (Pluth et al., 2011; Zhang et al., 2002). However, the focus of our 
work was to determine whether NIR oxazines could function as sensors for 
biological analytes; therefore, despite the limitations associated with the o-
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diaminobenzene PET donor, we choose to functionalize our sensors with this 
moiety. 
 
 
Figure 5.5: The electron rich o-diaminobenzene reacts with nitric oxide to 
produce the electron poor benzotriazole. A) Aerobic reaction of o-
diaminobenzene with NO. o-Diaminobenzene actually reacts with oxidation 
products of NO, such as N2O3 (Kojima et al., 2001). B) Oxidation reactions of NO 
in water. 
 
 PET is a short distance interaction, generally requiring van der Waals 
contact between donor and acceptor for effective quenching (Hush et al., 1985; 
Marmé et al., 2003). A commonly employed design used for fluorescent sensors 
to provide this contact is the fluorophore-spacer-PET donor structure (Figure 5.6) 
(Bryan et al., 1989; Hall et al., 2006). We thus modeled our sensor with the PET 
A 
B 
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donor separated from the dye by spacers of 1 to 3 methylene groups (Figure 
5.7). Molecular modeling suggested that the three carbon propylene spacer 
would allow the closest approach between donor and fluorophore with a 
predicted separation of 5.4 Å. Based off of this design, we set out to synthesize 
our NIR oxazine-based NO sensor. 
  
 
Figure 5.6: General architecture for design of fluorescent sensor. 
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Figure 5.7: Molecular modeling reveals that a 3-carbon spacer between the 
NIR oxazine scaffold and o-diaminobenzene allows the closest approach 
between PET donor and acceptor. A. Methylene spacer; B. Ethylene spacer; 
C. Propylene spacer. i. Chemical structure. ii. Ball and stick model showing 
closest distance obtainable between PET donor and dye scaffold. iii. van der 
Waals surface of PET-quenched dye structure. Molecular modeling performed by 
Brendan Hilbert. 
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Figure 5.7A. in silico model of NO sensor with PET donor and dye separated by 
methylene spacer. 
i 
ii 
iii 
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Figure 5.7B. in silico model of NO sensor with PET donor and dye separated by 
ethylene spacer. 
i 
ii 
iii 
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Figure 5.7C. in silico model of NO sensor with PET donor and dye separated by 
propylene spacer. 
i 
ii 
iii 
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 We first prepared the PET donor-spacer portion of the sensor (Scheme 
5.1). Beginning with 3,4-dinitrobenzoic acid, the corresponding benzaldehyde 2 
was prepared via borane reduction and Dess-Martin oxidation. 3,4-
Dinitrobenzaldehyde was homologated via a Horner-Wadsworth-Emmons 
reaction 3 to prepare the 3-carbon linker needed for attachment to the dye core. 
Palladium catalyzed hydrogenation resulted in alkene and nitro reduction to give 
3-(3,4-diamino-phenyl)-propionic acid ethyl ester 4. To prevent further reaction at 
the aromatic exocyclic amines, the compound was Boc-protected 5. Finally, 
saponification, borane reduction, and bromination resulted in the Boc-protected 
PET donor 8 in high yield. 
 
 
Scheme 5.1: Synthesis of PET donor for oxazine-based nitric oxide sensor. 
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 Oxazine dyes are generally formed by condensation of an arylazo 
compound with an aminophenol (Hintersteiner et al., 2005). Previous work in our 
lab has found that TBS protection of the phenol increases the yield of amino 
alkylation for dye functionalization and does not interfere with oxazine dye 
synthesis (Pauff and Miller, 2011; Pauff and Miller 2013). We therefore employed 
this method for synthesis of the NO sensor (Scheme 5.2). 3,4-Dihydro-7-hydroxy-
2(1H)-quinolinone was first reduced to 1,2,3,4-tetrahydroquinolin-7-ol 9 followed 
by TBS protection 10. N-alkylation of 10 with the PET donor 8 produced the first 
half of the dye scaffold 11. The arylazo portion of the dye 15 was synthesized 
from 3,4-dihydro-7-hydroxy-2(1H)-quinolinone via O-methylation, borane 
reduction, N-ethylation, and diazo coupling. Condensation of 11 and 15 in 
refluxing aqueous, acidic ethanol provided us with the PET-quenched NIR 
oxazine nitric oxide sensor 16. 
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Scheme 5.2: Synthesis of oxazine-based nitric oxide sensor. 
 
 We next synthesized the benzotriazole form of our oxazine sensor 17 by 
treating 16 with the NO donor DEA NONOate (Scheme 5.3); formation of the 
product was confirmed via analytical HPLC and high-resolution mass 
spectrometry (Figure 5.8). Having obtained both the o-phenylenediamine 16 and 
benzotriazole 17 forms of the dye, we next sought to examine the photophysical 
properties of the compounds to determine whether the quenching strategy was 
successful. 
Ex: 664 nm 
Em: 680 nm 
ΦFl: 0.011 
τFl: 1.5 ns 
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Scheme 5.3: Synthesis of unquenched (fluorescent) form of nitric oxide 
sensor.  
 
    
 
 
 
 
 
 
 
 
 
Ex: 666 nm 
Em: 679 nm 
ΦFl: 0.20 
τFl: 1.8 ns 
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 Absorption and emission spectra of 16 and 17 were obtained in PBS 
(Figure 5.9 and 5.10). While there was little change in the emission wavelengths 
between the two dyes, the integrated fluorescence intensity of the unquenched 
dye 17 was 7-fold higher than that of the parent dye 16 (Figure 5.11). Although 
the fluorophore and PET donor are covalently connected, they are unconjugated; 
therefore, the ground state electronics of the oxazine dye in 16 and 17 are 
unchanged (Hall et al., 2006). This means that dyes 16 and 17 should absorb 
light with equal efficiency and thus, the low photon output of the NO sensor must 
be related to a decreased ability to relax radiatively (Figure 5.9). In other words, 
the fluorescence of 16 is quenched. This quenching was confirmed by comparing 
the fluorescence quantum yields of the two dyes. Fluorescence quantum yield 
(ΦFl) is a function of both the photons emitted and the photons absorbed by a 
compound (Equation 5.1).  
 
The quantum yield of NO sensor 16 was decreased to less than 6% of that of the 
unquenched benzotriazole dye 17 (Table 5.1). Thus, assuming equal efficiency in 
photon absorption, 16 does not efficiently fluoresce. As the only difference 
between NIR oxazines 16 and 17 is the presence of the PET donor on 16, it can 
be concluded that the fluorescence of the oxazine dye is being quenched by 
PET.  
 
5.1 
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Figure 5.9: Absorbance spectra of 16 and 17 in PBS, pH 7.4. 10 mM DMSO 
stocks of 16 (A) and 17 (B) were dissolved in 1X PBS, pH 7.4 to give a final 
concentration of 10 µM. AU: absorbance units.  
 
 
 
A 
B 
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Figure 5.10: Emission spectra of 16 and 17 in PBS, pH 7.4. 10 mM DMSO 
stocks of 16 (A) and 17 (B) were dissolved in 1X PBS, pH 7.4 to give a final 
concentration of 10 µM. Fluorescence intensity was measured using excitation at 
665 nm for both 16 and 17. Excitation/Emission slit width: 5 nm. CPS: counts per 
second.  
 
A 
B 
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Figure 5.11: Integrated fluorescence intensity of 10 µM 16 and 17 in PBS, 
pH 7.4. 10 mM DMSO stocks of quenched NO Sensor 16 and unquenched 
benzotriazole 17 were dissolved in 1X PBS, pH 7.4 to give a final concentration 
of 10 µM. Fluorescence intensity was measured using excitation at 665 nm for 
both 16 and 17. Excitation/Emission slit width: 5 nm. Integrated fluorescence 
intensity was obtained by integrating the area under the emission curves from 
400-900 nm. AU: arbitrary units. 
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Compound 16 17 
λEx (nm) 664 666 
λEm (nm) 680 679 
ΦFl 0.011 0.20 
τFl (ns) 1.5 1.8 
 
Table 5.1: Photophysical properties of 16 and 17 in PBS, pH 7.4. Excitation 
and emission wavelengths and quantum yield were obtained using a 10 µM final 
dye concentration. Fluorescence lifetime was measured using a 1 µM final dye 
concentration. λ: wavelength. ΦFl: fluorescence quantum yield.  τFl: fluorescence 
lifetime. 
 
 Having confirmed that o-diaminobenzene can function as a PET donor for 
modulating NIR oxazine fluorescence, we wanted to determine the mechanism of 
quenching; i.e., static versus dynamic quenching. Static quenching is defined by 
formation of a ground state molecular complex that is non-fluorescent (Lakowicz, 
2006; Marmé et al., 2003). Dynamic quenching results from any energetic 
process, electronic or kinetic, that depopulates the excited state of the 
fluorophore (Lakowicz, 2006). These two mechanisms are distinguished by 
comparing the fluorescence lifetimes of the quenched and unquenched 
fluorophore; in other words, how long the molecule stays in the excited state 
before relaxing via fluorescence. In static quenching, the lifetimes of the 
quenched and unquenched fluorophore will be similar, but fewer photons will be 
observed from the quenched fluorophore. Therefore, for equal concentrations of 
quenched and unquenched dye, the quenched compound will appear to be at a 
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lower concentration than the unquenched molecule. During dynamic quenching, 
the length of the lifetime itself is shortened.  
 Using time-correlated single-photon counting (TCSPC), we measured the 
fluorescence lifetime of 1 µM 16 and 17 in PBS, ph 7.4 (Figure 5.12). The data 
was curve-fitted with a combination of two exponentials suggesting that the 
lifetime of both 16 and 17 consists of two components (Table 5.2). The narrowing 
of the exponential decay curve of 16 as compared to 17 in Figure 5.12 clearly 
indicates a decrease in the fluorescence lifetime of 16. As shown in Table 5.2, 
the lifetime of 16 has decreased by approximately 0.33 ns. This indicates that the 
fluorescence of our NO sensor is being dynamically quenched, a mechanism 
which can be directly correlated to the activity of PET. However, our results also 
indicate a significant degree of static quenching. The pre-exponential amplitude 
(A) of the fitted curve describes the quantity of photons involved in a given 
fluorescence lifetime. Based on the curve-fitted value of the amplitudes shown in 
Table 5.2, more than 99% of the photons of 16 appear to be associated with a 
lifetime of 3 ps. This is beyond the instrument’s measurement capacity and 
suggests the presence of a molecular species that relaxes almost 
instantaneously following photon absorption; i.e., a non-fluorescent complex. 
Thus, PET quenching of the NO sensor appears to involve both of the known 
quenching mechanisms.  
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Figure 5.12: Time correlated single photon counting (TCSPC) suggests a 
complex mechanism for quenching of NIR oxazine-derived NO sensor 16. 
Fluorescence decay of 1 µM 16 (A) and 17 (B) in 1X PBS, pH 7.4 was measured 
using TCSPC as described (see Methods). Data was fit using a sum of 
exponentials plus a constant.  
 
A 
B 
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Compound 16 17 
τFl(1) (ns) 1.46 +/- 1.83E-3 1.79 +/- 1.12E-3 
A1 (% total photons) 0.9% 53% 
τFl(2) (ps) 3.54+/- 0.281 76.2 +/- 9.49 
A2 (% total photons) 99.1% 47% 
χ2red  3.8 1.86 
 
Table 5.2: Values for curve fitting of TCSPC data. τFl: Exponential time 
constant. A: Pre-exponential amplitude. Values were calculated from a global 
analysis of a dilution series of the dyes (100 µM, 50 µM, 25 µM, 10 µM, 1 µM) 
using non-linear least squares fitting as described in methods (Dilution series not 
shown. The reduced chi squared values of the fits are slightly higher than ideal 
due to the excess number of photons employed in the analysis. While this 
prevented the residuals from achieving the desired randomness, it afforded an 
ideal fit that could be reproduced throughout the dilutions. 
 
  
 Upon observing that the fluorescence of 16 is indeed quenched via PET 
(Figure 5.12), and that this quenching can be relieved by treatment with nitric 
oxide (Figure 5.11), we needed to confirm that our sensor was actually specific 
for nitric oxide. Besides nitric oxide, living organisms contain a variety of other 
highly reactive molecules, including other nitrogen and oxygen species: nitrate 
(NO3-), nitrite (NO2-), superoxide anion (•O2-), hydrogen peroxide (H2O2), and 
hydroxyl radical (•OH), to name just a few (Ignarro et al., 1993; Novo and Parola, 
2008; Ray et al., 2012; Stuehr and Marletta, 1987). Work in the Nagano lab has 
shown that BODIPY sensors functionalized with o-diaminobenzene are specific 
for nitric oxide over other RNS and ROS. Reaction with NO showed a 280-fold 
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increase in fluorescence intensity over the untreated compound, compared to 
only a 2 to 3-fold increase from reaction with the other reactive species (Gabe et 
al., 2004). To confirm that this feature also held for our oxazine-based NO 
sensor, 1 µM 16 was treated with ROS (•OH and H2O2) and RNS (NO2- and NO3-) 
in PBS, ph 7.4 (Figure 5.13). Similar to the BODIPY NO sensor, there was only a 
1.3 to 1.7-fold increase in the fluorescence intensity of 16 upon treatment with 
the reactive nitrogen and oxygen species compared to the untreated compound. 
To ensure that the oxazine scaffold itself was not affected by these reactive 
species, the ROS/RNS-treated dye was incubated with nitric oxide (Figure 5.14). 
Treatment with nitric oxide resulted in a 4 to 6-fold increase in fluorescence 
intensity, and the fluorescence intensity was similar among the treatments. This 
suggests that the oxazine scaffold itself is unaffected by any ROS/RNS and that 
the limited fluxes in fluorescence intensity result from the limited reaction of the 
PET donor with species besides nitric oxide. 
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Figure 5.13: Changes in the fluorescence intensity of 16 upon treatment 
with ROS and RNS. Solutions of 16 (final concentration: 1 μM, 0.1% DMSO) 
were prepared in 1X PBS, pH 7.4. ROS and RNS treatments are as follows: 
nitrate was added as NaNO3 (100 µM), nitrite was added as NaNO2 (100 µM), 
H2O2 (1 mM), hydroxyl radical (•OH) was prepared in situ via addition of ferrous 
sulfate heptahydrate (100 µM) and H2O2 (1 mM), nitric oxide was added with 
DEA NONOate (10 µM). Upon treatment, the dye solutions were heated to 37 °C 
and stirred for 30 minutes. Fluorescence intensity was measured using excitation 
at 665 nm and emission at 679 nm. Excitation/Emission slit width: 2.5 nm. 
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Figure 5.14: Increase in the fluorescence intensity of ROS/RNS treated NO 
sensor upon treatment with nitric oxide. ROS/RNS treated solutions of 16 
were prepared as described in Figure 5.13 and heated with stirring at 37 °C for 
30 minutes. DEA NONOate (10 µM) was then added and the solutions were 
stirred for another 30 minutes at 37 °C. Fluorescence intensity was then 
measured using excitation at 665 nm and emission at 679 nm. 
Excitation/Emission slit width: 2.5 nm. 
 
 As a final proof of principle, we wanted to illustrate the ability of our sensor 
to detect changes in NO concentration over time. We therefore treated 16 with 
increasing concentrations of nitric oxide and monitored changes in fluorescence 
intensity over 30 minutes (Figure 5.15). DEA NONOate was used as the NO 
donor for this work. Under the conditions employed, the NO donor DEA 
NONOate has a half-life of 16 minutes and dissociates to give 1.5 moles of nitric 
oxide for every mole of compound (Keefer et al., 1996). At supra-molar 
concentrations of NO, there is a rapid increase in fluorescence intensity that 
begins to plateau even before the half-life of the NO donor is reached. Both the 
rate of reaction and the half-time to peak signal increase with increasing NO 
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concentrations, confirming that our sensor could indeed be employed in the 
temporal and spatial detection of NO (Table 5.3).  
 
 
Figure 5.15: NO sensor 16 can detect changes in nitric oxide concentration. 
Solutions of 16 (final concentration: 10 μM, 0.1% DMSO) were prepared in PBS, 
pH 7.4. Solutions of DEA NONOate in 1X PBS, pH 7.4 were prepared 
immediately before adding to dye solution. The reactions were incubated with 
stirring at room temperature and fluorescence intensity was measured every 5 
minutes using excitation at 665 nm and emission at 679 nm. Excitation/Emission 
slit width: 2 nm. Integrated fluorescence intensity was obtained by integrating the 
area under the emission curves from 624-800 nm. Data points were fitted with a 
one-phase association model. AU: arbitrary units. 
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DEA NONOate Concentration (µM) 5 50 100 
I0 (RFU) 4.590E6 4.974E6 4.890E6 
Plateau (RFU) 3.623E7 3.827E7 4.632E7 
k (min-1) 0.007343 0.1716 0.2195 
τ (min) 136.2 5.826 4.555 
τ1/2  (min) 94.40 4.038 3.157 
R2 (%) 99.67 99.57 99.97 
 
Table 5.3: Non-linear regression parameters for the one-phase association 
model employed in Figure 5.15. I0: Initial intensity. k: rate constant. τ: time 
constant.  τ1/2: half-life. RFU: relative fluorescence units. Parameters calculated 
with GraphPad Prism.  
 
 
 To show that our NIR oxazine-based sensing strategy is not limited to the 
detection of small molecules, we sought to prepare sensors that could be used to 
detect other biologically-relevant environmental conditions. Changes in biological 
pH are involved in a diverse range of cellular functions including the cell cycle, 
endocytosis, and ion conductivity and are thus stringently controlled (Madshus, 
1988). Due to the strict regulation of intracellular pH, detecting minor changes in 
pH requires a technique with high sensitivity, such as fluorescence imaging. 
Fluorescence-based sensors of pH have been prepared using both visible and 
NIR wavelength BODIPY-derivatives, but these suffer from the drawbacks 
previously described for BODIPY-type compounds (Jokic et al., 2012; Han et al., 
2013; Ni and Wu, 2014). We can improve upon the known fluorescence-based 
pH sensors by incorporating NIR oxazine-derivatives into the tool kit. 
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 During our work with NO Sensor 16, we had been concerned that the 
presence of the two slightly basic amines on the PET-donor could result in our 
compound being pH sensitive. However, incubation of 16 in solutions of 
decreasing pH only resulted in a 1.8-fold change in fluorescence intensity (Figure 
5.16). It is unlikely that both of the aromatic exocyclic amines would be 
protonated under the conditions we employed, which suggested to us that even a 
single aromatic exocyclic amine may have enough electron density to function as 
a PET donor.  
 
 
 
Figure 5.16: Oxazine-derived NO sensor 16 is relatively insensitive to pH. 
The fluorescence intensity of pH 3-8 buffered solutions of 16 (final concentration: 
1 μM, 0.1% DMSO) was measured using excitation at 665 nm and emission at 
680 nm. Excitation/Emission slit width: 3 nm. Integrated fluorescence intensity 
was obtained by integrating the area under the emission curves from 600-850 
nm.  AU: arbitrary units.  
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 One molecule that is both aromatic and bears a single exocyclic amine is 
aniline. Aniline is also slightly basic and can be protonated around pH 4-5. We 
hypothesized that the fluorescence of NIR oxazines could be quenched via an 
aniline-based PET donor and that this quenching could be relieved upon 
formation of the phenyl-ammonium cation (Figure 5.17). Furthermore, since our 
oxazine dyes are not particularly pH sensitive, we envisioned that our pH sensor 
would be specific for the pH range of the PET donor; i.e. pH 4-5.  
 
 
Figure 5.17: The electron-rich phenylamine can be reversibly protonated to 
produce the electron poor phenyl ammonium cation. 
 
 From work with our NO sensor, a propylene spacer allows van der Waals 
contact between an amino-substituted aromatic ring and the oxazine-dye 
scaffold. Building from this idea, we prepared a phenylamine-functionalized NIR 
oxazine (Scheme 5.4). Beginning with 3-(4-aminophenyl)propionic acid, the 
exocyclic aromatic amine was first Boc-protected to prevent the amino group 
from participating in subsequent reactions 18. Borane reduction of the carboxylic 
acid of 18 followed by bromination of the resulting alcohol 19 provided the Boc-
protected PET donor 20 in relatively high yield. N-alkylation of the TBS-protected 
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tetrahydroquinoline 10 with the PET donor 20 produced the first half of the dye 
scaffold 21. Condensation of 21 with the arylazo functionalized 
tetrahydroquinoline 15 in refluxing aqueous, acidic ethanol provided us with the 
PET-quenched NIR oxazine pH sensor 22. 
 
 
 
Scheme 5.4: Synthesis of oxazine-based pH sensor. 
  
 As the pKa of the phenyl-ammonium cation is between 4.6 and 4.9, we 
predicted that pH sensor 22 would be highly fluorescent at pH 4 and quenched at 
pH 7. The absorption and emission of 22 were therefore taken in PBS, pH 7.4 
and acetic acid/sodium acetate buffered solution, pH 4 (Figure 5.18). While the 
absorption and emission wavelengths were relatively unchanged in the different 
pH solutions, the acidic solution resulted in a 9-fold increase in the integrated 
fluorescence intensity compared to the PBS solution. This observation confirmed 
Ex: 663 nm 
Em: 677 nm 
τFl: 1.7 ns 
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that the phenylamine group can indeed function as a PET donor for modulating 
oxazine fluorescence (Figure 5.19).  
 
 
 
Figure 5.18: Absorption (A) and emission (B) spectra for pH sensor 22 in 
pH 4 and pH 7 solutions. A 10 mM DMSO stock of 22 was dissolved in 1X PBS, 
pH 7.4 or acetic acid/sodium acetate buffered solution, pH 4 to give a final 
concentration of 3.33 μM. Fluorescence intensity was measured using excitation 
at 663 nm. Excitation/Emission slit width: 5 nm. AU: absorbance units. CPS: 
counts per second.  
A 
B 
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Figure 5.19: Integrated fluorescence intensity of 22 in pH 4 and pH 7 
solutions. 10 mM DMSO stock of 22 was dissolved in 1X PBS, pH 7.4 or acetic 
acid/sodium acetate buffered solution, pH 4 to give a final concentration of 3.33 
μM. Fluorescence intensity was measured using excitation at 663 nm. Integrated 
fluorescence intensity was obtained by integrating the area under the emission 
curves from 400-900 nm. Excitation/Emission slit width: 5 nm. AU: arbitrary units. 
 
 To determine the range of the pH sensitivity of sensor 22, we measured 
the fluorescence intensity of 22 in solutions with pHs varying from 2-8 (Figure 
5.20). The integrated fluorescence intensity of the emission curves of 22 in the 
various pHs were then used to calculate the apparent pKa of our sensor (Figure 
5.21 and 5.22). The apparent pKa of pH sensor 22 was found to be 4.8, close to 
the value of the protonated PET donor itself. This finding suggests that by simply 
altering the identity of the pH sensitive PET donor, we can design NIR 
fluorophores for the detection of specific pH ranges. 
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Figure 5.20: Fluorescence intensity of 22 in pH 2-8 solutions. Solutions of 22 
(final concentration: 3.3 μM, 0.1% DMSO) were prepared in buffered solution 
having pHs of 2-8. Fluorescence intensity measured using excitation at 663 nm 
and emission at 676 nm. Excitation/Emission slit width: 2 nm. A. Emission 
spectra. B. Comparison of fluorescence intensities. CPS: counts per second. 
RFU: relative fluorescence units. 
A 
B 
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Figure 5.21: Integrated fluorescence intensity of pH sensor 22 in solutions 
of pH 2-8. Solutions of 22 (final concentration: 3.3 μM, 0.1% DMSO) were 
prepared in buffered solution having pHs of 2-8. Fluorescence intensity 
measured using excitation at 663 nm and emission at 676 nm. 
Excitation/Emission slit width: 2 nm. The integrated fluorescence intensity was 
obtained by calculating the area under the emission curves from 600-850 nm. 
AU: arbitrary units. 
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Figure 5.22: The apparent pKa of pH sensor 22 is 4.8. A plot of integrated 
fluorescence intensity (Figure 5.21) versus solution pH was fitted with a log 
versus response curve in GraphPad Prism to calculate the apparent pKa. AU: 
arbitrary units. R2 of fit: 99.99% 
 
 Figure 5.21 shows that there is more than a 13-fold increase in the 
integrated fluorescence intensity of 22 over the pH range of 8 to 3. At pH 2 
though, there seems to be a 31% decrease in integrated fluorescence intensity 
from the peak fluorescence at pH 3. The protonated PET donor on 22 will not be 
protonated a second time; therefore, one possibility to explain the decrease in 
fluorescence of 22 may be that the phenyl ammonium cation is affecting the pKa 
of the dye scaffold itself. Perhaps one of the dye-scaffold nitrogen atoms is being 
protonated leading to a decrease in fluorescence. This was not investigated 
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further at this time but, as it is unlikely that this feature is due to the 
acidity/basicity of the PET donor, this data point was excluded from the pKa 
calculation (Figure 5.22). 
 As a final characterization of our pH sensor, we wanted to determine the 
effect of pH on the lifetime of 22. Using TCSPC, we measured the fluorescence 
decay of 1 μM 22 in pH 3 to 7 solutions (Figure 5.23). The results were analyzed 
using both a local and global analysis of the data and the local fit was chosen for 
this work as it illuminated molecular features not seen in the global analysis 
(Table 5.4). Most of the data could be well fitted with two or three exponentials, 
suggesting that there were multiple components to the fluorescence lifetime of 
pH Sensor 22. This was extremely encouraging as we obtained a similar result 
when measuring the lifetime of NO Sensor 16 (Figure 5.12 and Table 5.2). The 
lifetime of one of our unquenched oxazines could be fit with a single exponential; 
i.e., it has a single component to its lifetime (Data not shown). The appearance of 
multiple lifetime components in our PET quenched dyes implies that the PET 
donor has an effect on the underlying electronic transitions of our NIR 
fluorophores.  
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Figure 5.23: Time correlated single photon counting (TCSPC) suggests that 
the pH-related PET-quenching of NIR oxazine-derived pH sensor 22 is 
complex. The fluorescence decay of 1 µM 22 in buffered solutions having pHs of 
3-7 was measured using TCSPC as described (see Methods). Data was fit using 
a sum of exponentials plus a constant as described in the methods. Solid lines 
indicate raw data. Dashed lines indicate fitted curve.  
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pH 3 4 5 6 7 
τFl(1) (ns) 1.67 +/- 
0.00499 
1.65 +/- 
0.00538 
1.56 +/- 
0.00375 
1.56 +/- 
0.00793 
1.47 +/- 
0.00872 
A1 
(% Total 
Photons) 
10.4 10.3 32.2 4 3.1 
τFl(2) (ps) 203 +/- 
13.5 
225 +/- 
19.7 
90.4 +/- 
1.39 
131 +/- 
12.5 
35.2 +/- 
0.957 
A2 
(%Total 
Photons) 
2.4 2.1 67.8 4.29 96.9 
τFl(3) (ps) 1 5.63 +/- 
2.77 
N/A 21.0 +/- 
1.77 
N/A 
A3 
(%Total 
Photons) 
87.2 87.6 N/A 91.7 N/A 
χ2red 1.43 1.34 1.36 1.48 1.79 
 
Table 5.4: Values for curve fitting of pH Sensor 22 TCSPC data. τFl: 
Exponential time constant. A: Pre-exponential amplitude. Values were calculated 
as described in methods using non-linear least squares fitting.  
 
 Like NO sensor 16, the lifetime of pH sensor 22 seems to be modulated 
by both static and dynamic quenching mechanisms. At pH 3, when 22 has the 
highest fluorescence output, it also has the longest lifetime: 1.67 ns (Figure 5.21 
and Table 5.4). With increasing pH, the lifetime decreases, reaching a minimum 
value of 1.47 ns at pH 7, when fluorescence output is at a minimum. This is a 
clear display of dynamic quenching, which is most certainly produced by 
photoinduced electron transfer. Furthermore, in general, the number of photons 
associated with the longer lifetime component decreases as pH increases. This 
indicates a decrease in the number of photons associated with this lifetime, and a 
decrease in concentration implies static quenching. 
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 However, the fluorescence lifetime of pH sensor 22 cannot be described 
by a simple two-mechanism scenario. At pH 5, near the pKa of 22, the 
concentration of photons associated with the long lifetime component actually 
increases. Additionally, while the lifetimes of 22 at pH 5 and 7 can be described 
by two components, at pH 3, 4, and 6, there is a 3rd lifetime component that is 
associated with the majority of emitted photons. The effects of PET-quenching on 
our pH sensor appear to be far more complex than observed with our NO sensor 
and will require a more detailed investigation before a valid explanation can be 
obtained. The primary conclusion obtainable from our current analysis is that 
changes in pH change the lifetime of our pH sensor. 
Conclusions 
 Probes and sensors that absorb and emit NIR light are vital tools in the 
study of cellular biology. Yet, the current NIR palette is primarily limited to two 
dye scaffolds, indocyanines and BODIPYs, both which suffer from inherent 
drawbacks limiting their use in living systems. In an effort to expand and improve 
the toolkit of viable NIR scaffolds for use as biological probes, we have 
successfully developed sensors of nitric oxide and pH based on the scarcely 
employed NIR pentacyclic oxazine.  
 Both our nitric oxide sensor 16 and pH sensor 22 are easily prepared from 
commercially available starting materials using regularly employed synthetic 
techniques (Schemes 5.1, 5.2, and 5.4). Prior to reaction with the analyte of 
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interest, the fluorescence of 16 and 22 are quenched via PET, a commonly 
employed method in the development of fluorescent sensors (Figures 5.11 and 
5.19). Furthermore, the only structural difference between 16 and 22 is the 
presence of a second amine on the electron-rich PET donor (Figure 5.5 and 
5.17). These features reveal the modularity and functional ease with which NIR 
oxazine based sensors can be prepared, thus allowing for the customization of 
sensors for a variety of analytes. 
 Our NIR sensors have a 6 to 13-fold increase in fluorescence intensity 
upon analyte detection (Figures 5.11, 5.15, 5.19, and 5.21). This is noticeably 
lower than for some visible wavelength sensors derived from fluorescein and 
rhodamine (Kojima et al., 1998, Tian et al., 2012). However, the low background 
noise associated with NIR imaging means the signal to noise ratio of our NIR 
probes could actually exceed the signal obtained from their visible wavelength 
counterparts when applied to living systems.  
 One of the most exciting features discovered during this work was the 
targeted and modular nature of our pH sensor. pH sensor 22 has a pKa of 4.8 
(Figure 5.22). This is within the pKa range of the protonated aniline PET donor, 
suggesting that the detection of pH is unaffected by our dye scaffold. Therefore, 
by simply choosing the right protonatable group that can also function as a PET 
donor, a NIR oxazine-based pH sensor can be developed for a wide range of pH 
values. 
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 Much of the work performed when developing fluorescent probes focuses 
on their synthesis and reactivity with the target analyte. Unfortunately, very little 
work has been undertaken to investigate the actual mechanisms by which the 
fluorescence of these sensors are quenched. This limits our ability to understand 
the mechanics guiding the behavior of molecules frequently employed in 
biochemistry and biology. We sought to fill this gap by examining the effects of 
PET-quenching on the fluorescence lifetimes of our probes through time 
correlated single photon counting. We were quite gratified to find that the 
fluorescence of NO sensor 16 and pH sensor 22 was quenched by similar 
mechanisms. Both molecules undergo static and dynamic quenching, which is 
logical since these two compounds differ by only a single aromatic exocyclic 
amine (Table 5.2 and 5.4; Scheme 5.2 and 5.4). However, the aniline PET donor 
of 22 also appears to alter the lifetimes of the NIR fluorophore in ways that are 
distinct from NO sensor 16. This suggests that there are minor modifications to 
the fluorophore structure that can drastically alter the underlying mechanics of 
quenching. This needs to be investigated in far greater detail as this would 
provide insight into the structural and/or chemical features that favor a given 
electronic relaxation pathway. Apart from a simply academic pursuit, this finding 
would be directly applicable to both chemistry and biology. Understanding how 
fluorescence-quenched probes actually relax from an exited state could aid in the 
intelligent design of molecules for probing biological environments. 
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Materials and Methods 
General Methods 
Chemicals were purchased from Aldrich, Acros, Matrix, Oakwood, and TCI and 
were used without further purification. Diethylammonium (Z)-1-(N,N-
diethylamino)diazen-1-ium-1,2-diolate (DEA NONOate) was purchased from 
Cayman Chemical. 10X phosphate buffered saline (PBS) was purchased from 
Aldrich and diluted to 1X with deionized water for all experiments. Organic 
solvents were ACS grade or Chromasolv® for HPLC grade and were purchased 
from Aldrich. Dry solvents were purchased from Acros. NMR solvents were 
purchased from Cambridge Isotope Laboratories. Unless otherwise stated, all 
reactions were performed under argon using dry organic solvents. 
NMR spectra were recorded at 400 MHz for 1H and 101 MHz 13C using a Varian 
Mercury 400 MHz instrument. High-resolution electrospray ionization mass 
spectra were obtained on a Waters QToF Premier exact mass spectrometer. 
Absorbance measurements were obtained using an Agilent Cary Series 100 UV-
Vis spectrophotometer. Fluorescence spectra were obtained using a Jobin Yvon 
Horiba SPEX FluoroMax-3. Data analysis was performed using GraphPad Prism. 
Molecular Modeling 
Molecular models were generated using Schrödinger’s Maestro (Schrödinger 
Release 2014-2: Maestro, version 9.8, Schrödinger, LLC, New York, NY, 2014) 
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Molecule conformations were minimized with the SchrödingerSemiempirical 
NDDO Module (Schrödinger, Suite 2012 Semiempirical NDDO Module, 
Schrödinger, LLC, New York, NY 2012). Other possible conformations were 
confirmed with SchrödingerConfgen constraining the distance between the 
diaminobenzene ring and center of the dye to 10 angstroms (Watts et al., 2010). 
Reversed-phase High-performance Liquid Chromatography   
Analytical and semi-preparative HPLC were performed on a Hewlett Packard 
Agilent 1100 HPLC equipped with a G1315A DAD absorbance detector. 
Absorbance detector was set at 800 nm for reference. All methods used aqueous 
0.1% trifluoroacetic acid as Solvent A and acetonitrile/0.1% trifluoroacetic acid as 
Solvent B. Acetonitrile and trifluoroacetic acid were HPLC grade and were 
purchased from Aldrich. HPLC methods were as follows: 
Analytical  
Analytical HPLC was performed on a 4.6 x 250 mm C-18 column using a flow 
rate of 1.4 mL/min. Absorbance detector set at 280, 360, 615, 660 nm. 10% B for 
5 minutes, 10-45% B over 35 minutes, 45-100% B over 5 minutes, 100% B for 10 
minutes. 
Semi-preparative 
Compounds were purified on a 10 x 250 mm C-18 column using a flow rate of 5 
mL/min. 
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Compound 16: Absorbance detector set at 211, 244, 299, 409, and 659 nm. 0% 
B for 5 minutes, 0-40% B over 40 minutes, 40-100% B over 5 minutes, 100% B 
for 5 minutes.  
Compound 17: Absorbance detector set at 252, 610, 659, and 666 nm. 10% B 
for 5 minutes, 10-50% B over 45 minutes, 50-100% B over 5 minutes, 100% B for 
10 minutes. 
Absorbance Measurements 
Absorbance spectra were obtained from 400-800 nm using a 1 nm data interval 
and 0.1 s average time. The instrument was set for double beam mode with a 
spectral bandwidth of 2 nm and a scan of 600 nm/min. Samples were contained 
in Starna fluorometer cells having a path length of 10 mm and composed of 
optical glass. Absorbance of a blank sample was measured and subtracted from 
the samples to obtain the final spectra.  
Fluorescence Measurements 
Emission spectra were obtained using 1 nm increments and an integration time 
of 0.1 s. Samples were contained in Starna fluorometer cells having a path length 
of 10 mm and composed of optical glass. Excitation wavelength, slit width, and 
wavelength span was adjusted for the experiments as needed. 
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Reaction of Nitric Oxide Sensor with Reactive Nitrogen/Oxygen Species 
Stock solutions of reactive nitrogen/oxygen species in 1X PBS were freshly 
prepared as follows: 40 mM DEA NONOate (•NO donor), 400 mM ferrous sulfate 
heptahydrate (FeSO4•7H2O), 4 M hydrogen peroxide (H2O2), 400 mM sodium 
nitrate (NaNO3), 400 mM sodium nitrite (NaNO2). DEA NONOate solution was 
prepared immediately before adding to the reaction. Solutions of 16 (stock 
solution: 10 mM in DMSO; final concentration: 1 μM, 0.1% DMSO) were 
prepared in 1X PBS, pH 7.4 (4 mL). Dye solutions were treated with stock 
solutions of ROS/RNS as follows: •NO (10 µM DEA NONOate), H2O2 (1 mM), 
NaNO3 (100 µM), NaNO2 (100 µM), •OH (hydroxyl radical was prepared in situ 
via addition of 100 µM FeSO4•7H2O and 1 mM H2O2. An untreated solution of 16 
in 1X PBS, pH 7.4 was used as a control. Upon treatment, the dye solutions were 
heated to 37 °C and stirred for 30 minutes. Emission spectrum for each solution 
was then collected using excitation at 665 nm and emission at 679 nm. The 
excitation and emission slit widths were both set to 2.5 nm. 
Solutions of 16 treated with RNS/ROS were subsequently treated with •NO 
through addition of 10 µM DEA NONOate (freshly prepared as a 40 mM DEA 
NONOate stock solution in 1X PBS, pH 7.4). The •NO-treated solutions were 
heated to 37 °C and stirred for 30 minutes. Emission spectrum for each solution 
was then collected using excitation at 665 nm and emission at 679 nm. The 
excitation and emission slit widths were both set to 2.5 nm.  
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Reaction of Nitric Oxide Sensor with Increasing Concentrations of Nitric 
Oxide 
Solutions of 16 (stock solution: 10 mM in DMSO; final concentration: 10 μM, 
0.1% DMSO) were prepared in 1X PBS, pH 7.4 (3 mL). Emission spectrum for 
the untreated solutions were collected using excitation at 665 nm, emission at 
679 nm, and excitation/emission slit widths of 2 nm. This was denoted as the 
zero time point.  •NO was introduced into the reaction via the •NO donor, DEA 
NONOate. Stock solutions of DEA NONOate were prepared immediately before 
adding to the dye solution. The concentrations of the DEA NONOate stock 
solutions were: 5 mM, 50 mM, 100 mM; these concentrations were chosen to 
ensure that the total volume of the dye-•NO reaction would be relatively 
unchanged. The 10 μM dye solutions were treated with either 5 µM, 50 µM, or 
100 µM DEA NONOate via dilution of the appropriate stock DEA NONOate 
concentration into the reaction. The reactions were then incubated with stirring at 
room temperature and emission spectra were collected every 5 minutes for 30 
minutes using excitation at 665 nm and emission at 679 nm. The excitation and 
emission slit widths were both set to 2 nm.  
Effects of pH on Fluorescence Intensity 
Dye solutions (stock concentration: 10 mM in DMSO) were prepared in buffered 
solutions (3 mL) having pHs of 2-8 to give a final DMSO volume of less than 
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0.1%). Aqueous pH buffered solutions were prepared as described in Table 5.5. 
Emission spectrum for each solution was then collected as described below. 
Compound 16: Final concentration: 1 μM. Excitation at 665 nm, emission 
measured at 680 nm, excitation/emission slit width: 3 nm. 
Compound 22: Final concentration: 3.33 μM. Excitation at 663 nm, emission 
measured at 676 nm, excitation/emission slit width: 2 nm. 
 
pH Acid Acid Volume (mL) Base Base Volume (mL) 
2 0.2 M HCl 13 0.2 M KCl 50 
3 0.1 M AcOH 982.3 0.1 M NaOAc 17.7 
4 0.1 M AcOH 847 0.1 M NaOAc 153 
5 0.1 M AcOH 357 0.1 M NaOAc 643 
6 0.1 M AcOH 52.2 0.1 M NaOAc 947.8 
7 1 X PBS 
8 0.1 M HCl 39 0.025 M Borax 100 
                                                                                                                         
Table 5.5: Preparation of buffered solutions for pH sensitivity experiments. 
1X PBS was prepared from a 10X stock solution by diluting 100 mL into 900 mL 
deionized water. HCl: hydrochloric acid. AcOH: acetic acid. KCl: potassium 
chloride. NaOAc: sodium acetate. Borax: sodium tetraborate decahydrate 
(Na2B4O7•10H2O).  
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Time-resolved Fluorescence 
Excited-state decay lifetimes were measured using the time-correlated single 
photon counting (TCSPC) method as described previously (Lakowicz, 2006; O’ 
Connor and Phillips, 1984). Excitation was provided by a mode-locked 
Titanium:sapphire laser emitting ~150 fs pulses at 685 nm ± 3 nm with a 76 MHz 
repetition rate. The output of the laser was passed through a pair of Glan-
Thompson polarizers, which act as an attenuator and flip the excitation 
polarization to vertical. Emission was collected by a 35 mm plano-convex lens, 
passed through a magic-angle (54.7º) Glan-Taylor polarizer, and then focused 
into a 0.25 m grating monochromator (CVI Laser). The monochromator was set 
to a detection wavelength of 715 nm, slit width of 3 mm, and spectral bandwidth 
of 11.31 nm (dispersion of 3.77 nm/mm). Detection utilized an id100 low-noise 
single-photon avalanche photodiode (idQuantique) and a Becker-Hickl SPC150 
single-photon counting card. A 1 mm thick quartz slide was used to pick-off ~4% 
of the excitation and focused onto a PHD400 fast photodiode to provide the 
TCSPC clock synchronization pulse. The sample was placed in a 1 cm x 1 cm 
S1UV fused silica cuvette and stirred during data collection. A buffer blank was 
collected for each sample. The blank count rate was typically less than 1% of that 
of the sample. An instrument response function was collected using a blank 
sample with identical configuration, with the exception that the monochromator 
was shifted near to the excitation wavelength to allow scattered light to enter the 
detector. 
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Dye samples were prepared from a 10 mM DMSO stock and diluted to a 1 mM 
stock in the appropriate buffer immediately before experiment. Experimental 
concentrations were then prepared by dilution of the 1 mM stock into the final 
working volume of 1 mL (final DMSO volume ≤ 0.007%). Buffers as described in 
Table 5.5.  
All data analysis utilized the normalized instrument response in an iterative 
reconvolution non-linear least squares fitting package (Kathuria et al., 2014). 
Data were fit using a sum of exponentials plus a constant. A number of 
exponentials were determined by examination of the residuals, reduced χ2, and 
an F-test on the inclusion of an additional exponential. 
Synthetic Procedures 
 
(3,4-Dinitro-phenyl)-methanol (1). 3,4-Dinitrobenzoic acid (2.2 g, 10 mmol) was 
dissolved in THF (10 mL) and cooled to 0°C. A 1 M solution of BH3·THF (52 mL) 
was added to the reaction dropwise via an addition funnel, resulting in the yellow 
solution becoming pink. The reaction was then brought to room temperature and 
stirred overnight, leading to a color change from pink to deep purple. The solution 
was then cooled to -15 °C and excess borane was quenched by the slow addition 
of methanol (24 mL), resulting in another color change from purple to bright 
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yellow. The solution was concentrated via rotary evaporation and the crude 
material was dissolved in 1 M HCl (200 mL). The aqueous phase was extracted 
with ethyl acetate (5 X 200 mL) and the combined organic phases were washed 
with water (150 mL), brine (150 mL), and dried over Na2SO4. Removal of the 
solvent via rotary evaporation provided the pure product as a yellow-orange solid 
(2 g, 95%). 1H-NMR (DMSO-d6): δ 8.2 (d, 1H, J = 8.3 Hz), 8.084-8076 (m, 1H), 
7.87-7.84 (dm, 1H), 5.73 (t, 1H, J = 5.8 Hz), 4.67 (d, 2H, J = 5.7 Hz). 13C-NMR 
(DMSO-d6): δ 151.6, 143, 140.9, 131.7, 126.3, 123.1, 62. HR-EIMS m/z 
calculated for C7H7N2O5: 199.0355, found: 199.0344. 
  
 
3,4-Dinitro-benzaldehyde (2). Dess-Martin periodinane (5 g, 12 mmol) was 
added to a solution of 1 (1.56 g, 7.87 mmol) in CH2Cl2 (40 mL) and stirred for 2 
hours. The reaction was diluted into ether (400 mL), added to a 5 % Na2S2O3 
solution in saturated NaHCO3 (260 mL), and stirred for 10 minutes at ambient 
conditions. The organic phase was collected and the aqueous phase was 
extracted with ether (6 X 50 mL). The combined organic phases were washed 
with 5% NaHCO3 (350 mL), water (350 mL), and brine (350 mL) and dried over 
Na2SO4. The organic phase was concentrated via rotary evaporation and the 
crude material was purified by flash column chromatography (0-50% ethyl 
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acetate/hexanes) to yield the pure product as a yellow-orange solid (1.41 g, 
91%). 1H-NMR (CDCl3): δ 10.16 (s, 1H), 8.47 (d, 1H, J = 1.6 Hz), 8.29 (dd, 1H, J 
= 1.6 Hz, 8.2 Hz), 8.08 (d, 1H, J = 8.2 Hz). 13C-NMR (DMSO-d6): δ 191.1, 145.3, 
142.7, 140.0, 135.7, 127.3, 126.7. HR-EIMS m/z calculated for C7H3N2O5: 
195.0042, found: 195.0134.  
 
 
3-(3,4-Dinitro-phenyl)-acrylic acid ethyl ester (3). Triethyl phosphonoacetate 
(1.1 mL, 5.4 mmol) was added to a solution of LiBr (566 mg, 6.51 mmol) in THF 
(6 mL) and stirred for 5 minutes at room temperature. Et3N (0.83 mL, 5.97 mmol) 
was then added to the reaction and stirring was continued for an additional 10 
minutes, resulting in a white cloudy mixture. A solution of 2 (1.06 g, 5.40 mmol) in 
THF (6 mL) was added to the mixture dropwise over a period of 30 minutes 
resulting in a color change from white to brown. The reaction was stirred for an 
additional 3 hours and then diluted into 1 M HCl (120 mL) resulting in formation 
of a yellow precipitate. The product was extracted with diethyl ether (1 X 120 mL, 
4 X 50 mL) and the combined organic phases were washed with brine (2 X 50 
mL) and dried over Na2SO4. The solvent was evaporated under vacuum to yield 
the pure product as a lightweight yellow solid (1.28 g, 89%). 1H-NMR (CDCl3): 
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δ 8.01 (d, 1H, J = 1.6 Hz), 7.98 (d, 1H, J = 8.4 Hz), 7.84 (dd, 1H, J = 1.7 Hz, 8.4 
Hz), 7.68 (d, 1H, J = 16.1 Hz), 6.61 (d, 1H, J = 16.0 Hz), 4.3 (q, 2H, J = 7.1 Hz), 
1.36 (t, 3H, J = 7.1 Hz). 13C-NMR (CDCl3): δ 165.5, 143.8, 142.7, 140.6, 139.4, 
132.2, 126.2, 125.1, 123.9, 61.6, 14.4. HR-EIMS m/z calculated for 
C11H10N2O6Na: 289.0437, found: 289.0439.  
 
 
3-(3,4-Diamino-phenyl)-propionic acid ethyl ester (4). 10% Pd/C (40 mg, 0.38 
mmol) was added to a suspension of compound 3 (1 g, 4 mmol) in methanol (60 
mL) and the black mixture was stirred at room temperature. The reaction was 
then treated with hydrogen (via a balloon connected to an inlet adapter) for 19 
hours and filtered over a pad of AW Standard Super-Cel® NF Celite® to remove 
the catalyst. The Celite® was washed with methanol (400 mL) and the combined 
organic collections were concentrated under vacuum to yield the pure product as 
a viscous brown oil (765 mg, 98%). 1H-NMR (DMSO-d6): δ 6.37 (d, 1H, J = 7.7 
Hz), 6.32 (d, 1H, J = 2 Hz), 6.19 (dd, 1H, J = 2.0 Hz, 7.8 Hz), 4.32 (br s, 4H), 
4.01 (q, 2H, J = 7.1 Hz), 2.57 (t, 2H, J = 7.4 Hz), 2.45-2.41 (m, 2H), 1.14 (t, 3H, J 
= 7.1 Hz). 13C-NMR (DMSO-d6): δ 173.1, 135.6, 133.7, 129.7, 117.4, 115.2, 
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115.1, 60.3, 36.6, 30.7, 14.8. HR-EIMS m/z calculated for C11H17N2O2: 209.1290, 
found: 209.1305. 
 
 
3-(3,4-Bis-tert-butoxycarbonylamino-phenyl)-propionic acid ethyl ester (5). 
Compound 4 (765 mg, 3.67 mmol) was dissolved in THF (29 mL) and cooled to 
0°C. A solution of Di-tert-butyl dicarbonate (3.21 g, 14.7 mmol) in THF (9 mL) 
was then added dropwise to the reaction. The reaction was then brought to room 
temperature and stirred overnight. The solution was poured into water (400 mL) 
and the product was extracted with dichloromethane (6 X 100 mL). The 
combined organic phases were washed with brine (300 mL) and dried over 
Na2SO4. The solvent was evaporated under vacuum and the crude material was 
purified by flash column chromatography (0-25% ethyl acetate/hexanes) to yield 
the pure product as a viscous purple oil (1.15 g, 77%). 1H-NMR (DMSO-d6): 
δ 8.42-8.40 (m, 2H), 7.33-7.3 (m, 2H), 6.89 (dd, 1H, J = 2.0 Hz, 8.3 Hz), 4.02 (q, 
2H, J = 7.1 Hz), 2.76 (t, 2H, J = 7.5 Hz), 2.54 (t, 2H, J = 7.5 Hz), 1.45 (s, 9H), 
1.44 (s, 9H), 1.14 (t, 3H, J = 7.1 Hz). 13C-NMR (DMSO-d6): δ 172.8, 154, 153.8, 
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137.2, 130.8, 128.6, 124.7, 124.5, 124, 80.0, 79.9, 60.5, 35.9, 30.5, 28.7, 14.7. 
HR-EIMS m/z calculated for C21H33N2O6: 409.2339, found: 409.2326. 
 
 
3-(3,4-Bis-tert-butoxycarbonylamino-phenyl)-propionic acid (6). Compound 
5 (1.82 g, 4.44 mmol) was dissolved in a 9:1 v/v solution of 
dichloromethane/methanol (81 mL) and cooled to 0°C. 2 M methanolic NaOH (9 
mL) was slowly added to the reaction to give a final NaOH concentration of 0.2 M 
(Theodorou et al., 2007). The reaction was then brought to room temperature 
and stirred overnight. The solution was concentrated under vacuum and the 
resulting residue was dissolved in water (200 mL). The aqueous phase was 
extracted with diethyl ether (3 X 70 mL), cooled in an ice bath, and acidified to pH 
6 with 1 M HCl. The resulting precipitate was extracted with ethyl acetate (3 X 
100 mL) and the combined organic phases were washed with brine (100 mL) and 
dried over Na2SO4. The solvent was evaporated under vacuum to yield the pure 
product as a pale, pink solid (1.29 g, 76%). 1H-NMR (DMSO-d6): δ 12.12 (br s, 
1H), 8.41 (br s, 2H), 7.32-7.29 (m, 2H), 6.90 (dd, 1H, J = 1.8 Hz, 8.3 Hz), 2.73 (t, 
244 
 
2H, J = 7.5 Hz), 2.46 (t, 2H, J = 7.5 Hz), 1.44 (s, 9H), 1.44 (s, 9H). 1H-NMR 
(CD3OD): δ 7.32-7.30 (m, 2H), 7 (dd, 1H, J = 2.0 Hz, 8.2 Hz), 2.87 (t, 2H, J = 7.8 
Hz), 2.58 (t, 2H, J = 7.9 Hz), 1.51 (s, 9H), 1.5 (s, 9H). 13C-NMR (DMSO-d6): 
δ 174.3, 154, 15, 137.6, 130.8, 128.6, 124.7, 124.5, 124.0, 80.0, 79.9, 36, 30.6, 
28.7. HR-EIMS m/z calculated for C19H29N2O6: 381.2026, found: 381.2001.  
  
 
[2-tert-Butoxycarbonylamino-5-(3-hydroxy-propyl)-phenyl]-carbamic acid 
tert-butyl ester (7). Compound 6 (1.19 g, 3.13 mmol) was dissolved in THF (33 
mL) and cooled to 0°C. A 1 M solution of BH3·THF (33 mL) was added to the 
reaction dropwise via an addition funnel, resulting in the pale pink solution 
becoming pale yellow. The reaction was then brought to room temperature and 
stirred overnight leading to an almost complete loss of color. The solution was 
then cooled to -15 °C and excess borane was quenched by the slow addition of 
methanol (12 mL), resulting in the return of a pale pink hue. The solution was 
concentrated via rotary evaporation and the crude material was dissolved in 1 M 
HCl (100 mL). The aqueous phase was extracted with ethyl acetate (1 X 100 mL, 
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4 X 50 mL) and the combined organic phases were washed with 0.1 M HCl (100 
mL), water (100 mL) and brine (100 mL) and dried over Na2SO4. The solvent was 
evaporated under vacuum and the crude material was purified by flash column 
chromatography (0-50% ethyl acetate/hexanes) to yield the pure product as a 
fluffy white solid (1.02 g, 89%). 1H-NMR (DMSO-d6): δ 8.40-8.38 (m, 2H), 7.30-
7.28 (m, 2H), 6.87 (dd, 1H, J = 2 Hz, 8.2 Hz), 4.44 (t, 1H, J = 5.2 Hz), 3.38 (q, 
2H, J = 5.2 Hz), 2.52 (t, 2H, J = 7.5 Hz), 1.69-1.62 (m, 2H), 1.45 (s, 9H), 1.44 (s, 
9H). 13C-NMR (DMSO-d6): δ 154.0, 153.8, 138.9, 130.9, 128.1, 124.8, 124.6, 
124.0, 80.0, 79.9, 60.7, 35.1, 31.9, 28.7. HR-EIMS m/z calculated for 
C19H30N2O5Na: 389.2047, found: 389.2034. 
  
 
[5-(3-Bromo-propyl)-2-tert-butoxycarbonylamino-phenyl]-carbamic acid 
tert-butyl ester (8). Ethyl tribromoacetate (0.4 mL, 2.72 mmol) was added to a 
solution of 7 (996 mg, 2.72 mmol) and triphenylphosphine (1.07 g, 4.08 mmol) in 
dichloromethane (10 mL) (Tongkate et al., 2008). The reaction was stirred at 
room temperature and monitored by TLC (25% ethyl acetate/hexanes). After 40 
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minutes, no trace of 7 remained and the reaction was quenched with ice water 
(100 mL) and stirred at ambient conditions for 5 minutes. The aqueous phase 
was extracted with dichloromethane (1 X 100 mL, 2 X 50 mL) and the combined 
organic phases were washed with brine (100 mL) and dried over Na2SO4. The 
solvent was evaporated under vacuum and the crude material was purified by 
flash column chromatography (0-25% ethyl acetate/hexanes) to yield the pure 
product as a viscous, yellow oil. Upon washing with dichloromethane and drying 
under reduced pressure, the product becomes an airy white solid (1.05 g, 
90%).1H-NMR (CDCl3): δ 7.29-7.24 (m, 2H), 7.07-6.97 (m, 2H), 6.81 (dd, 1H, J = 
1.8 Hz, 8.2 Hz), 3.29 (t, 2H, J = 6.6 Hz), 2.61 (t, 2H, J = 7.1 Hz), 2.03 (p, 2H, J = 
6.6 Hz, 7 Hz), 1.46 (s, 9H), 1.45 (s, 9H). 13C-NMR (CDCl3): δ 154.3, 154.0, 138.0, 
130.9, 128.0, 125.2, 124.8, 123.9, 80.8, 34.2, 33.6, 33.3, 28.5, 28.5. HR-EIMS 
m/z calculated for C19H29BrN2O4Na: 451.1203 and 453.1182, found: 451.1196 
and 453.1175.  
 
 
1,2,3,4-tetrahydroquinolin-7-ol (9). 7-hydroxy-3,4-dihydro-1H-quinolin-2-one 
(2.19 g, 13.4 mmol) was dissolved in THF (20 mL) and cooled to 0 °C. 1 M 
BH3·THF (136 mL, 136 mmol) was added to the solution dropwise via an addition 
funnel over 85 minutes and the reaction was refluxed overnight. The reaction 
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was then cooled in a methanol/ice bath and quenched by the slow addition of 
methanol (24 mL). After quenching, the solution was acidified to pH 1 with 
concentrated hydrochloric acid (12 mL) and heated to 60 °C for 1 hour. The 
reaction was then cooled to 0 °C, neutralized with concentrated sodium 
hydroxide, and extracted with ethyl acetate (1X200 mL, 3X50 mL). The combined 
organic phases were washed with water (2X100 mL), brine (1X80 mL, 3X50 mL), 
and dried over sodium sulfate. Solvent was removed via rotary evaporation and 
the crude material was purified by flash column chromatography (0-25% ethyl 
acetate/hexanes) to yield the pure product as a white crystalline solid (1.91 g, 94 
%). 1H-NMR (CDCl3): δ 6.79 (d, 1H, J = 8.1 Hz), 6.09 (dd, 1H, J = 2.5 Hz, 8.1 
Hz), 5.97 (d, 1H, J = 2.5 Hz), 4.19 (br s, 1H), 3.27 (t, 2H, J = 5.5 Hz), 2.68 (t, 2H, 
J = 6.4 Hz), 1.94-1.88 (m, 2H). 13C-NMR (CDCl3): δ 155, 145.4, 130.6, 114.7, 
105.7, 101.9, 42.2, 26.4, 22.6. HR-EIMS: m/z calculated for C9H12NO: 150.0919, 
found: 150.0938. 
 
 
7-(tert-Butyl-dimethyl-silanyloxy)-1,2,3,4-tetrahydroquinoline (10). Imidazole 
(1.14 g, 16.8 mmol) was added to a solution of 9 (1 g, 6.7 mmol) in DMF (13.4 
mL) and stirred at room temperature for 10 minutes. tert-
Butyldimethylchlorosilane (1.2 g, 8.04 mmol) was added to the reaction and the 
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solution was stirred at room temperature overnight. The reaction was diluted into 
5% NaHCO3 (140 mL) and extracted with ethyl acetate (6 X 50 mL). The 
combined organic phases were washed with 0.1 M HCl (100 mL), brine (100 mL), 
and dried over Na2SO4. The solvent was evaporated under vacuum and the 
crude material was purified by flash column chromatography (0-10% ethyl 
acetate/hexanes) to yield the pure product as a crystalline, white solid (1.61 g, 
91%). 1H-NMR (CDCl3): δ 6.76 (d, 1H, J = 8.1 Hz), 6.11 (dd, 1H, J = 2.4 Hz, 8.1 
Hz), 5.98 (d, 1H, J = 2.4 Hz), 3.73 (br s, 1H), 3.26 (t, 2H, J = 5.5 Hz), 2.68 (t, 2H, 
J = 6.4 Hz), 1.94-1.88 (m, 2H), 0.96 (s, 9H), 0.17 (s, 6H). 13C-NMR (CDCl3): δ 
154.8, 145.9, 130.2, 114.8, 109.1, 105.8, 42.2, 26.8, 26.2, 22.8, 18.6, -4. HR-
EIMS: m/z calculated for C15H26NOSi: 264.1784, found: 264.1752. 
 
 
(2-tert-Butoxycarbonylamino-5-{3-[7-(tert-butyl-dimethyl-silanyloxy)-3,4-
dihydro-2H-quinolin-1-yl]-propyl}-phenyl)-carbamic acid tert-butyl ester 
(11). A reaction vial charged with compound 10 (250 mg, 0.949 mmol) and 
K2CO3 (158 mg, 1.14 mmol) was evacuated and backfilled with argon. 
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Compound 8 (490 mg, 1.14 mmol) dissolved in DMF (2 mL) was added to the 
reaction vial and the mixture was heated to 65 °C and stirred for 2 days. The 
reaction was then cooled to room temperature, diluted into water (20 mL), and 
acidified to pH 1 with 1 M HCl. The aqueous phase was extracted with ethyl 
acetate (1 X 30 mL, 4 X 10 mL) and the combined organic phases were washed 
with 0.1 M HCl (30 mL) and brine (50 mL), and dried over Na2SO4. The solvent 
was evaporated under vacuum and the crude material was purified by flash 
column chromatography (0-5% ethyl acetate/hexanes) to yield the pure product 
as a viscous, gold oil (261 mg, 45%). 1H-NMR (CDCl3): δ 7.35 (br s, 2H), 6.94 (d, 
1H, J = 8.1 Hz), 6.75 (d, 2H, J = 8.0 Hz), 6.62 ( br s, 1H), 6.04 (br s, 2H), 3.21 (t, 
4H, J = 7.2 Hz), 2.66 (t, 2H, J = 6.3 Hz), 2.61 (t, 2H, J = 7.8 Hz), 1.93-1.84 (m, 
4H), 1.51 (s, 9H), 1.51 (s, 9H), 0.97 (s, 9H), 0.18 (s, 6H). HR-EIMS: m/z 
calculated for C34H54N3O5Si: 612.3820, found: 612.3833. 
 
 
7-Methoxy-3,4-dihydro-1H-quinolin-2-one (12). Potassium carbonate (3.8 g, 
27.8 mmol) was suspended in a solution of 7-hydroxy-3,4-dihydro-1H-quinolin-2-
one (3 g, 18.4 mmol) in DMF (37 mL). Methyl iodide (1.5 mL, 23.9 mmol) was 
added to the mixture, which resulted in the reaction becoming white and opaque. 
The reaction was then heated to 65 °C and stirred overnight. The mixture was 
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cooled to room temperature, poured into water (350 mL) and acidified to pH 5 
with 1 M HCl (30 mL) with stirring. After 5 minutes, a frothy solid was suspended 
atop the aqueous solution which was then dissolved in ethyl acetate (150 mL). 
The organic phase was collected and the aqueous phase was further acidified to 
pH 1 with 1 M HCl (10 mL) and extracted with ethyl acetate (9 X 60 mL). The 
combined organic phases were washed with water (2 X 200 mL), brine (450 mL), 
and dried over Na2SO4. The solvent was evaporated under vacuum and the 
crude material was purified by flash column chromatography (0-50% ethyl 
acetate/hexanes) to yield the pure product as a white crystalline solid (2.84 g, 87 
%). 1H-NMR (CDCl3): δ 7.77 (br s, 1H), 7.06 (d, 1H, J = 8.3 Hz), 6.53 (dd, 1H, J = 
2.5 Hz, 8.3 Hz), 6.30 (d, 1H, J = 2.4 Hz), 3.78 (s, 3H), 2.9 (t, 2H, J = 7.9 Hz), 2.62 
(t, 2H, J = 7.8 Hz). 13C-NMR (CDCl3): δ 172.8, 159.4, 138.5, 128.8, 115.9, 108.5, 
101.9, 55.7, 31.3, 24.8. HR-EIMS m/z calculated for C10H12NO2: 178.0868, 
found: 178.0867.  
 
 
7-Methoxy-1,2,3,4-tetrahydroquinoline (13). Compound 12 (2.77 g, 15.6 mmol) 
was dissolved in THF (60 mL) and cooled to 0 °C. 1 M BH3·THF (235 mL) was 
added to the solution dropwise through an addition funnel over 1.5 hours and the 
reaction was refluxed overnight. The reaction was then cooled in a methanol/ice 
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bath and quenched by the slow addition of methanol (40 mL). After quenching, 
the solution was acidified to pH 1 with concentrated hydrochloric acid (5 mL) 
resulting in formation of a white precipitate. The mixture was heated to 65 °C for 
1 hour, cooled to 0 °C, and neutralized with 6.25 M NaOH (22 mL), resulting in 
the mixture obtaining a dull, yellow hue. The mixture was diluted into 50 % ethyl 
acetate/water (600 mL) and the organic phase was separated. The aqueous 
phase was further extracted with ethyl acetate (2 X 100 mL) and the combined 
organic phases were washed with brine (2 X 500 mL) and dried over sodium 
sulfate. Solvent was removed via rotary evaporation and the crude material was 
purified by flash column chromatography (0-25% ethyl acetate/hexanes) to yield 
the pure product as a non-viscous, yellow-orange oil (2.45, 96%). 1H-NMR 
(CDCl3): δ 6.83 (d, 1H, J = 8.2 Hz), 6.2 (dd, 1H, J = 2.5 Hz, 8.2 Hz), 6.03 (d, 1H, 
J = 2.5 Hz), 3.8 (br s, 1H), 3.73 (s, 3H), 3.28 (t, 2H, J = 5.5 Hz), 2.69 (t, 2H, J = 
6.4 Hz), 1.95-1.88 (m, 2H). 13C-NMR (CDCl3): δ 159.2, 146.0, 130.4, 114.3, 
103.0, 99.7, 55.4, 42.3, 26.7, 22.8. HR-EIMS m/z calculated for C10H14NO: 
164.1075, found: 164.1075. 
 
 
1-Ethyl-7-methoxy-1,2,3,4-tetrahydroquinoline (14). Potassium carbonate 
(1.16 g, 8.38 mmol) was suspended in a solution of compound 13 (912 mg, 5.59 
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mmol) in DMF (5 mL). Ethyl iodide (0.54 mL, 6.75 mmol) was added to the 
mixture and the reaction was heated to 65 °C and stirred overnight. The mixture 
was cooled to room temperature, diluted into water (80 mL), and acidified to pH 3 
with 1 M HCl. The aqueous phase was extracted with ethyl acetate (1 X 80 mL, 5 
X 50 mL) and the combined organic phases were washed with water (3 X 60 mL) 
and brine (80 mL) and dried over Na2SO4. The solvent was evaporated under 
vacuum and the crude material was purified by flash column chromatography (0-
5% acetone/hexanes) to yield the pure product as a pale yellow oil (907 mg, 85 
%). 1H-NMR (CDCl3): δ 6.84 (d, 1H, J = 8.1 Hz), 6.18 (d, 1H, J = 2.1 Hz), 6.13 
(dd, 1H, J = 2.4 Hz, 8.1 Hz), 3.78 (s, 3H), 3.32 (q, 2H, J = 7.1 Hz), 3.24 (t, 2H, J = 
5.6 Hz), 2.68 (t, 2H, J = 6.4 Hz), 1.96-1.9 (m, 2H), 1.14 (t, 3H, J = 7.1Hz). 13C-
NMR (CDCl3): δ 159.6, 146.1, 129.7, 115.6, 99.8, 97.6, 55.4, 48.6, 45.7, 27.8, 
22.8, 11.1. HR-EIMS m/z calculated for C12H18NO2: 192.1388, found: 192.1379.  
 
 
(1-Ethyl-7-methoxy-1,2,3,4-tetrahydro-quinolin-6-yl)-(4-nitro-phenyl)-diazene 
(15). 4-Nitrobenzenediazonium tetrafluoroborate (573 mg, 2.42 mmol) was 
suspended in 10% H2SO4 (1.6 mL) and added dropwise to a solution of 14 (462 
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mg, 2.42 mmol) in methanol (2 mL) resulting in an opaque, deep red 
appearance. The solution was stirred at ambient conditions for 1 hour and then 
cooled in an ice bath. The reaction was neutralized with ammonium hydroxide 
solution (28-30%) and the crude product was isolated via filtration and washed 
with water (300 mL) to give a red-black solid. The crude material was then 
recrystallized in n-butanol/water to provide the pure compound as purple-black 
crystals (524 mg, 64%). 1H-NMR (CDCl3): δ 8.26 (d, 2H, J = 8.9 Hz), 7.84 (d, 2H, 
J = 8.9 Hz), 7.58 (s, 1H), 6.11 (s, 1H), 4.00 (s, 3H), 3.46 (q, 2H, J = 7.1 Hz), 3.38 
(t, 2H, J = 5.6 Hz), 2.71 (t, 2H, J = 6.0 Hz), 1.95(p, 2H, J = 5.6 Hz, 6.1 Hz), 1.26 
(t, 3H, J = 7.1Hz). 13C-NMR (CDCl3): δ 160.3, 158, 151.4, 146.7, 133.6, 124.9, 
122.5, 117.7, 116.5, 92.8, 56.5, 49.2, 46.3, 27.5, 22.2, 11.5. HR-EIMS m/z 
calculated for C18H21N4O3: 341.1614, found: 341.1625.  
 
 
11-[3-(3,4-diamino-phenyl)-propyl]-1-ethyl-3,4,8,9,10,11-hexahydro-2H-13-
oxa-6,11-diaza-1-azonia-pentacene trifluoroacetate (16). Compound 11 (80 
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mg, 131 µmol) and 15 (45 mg, 131 µmol) were dissolved in a 10:1 solution of 
EtOH/H2O (1 mL/100 µL). Concentrated HCl (70 µL) was added to the solution 
with stirring and the reaction was heated to 80 °C for 3 hours. The reaction was 
cooled to room temperature and concentrated under vacuum. The crude material 
was purified via RP-HPLC (0-40% 0.1% Trifluoroacetic acid in acetonitrile/0.1% 
Trifluoroacetic acid in water) to yield the pure product as a blue solid (16 mg, 
21%). 1H-NMR (CD3OD): δ 7.46 (s, 1H), 7.43 (s, 1H), 7.01 (s, 1H), 6.69 (d, 1H, J 
= 7.8 Hz), 6.62 (d, 1H, J = 1.9 Hz), 6.51 (dd, 1H, J = 2 Hz, 7.8 Hz), 6.47 (s, 1H), 
3.75 (q, 2H, J = 7.2Hz), 3.7 (t, 2H, J = 5.6 Hz), 3.65-3.59 (m, 4H), 2.93 (t, 2H, J = 
5.9 Hz), 2.89 (t, 2H, J = 5.9 Hz), 2.59 (t, 2H, J = 7 Hz), 2.08-1.97 (m, 6H), 1.37 (t, 
3H, J = 7.2 Hz). HR-EIMS m/z calculated for C29H34N5O: 468.2763, found: 
468.2775. 
 
 
11-[3-(3H-benzotriazol-5-yl)-propyl]-1-ethyl-3,4,8,9,10,11-hexahydro-2H-13-
oxa-6,11-diaza-1-azonia-pentacene trifluoroacetate (17). Compound 16 (6.11 
mg, 10.5 µM) was suspended in PBS, pH 7.4 (1 mL). A solution of 
Diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (DEA 
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NONOate) (2.38 mg, 11.6 µM) in PBS, pH 7.4 (1 mL) was added to the reaction 
and the mixture was stirred at ambient conditions for 1 hour. The reaction was 
dried under speed vacuum and purified via RP-HPLC (10-50% 0.1% 
Trifluoroacetic acid in acetonitrile/0.1% Trifluoroacetic acid in water) to yield the 
pure product as a blue solid (1.2 mg, 20%). HR-EIMS m/z calculated for 
C29H31N6O: 479.2559, found: 479.2523.  
 
 
3-(4-tert-Butoxycarbonylamino-phenyl)-propionic acid (18). 3-(4-
Aminophenyl)propionic acid (500 mg, 3.03 mmol) was dissolved in THF (15 mL) 
and cooled to 0°C. A solution of Di-tert-butyl dicarbonate (1.32 g, 6.05 mmol) in 
THF (15 mL) was then added dropwise to the reaction. The reaction was then 
brought to room temperature and stirred overnight. The solution was poured into 
water (300 mL) and acidified to pH 4 with 1 M HCl, resulting in precipitation of a 
yellow solid. The product was then extracted with dichloromethane (3 X 100 mL) 
and the combined organic phases were washed with brine (300 mL) and dried 
over Na2SO4. The solvent was evaporated under vacuum to yield a yellow solid 
that was identified by NMR to be the product and residual Boc2O. The crude 
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material was dissolved in an 1:2 ethyl acetate/water mixture (300 mL), basified to 
pH 9 with 5 M NaOH and the organic phase was separated. The aqueous phase 
was further extracted with ethyl acetate (2 X 200 mL) and dichloromethane (100 
mL) to remove any remaining impurity. The aqueous phase was then acidified to 
pH 1 with 1 M HCl, extracted with dichloromethane (3 X 100 mL), and the 
combined organic phases washed with brine (200 mL) and dried over Na2SO4. 
Evaporation of the solvent under vacuum gave the pure product as an off-white 
solid (689 mg, 86%). 1H-NMR (DMSO-d6): δ 12.08 (s, 1H), 9.22 (s, 1H), 7.32 (d, 
2H, J = 8.3 Hz), 7.07 (d, 2H, J = 8.5 Hz), 2.71 (t, 2H, J = 7.7 Hz), 2.45 (t, 2H, J = 
7.7 Hz), 1.44 (s, 9H). 1H-NMR (CD3OD): δ 7.28 (d, 2H, J = 8.4 Hz), 7.11 (d, 2H, J 
= 8.5 Hz), 2.84 (t, 2H, J = 7.8 Hz), 2.55 (t, 2H, J = 7.9 Hz), 1.50 (s, 9H). 13C-NMR 
(DMSO-d6): δ 174.5, 153.5, 138.2, 135.0, 129.0, 118.8, 79.5, 36.1, 30.4, 28.8. 
HR-EIMS m/z calculated for C14H19NO4Na: 288.1212, found: 288.1225. 
 
 
[4-(3-Hydroxy-propyl)-phenyl]-carbamic acid tert-butyl ester (19). Compound 
18 (500 mg, 1.88 mmol) was dissolved in THF (19 mL) and cooled to 0°C. A 1 M 
solution of BH3·THF (19 mL) was added to the reaction dropwise over 35 
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minutes, resulting in the pale yellow solution becoming clear and colorless. The 
reaction was then brought to room temperature and stirred overnight. The 
solution was cooled to 0 °C and excess borane was quenched by the slow 
addition of methanol (10 mL). The solution was concentrated via rotary 
evaporation to give a clear oil which was dissolved in ethyl acetate (200 mL). The 
organic phase was washed with 1 M NaOH (2 X 50 mL), 1 M HCl (100 mL), and 
brine (100 mL) and dried over Na2SO4. The solvent was evaporated under 
vacuum and the crude material was purified by flash column chromatography (0-
50% ethyl acetate/hexanes) to yield the pure product as a viscous, clear, 
colorless oil which becomes a white solid when cooled to 4 °C (473 mg, 
Quantitative). 1H-NMR (CDCl3): δ 7.26 (d, 2H, J = 7.8 Hz), 7.11 (d, 2H, J = 8.4 
Hz), 6.45 (br s, 1H), 3.65 (q, 2H, J = 5.3 Hz), 2.66 (t, 2H, J = 7.4 Hz), 1.89-1.82 
(m, 2H), 1.51 (s, 9H), 1.36 (t, 1H, J = 5.1 Hz). 1H-NMR (CD3OD): δ 7.27 (d, 2H, J 
= 8.3 Hz), 7.09 (d, 2H, J = 8.4 Hz), 3.55 (t, 2H, J = 6.5 Hz), 2.61 (t, 2H, J = 7.4 
Hz), 1.83-1.76 (m, 2H), 1.50 (s, 9H). 13C-NMR (CDCl3): δ 153.1, 136.7, 136.4, 
129.1, 119.0, 80.6, 62.4, 34.5, 31.6, 28.6. HR-EIMS m/z calculated for 
C14H21NO3Na: 274.1419, found: 274.1433. 
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[4-(3-Bromo-propyl)-phenyl]-carbamic acid tert-butyl ester (20). Ethyl 
tribromoacetate2 (0.26 mL, 1.79 mmol) was added to a solution of 19 (451 mg, 
1.79 mmol) and triphenylphosphine (717 mg, 2.69 mmol) in dichloromethane (3.6 
mL) (Tongkate et al., 2008). The reaction was stirred at room temperature and 
monitored by TLC (25% ethyl acetate/hexanes).  After 55 minutes, no trace of 19 
remained and the reaction was quenched with ice water (80 mL) and stirred at 
ambient conditions for 5 minutes. The aqueous phase was extracted with 
dichloromethane (1 X 20 mL, 2 X 30 mL) and the combined organic phases were 
washed with brine (30 mL) and dried over Na2SO4. The solvent was evaporated 
under vacuum and the crude material was purified by flash column 
chromatography (0-10% ethyl acetate/hexanes) to yield the pure product as a 
white, crystalline solid (395 mg, 70%). 1H-NMR (DMSO-d6): δ 9.23 (s, 1H), 7.34 
(d, 2H, J = 8.4 Hz), 7.06 (d, 2H, J = 8.5 Hz), 3.46 (t, 2H, J = 6.6 Hz), 2.61 (t, 2H, J 
= 7.1 Hz), 2.03 (p, 2H, J = 6.4 Hz, 7.2 Hz), 1.44 (s, 9H). 13C-NMR (DMSO-d6): 
δ 153.5, 138.2, 134.7, 129.2, 118.9, 79.5, 35.1, 34.7, 33.4, 28.8. HR-EIMS m/z 
calculated for C14H20BrNO2Na: 336.0575 and 338.0556, found: 336.0535 and 
338.0516.  
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(4-{3-[7-(tert-Butyl-dimethyl-silanyloxy)-3,4-dihydro-2H-quinolin-1-yl]-
propyl}-phenyl)-carbamic acid tert-butyl ester (21). Potassium carbonate (81 
mg, 0.59 mmol) was suspended in a solution of compound 10 (129 mg, 0.49 
mmol) in DMF (2 mL). Compound 20 (200 mg, 0.636 mmol) was added to the 
mixture and the reaction was heated to 70 °C and stirred overnight. The reaction 
was then cooled to room temperature, diluted into water (50 mL), and acidified to 
pH 1 with 1 M HCl. The aqueous phase was extracted with ethyl acetate (1 X 60 
mL, 4 X 20 mL) and the combined organic phases were washed with 0.1 M HCl 
(80 mL), water (80 mL), and brine (80 mL), and dried over Na2SO4. The solvent 
was evaporated under vacuum and the crude material was purified by flash 
column chromatography (0-5% ethyl acetate/hexanes) to yield the pure product 
as an orange oil (136 mg, 56%). 1H-NMR (CDCl3): δ 7.29 (d, 2H, J = 8.2 Hz), 
7.12 (d, 2H, J = 8.5 Hz), 6.76 (d, 1H, J = 7.9 Hz), 6.51 (s, 1H), 6.06 (dd, 1H, J = 
2.3 Hz, 7.9 Hz), 6.03 (d, 1H, J = 2.3 Hz), 3.23-3.2 (m, 4H), 2.67 (t, 2H, J = 6.3 
Hz), 2.62 (t, 2H, J = 7.6 Hz), 1.94-1.85 (m, 4H), 1.53 (s, 9H), 0.99 (s, 9H), 0.19 
(s, 6H). 13C-NMR (CDCl3): δ 155.1. 146.2, 136.7, 136.4, 129.6, 129, 118.9, 
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115.6, 107.1, 102.8, 51.3, 49.4, 33.0, 28.6, 28, 27.7, 26.1, 22.7, 18.5, -4.0. HR-
EIMS: m/z calculated for C29H44N2O3SiNa: 519.3019, found: 519.2989. 
 
 
11-[3-(4-Amino-phenyl)-propyl]-1-ethyl-3,4,8,9,10,11-hexahydro-2H-13-oxa-
6,11-diaza-1-azonia-pentacene chloride (22).Compound 15 (93 mg, 274 µmol) 
and 21 (136 mg, 274 µmol) were dissolved in a 10:1 solution of EtOH/H2O (1.5 
mL/150 µL). Concentrated HCl (105 µL) was added to the solution with stirring 
and the reaction was heated to 80 °C for 2 hours. The reaction was cooled to 
room temperature and the crude dye was isolated via flash chromatography (0-
50% methanol/dichloromethane). The pure product was isolated with a 2nd round 
of flash chromatography (0-10% methanol/dichloromethane) to yield a blue solid 
(29.55 mg, 22%). 1H-NMR (CD3OD): δ 7.36 (s, 1H), 7.32 (s, 1H), 7 (d, 2H, J = 8.3 
Hz), 6.92 (s, 1H), 6.72 (d, 2H, J = 8.3 Hz), 6.37 (s, 1H), 3.74-3.51 (m, 9H), 3.6 (t, 
2H, J = 5.8 Hz), 3.53 (t, 2H, J = 8 Hz), 2.89 (t, 2H, J = 6.3 Hz), 2.84 (t, 2H, J = 6.4 
Hz), 2.61 (t, 2H, J = 7.0 Hz), 2.05-1.94 (m, 7H), 1.35 (t, 3H, J = 7.1 Hz). 13C-NMR 
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(CD3OD): δ 154.2, 154.1, 148.7, 148.4, 146, 134.1, 133.9, 130.5, 130.4, 130.3, 
129.1, 129.0, 128.9, 115.8, 95.0, 94.9, 52.0, 50.7, 50, 47.8, 31.8, 28.2, 27.3, 
27.2, 20.8, 20.7, 10.6. HR-EIMS m/z calculated for C29H33N4O: 453.2654, found: 
453.2647.  
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CHAPTER VI: Discussion 
 Live cell and in vivo fluorescence imaging have led to innumerable and 
unquestioningly vital discoveries in biology. Since the inclusion of the Green 
Fluorescent Protein and its derivatives in basic research, we have been able to 
study protein localization, kinetics, and intracellular interactions in real time 
(Tavaré et al., 2001; Zimmer, 2002). Organic fluorophores like rhodamine and 
fluorescein have also been extensively exploited in the biological field. 
Rhodamine 123 has been utilized in studies of mitochondrial function and ABC 
transporter activity (Johnson et al., 1980; Twentyman et al., 1994). FITC has long 
been used in flow cytometry but has also been employed in the study of the 
extracellular matrix (Hsieh et al., 1980). The list of achievements attributable to 
the use of fluorescence is vast and the work we have presented is by no means 
an attempt to discount even the smallest of contributions. Nevertheless, like most 
advances in science, more can always be done. 
 While fluorescent proteins and organic fluorophores have aided the life 
sciences, most of these molecules absorb and emit visible light (400-650 nm), a 
feature which limits their use for the very purposes in which they are employed. 
Cellular autofluorescence of visible light means low signal to noise ratio for these 
fluorophores during cell imaging (Escobedo et al., 2010; Rao et al., 2007). 
Absorption of visible light by hemoglobin and other biological molecules results in 
limited uses of visible light absorbing fluorophores when imaging live animals 
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(Hilderbrand and Weissleder, 2010; Rao et al., 2007). Fortunately, the solution to 
these problems is simple: NIR light. NIR light (650-900 nm) is optimal for imaging 
live cells and organisms; therefore, NIR fluorophores are the ideal imaging 
reagents (Escobedo et al., 2010; Frangioni, 2003; Guo et al., 2014; Hilderbrand 
and Weissleder, 2010; Shcherbakova and Verkhusha, 2013; Weissleder, 2001). 
 Unfortunately, as discussed in Chapter I, NIR fluorophores themselves are 
not optimal imaging reagents. There are very few NIR absorbing fluorescent 
proteins, and NIR organic fluorophores have inherent flaws (Bunting et al., 1989; 
Cunningham et al., 2010; Johnson, 1998; Keppler et al., 2006; Shcherbakova 
and Verkhusha, 2013). The planarity and high degree of conjugation required for 
absorption of NIR light means that NIR fluorophores are hydrophobic and 
cationic. The hydrophobicity of these compounds often leads to dye aggregation 
in water, which for some of these dyes, in particular the polymethine family of 
NIR dyes, results in fluorescence quenching (Mishra et al., 2000; Mujumdar et 
al., 1993; Peng and Draney, 2004; Zhegalova et al., 2014). Hydrophobic dyes 
also tend to accumulate in hydrophobic environments, such as membranes 
(Cunningham et al., 2010; Johnson, 1998). Furthermore, the cationic nature of 
NIR dyes produces mitochondrial staining due to accumulation in the negatively 
charged mitochondrial membrane (Bunting et al., 1989). Therefore, unless 
mitochondrial and membrane staining are desired, NIR dyes are not the ideal 
choice for imaging within biological environments like the cytoplasm and blood. 
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 To prevent dye aggregation and eliminate the cationic charge on NIR 
dyes, these molecules are often functionalized with highly polar sulfonate groups 
(Li et al., 2008; Morgan et al., 2011; Mujumdar et al., 1993; Niu et al., 2009; 
Panchuk-Voloshina et al., 1999). As discussed in Chapters II and III, sulfonation 
imparts a high level of water-solubility to molecules. However, addition of the 
sulfonate group often affects synthetic tractability. This functionality can limit the 
ease of purification, often necessitating semi-preparative HPLC purification, a 
procedure associated with a decrease in product yields. Furthermore, due to the 
high polarity of the sulfonate group, reactions in non-polar organic solvents can 
be problematic owing to the insolubility of the sulfonate-functionalized compound. 
This problem has been addressed for other functionalities using protecting 
groups (Green and Wuts, 1999). Unfortunately, the palette of sulfonate protecting 
groups is not as vast as for amines, hydroxyls, carbonyls, etc. In particular, 
sulfonate protecting groups tend to be either too difficult to remove or too labile to 
be employed (Miller, 2010).  
 We sought to overcome this problem, particularly since my work 
necessitates the use of sulfonated dyes. In Chapter II, I presented a new 
sulfonate protecting group which has features desirable for synthetic organic 
chemistry. Our TFMT group is easily prepared from commercially available 
materials (two steps from p-Tolualdehyde), readily attached to sulfonates (≥85% 
yields), stable to a variety of synthetic conditions, and importantly, cleanly 
cleaved by trifluoroacetic acid to give the pure sulfonated compound (>98% 
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purity) in high yield (99% yield of dye) without the need for column or HPLC 
purification. AlexaFluor dyes (Molecular Probes, Inc.) are simply the sulfonated 
counterparts of other dyes and tend to be quite costly due to the difficulty 
associated with their production. Through implementation of our TFMT group, 
these same dyes can be produced in any lab without requiring the difficult 
sulfonate purification that may necessitate their purchase. Furthermore, the use 
of TFA as the TFMT-deprotection reagent has implications apart from dye 
chemistry. TFA is commonly employed in the deprotection of acid-labile 
protecting groups, such as Boc (Green and Wuts, 1999). The TFMT sulfonate 
protecting group is thus not only a viable tool for the chemistry of sulfonated dyes 
and other molecules in solution phase chemistry, but could potentially be 
employed in the preparation of sulfonated peptides during Fmoc solid-phase 
peptide synthesis. TFMT could therefore aid in the synthesis of non-natural 
amino acids and peptides and could thus find use in biochemical studies or even 
contribute to the development of novel pharmaceuticals. 
 Although the development of our TFMT sulfonate protecting group was a 
great advance in the preparation of sulfonated dyes, in Chapters III and IV we 
discussed the impediments brought about by sulfonation with regard to live cell 
imaging. In particular, although sulfonation imparts water-solubility, it also 
prevents the dye from diffusing through cells. As this defeats the purpose of 
developing water-soluble NIR imaging reagents, we set our sights on rapidly 
overcoming this hurdle.  
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 In Chapter III, I described the synthesis and in vitro evaluation of NIR 
oxazine dyes functionalized with AcOTFMB-sulfonate esters. AcOTFMB was 
developed in our lab as an esterase-labile sulfonate protecting group and was 
successfully used to deliver the small fluorophore dansyl sulfonate into live cells 
(Rusha and Miller, 2011). However, the synthesis of the AcOTFMB-
functionalized dansyl sulfonate was simple, requiring only a single step from the 
commercially available dansyl chloride to product. Unfortunately, attempts to 
prepare our oxazine dyes as sulfonyl chlorides directly from the sulfonates failed 
to deliver consistent, significant yields of product, a problem which will be 
discussed shortly. This meant that the AcOTFMB group would have to be 
prepared as a sulfonate ester, attached to dye precursor, and undergo the 
relatively harsh conditions of dye formation. Fortunately, no major difficulties 
arose during the preparation of our dyes and we successfully developed both 
mono-sulfonate and bis-sulfonate AcOTFMB ester-functionalized NIR oxazine 
dyes. Our AcOTFMB sulfonate ester NIR oxazines are chemically stable but are 
rapidly converted to the hydrophilic, free sulfonates upon treatment with pig liver 
esterase in vitro. This confirms that AcOTFMB can be utilized in NIR dyes and, 
like its dansyl sulfonate counterpart, will aid in the delivery of sulfonated NIR 
fluorophores; a result that was decisively confirmed by our work discussed in 
Chapter IV. 
 We are highly encouraged by the ability to apply AcOTFMB to our NIR 
oxazines and have no question that this can be applied to other NIR scaffolds 
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such as BODIPY dyes and the heptamethine indocyanines. Like Tsien’s use of 
carboxylate esters to deliver visible wavelength fluorophores bearing carboxylic 
acids into cells, we believe application of AcOTFMB could expand the 
intracellular use of NIR dyes to levels seen for fluorescein and rhodamine (Minta 
and Tsien, 1989; Minta et al., 1989; Tsien, 1981; Tsien, 1989). However, this 
work is far from complete. As alluded to above, the ideal synthetic route would be 
to prepare the dye itself as a sulfonyl chloride and then directly attach the 
ACOTFMB group to the dye. This would prevent any loss of the AcOTFMB-
sulfonate ester during dye synthesis. In particular, while we found that this group 
could survive reaction in hot acetic acid or refluxing ethanol and hydrochloric 
acid, the synthesis of rhodamines usually requires refluxing acetic acid, a 
relatively harsh condition which could result in ester deprotection. We explored 
several routes for developing activated sulfonates including sulfonyl chlorides 
(phosphorous oxychloride, phosphorous pentachloride, thionyl chloride) and 
fluorides (DAST), but none were greatly promising. By addressing this issue, one 
can imagine an assembly line scenario where NIR sulfonated dyes are easily 
prepared via TFMT-assisted synthesis, activated by chlorination/fluorination, and 
functionalized with AcOTFMB or other biologically relevant functionality to rapidly 
produce the desired imaging reagent in high yield without the cost associated 
with outsourcing. 
 Whereas our work with TFMT and AcOTFMB seeks to aid in the 
development of NIR dyes for live cell and whole animal imaging, we also sought 
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to increase the palette of NIR reagents used during imaging. As discussed in 
Chapters I and V, the majority of NIR imaging is performed with derivatives of 
heptamethine indocyanine dyes (Escobedo et al., 2010; Frangioni, 2003; Rao et 
al., 2007). However, as outlined throughout this work, NIR oxazines are an 
excellent alternative to NIR indocyanine dyes having such favorable 
characteristics as high photostability and decreased hydrophobicity (Anzalone et 
al., 2013; Vogelsang et al., 2009). By applying our AcOTFMB strategy to the 
pentacyclic NIR oxazine scaffold, I developed sulfonated oxazine dyes that could 
be used for live cell and in vivo imaging (Chapter III). 
 In Chapter IV, I showed that, not only can AcOTFMB-sulfonate esters be 
used to deliver sulfonated NIR dyes into live cells, but that NIR oxazine dyes can 
be used to image both live cells and mice. One of our dyes, the bis-sulfonated 
Sulf-Ox2, delivered as AcOTFMB-Ox2, displays truly cytoplasmic fluorescence, 
indicating that Sulf-Ox2 can access the entire cell. Most organic dyes, NIR and 
otherwise, do not have this ability (Cunningham et al., 2010; Thorp-Greenwood 
et al., 2012) which reinforces the advantage of utilizing sulfonated fluorophores. 
This is of particular interest in the field for two reasons: our NIR fluorophore was 
one of the first to display true cytoplasmic fluorescence, and it was derived from 
an oxazine dye. This clearly confirms that, despite the popularity of indocyanine 
dyes for NIR imaging, NIR oxazines are strong candidates for potential imaging 
reagents. Our NIR AcOTFMB-Ox2 dye rapidly diffuses into cells, is quickly 
converted into Sulf-Ox2, and can be exported from cells via drug efflux 
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transporters. With the appropriate protein-labeling functionalization, use of 
AcOTFMB-Ox2 would allow for bright, diffuse intracellular fluorescence with low 
background since unbound dye would be easily cleared from the cell by 
transporter activity. Our attempts at functionalizing our dyes for protein labeling 
were unsuccessful, but work on this front should be continued. The ability to 
fluorescently label both nuclear and cytoplasmic proteins with NIR fluorophores 
would be an essential tool when studying protein function and localization in cells 
and animals. 
  Achieving diffuse, NIR intracellular fluorescence from live cells was a 
hallmark of our work and our imaging results in live mice, while preliminary, were 
very promising. However, we wanted to demonstrate that NIR oxazines were a 
multi-purpose reagent, and in Chapter V, I describe the synthesis and in vitro 
characterization of nitric oxide and pH sensors derived from the pentacyclic 
oxazine scaffold. Our NIR oxazine-derived nitric oxide and pH sensors rapidly 
report on their target via an increase in fluorescence intensity. While the off/on 
signal change is not as extreme as that observed for similar visible wavelength 
fluorescent sensors, the higher signal to noise ratio achievable by NIR dyes 
when used in live cells and organisms may favor the use of our molecules. More 
importantly, we have shown that NIR oxazines can indeed function as sensors of 
biologically relevant environmental conditions. Whereas BODIPYs, indocyanines, 
oxazines, and silicon-rhodamines have been employed for NIR imaging, small 
molecule NIR sensors, with a few exceptions, are primarily heptamethine 
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indocyanine derivatives (Han et al., 2013; Han et al., 2013; Karton-Lifshin et al., 
2011; Li et al., 2011; Sasaki et al., 2005). Our work indicates that this limitation is 
unwarranted.  
 While we are excited about the ability of our NIR oxazines to function as 
fluorescent sensors, the results from my work would benefit from optimization. 
We obtained a maximum 12-fold increase in fluorescence intensity between the 
off/on states of our sensors. The quantum yield of the visible wavelength 
diaminofluorescein nitric oxide sensor developed in the Nagano lab was reported 
to increase by 100 times upon reaction with nitric oxide (Kojima et al., 1998). To 
improve the sensitivity of our sensors for use in live cells, we should likewise 
focus on maximizing the difference in off/on fluorescence intensity. The key 
optimization will be modulation of the quenched form of our dyes. Organic 
fluorophores utilized as sensors often employ PET as the mechanism of 
modulating fluorescence (Kobayashi et al., 2010; Ni and Wu, 2014; Song et al., 
2005). Work by Sauer has shown that the fluorescence of NIR oxazines is well 
modulated by PET and this finding held in our work (Doose et al., 2009; Marmé 
et al., 2003; Valana et al., 2003). Yet, the fact that we still obtained a measurable 
amount of fluorescence with our quenched molecules indicates that the PET 
donor we employed was less than ideal. By focusing efforts on increasing the 
electron donating ability of our PET quencher, potentially via addition of another 
electron-rich functionality, the off-state fluorescence output of our dye could be 
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minimized which would result in a net increase in on-state fluorescence worthy of 
a commercial, biological sensor.  
 Overall, this work aimed to increase the palette of NIR imaging reagents 
for use in live cells and animals. This was achieved specifically for oxazine dyes 
by showing they had the same potential uses as the more commonly employed 
NIR BODIPYs and indocyanines. NIR oxazines are fairly underrepresented as 
sensors and intracellular fluorophores, but they need not be. Our NIR oxazines 
can sense small molecules, sense environmental changes, label mitochondria, 
illuminate the cytoplasm, and even fluoresce within living animals. More generally 
though, we sought to increase the utility of all NIR dyes. Due to their 
hydrophobicity, the use of NIR fluorophores in live cells is often limited, and the 
sulfonation, which neutralizes this problem, hinders their intracellular delivery. 
However, we shall overcome. Sulfonated NIR dyes can be successfully delivered 
into cells, and these molecules can be employed for any level of imaging which 
has been the purview of visible light emitting fluorophores. We can achieve 
biological imaging that is unimpeded by background and unattenuated by off-
target light absorption. The key, as always, is chemistry. 
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APPENDIX 1 
Multimedia Legend 
Movies 4.1-4.8: Real-time monitoring of AcOTFMB-Ox1 and 2 and TFMB-Ox 
1 and 2 diffusion into U2-OS cells. Cells were pretreated with OPTI-MEM 1 
and monitored via spinning disc confocal microscopy as described (see Chapter 
IV Methods). After a brief interval, dye was added and the cells were again 
monitored via spinning disc confocal microscopy. AcOTFMB-Ox1 (4.1 and 4.2): 
Cells imaged 3 minutes before dye addition, 33 minutes after dye addition. 
TFMB-Ox1 (4.3 and 4.4): Cells imaged 3 minutes before dye addition, 33 
minutes after dye addition. AcOTFMB-Ox2 (4.5 and 4.6): Cells imaged 5 minutes 
before dye addition, 31 minutes after dye addition. TFMB-Ox2 (4.7 and 4.8): 
Cells imaged 2 minutes before dye addition, 34 minutes after dye addition. Cell 
movies were prepared using the Universal Imaging Metamorph software and 
show both DIC and NIR imaging with playback at 1.5 frames/second. 
Note: Movies available on the electronic copy of this thesis or by contacting Dr. 
Stephen Miller at the University of Massachusetts Medical School. 
 
 
  
